https://hospitalpharmacyeurope.com/clinical-zones/oncology/european-approval-of-sc-atezolizumab-offers-quicker-and-more-flexible-cancer-treatment/ 2024-01-18T15:06:31+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2024/01/European_approval_of_SC_atezolizumab_offers_quicker_and_more_flexible_cancer_treatment.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/prostate-cancer-mortality-rate-similar-on-follow-up-in-trial-of-three-treatment-interventions/ 2024-01-24T11:14:46+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/03/Prostate-cancer-mortality-rate-similar-on-follow-up-in-trial-of-three-treatment-interventions.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/metastatic-hormone-sensitive-prostate-cancer-survival-improved-with-darolutamide/ 2024-01-24T11:16:30+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/02/Metastatic-hormone-sensitive-prostate-cancer-survival-improved-with-darolutamide.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/novel-prostate-cancer-screening-test-found-to-be-highly-accurate/ 2024-01-24T11:18:46+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/02/Novel-prostate-cancer-screening-test-found-to-be-highly-accurate.jpg https://hospitalpharmacyeurope.com/clinical-zones/haematology/curative-exa-cel-gene-therapy-approved-in-europe-for-severe-sickle-cell-disease/ 2024-02-14T12:02:38+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2024/02/Curative_exa-cel_gene_therapy_approved_in_Europe_for_severe_sickle_cell_disease.jpg https://hospitalpharmacyeurope.com/news/five-new-council-members-appointed-by-the-gphc-for-2024-and-2025/ 2024-02-15T11:25:05+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2024/02/Five_new_council_members_appointed_by_the_GPhC_for_2024_and_2025.jpg https://hospitalpharmacyeurope.com/clinical-zones/addressing-the-gender-pain-gap-subject-of-new-review-by-fip/ 2024-02-16T20:45:52+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2024/02/Addressing_the_gender_pain_gap_subject_of_new_review_by_FIP.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/tislelizumab-receives-positive-chmp-opinion-for-three-nsclc-indications/ 2024-02-29T16:13:32+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2024/02/Tislelizumab_receives_positive_CHMP_opinion_for_non-small_cell_lung_cancer.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/olive-oil-derived-drug-shows-early-promise-for-patients-with-glioblastoma/ 2024-03-01T09:56:32+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2024/02/Olive_oil-derived_drug_shows_early_promise_for_patients_with_glioblastoma.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/no-clinical-benefit-for-nivolumab-plus-ipilimumab-over-nivolumab-in-recurrent-metastatic-head-neck-scc/ 2024-03-07T14:44:25+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/04/No-clinical-benefit-for-nivolumab-plus-ipilimumab-over-nivolumab-in-recurrent-metastatic-head-neck-SCC.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/aspirin-use-benefits-curtailed-by-statins-in-those-without-atherosclerotic-disease/ 2024-03-07T15:05:28+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/02/Aspirin-use-benefits-curtailed-by-statins-in-those-without-atherosclerotic-disease.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/uk-analysis-reveals-significant-increase-in-hospital-admissions-for-copd-and-asthma/ 2024-03-07T15:24:49+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/02/UK-analysis-reveals-significant-increase-in-hospital-admissions-for-COPD-and-asthma.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/simple-treatment-strategies-could-reduce-high-risk-of-myocardial-infarction-in-kidney-failure/ 2024-03-12T15:28:50+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2024/03/Simple_treatment_strategies_could_reduce_high_risk_of_myocardial_infarction_in_kidney_failure.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/positive-chmp-opinion-for-cilta-cel-as-second-line-r-r-multiple-myeloma-treatment/ 2024-03-13T11:42:26+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2024/03/Positive_CHMP_opinion_for_cilta-cel_as_second-line_R_R_multiple_myeloma_treatment.jpg https://hospitalpharmacyeurope.com/clinical-zones/aztreonam-avibactam-receives-positive-chmp-opinion-for-multidrug-resistant-infections/ 2024-03-26T12:43:09+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2024/03/Aztreonam-avibactam_receives_positive_CHMP_opinion_for_multidrug-resistant_infections.jpg https://hospitalpharmacyeurope.com/clinical-zones/mental-health/aripiprazole-once-every-two-months-long-acting-injectable-gains-eu-approval-for-schizophrenia/ 2024-04-02T11:01:28+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2024/04/Aripiprazole_once-every-two-months_long-acting_injectable_gains_EU_approval_for_schizophrenia.jpg https://hospitalpharmacyeurope.com/clinical-zones/neurology/cladribine-indication-expanded-by-mhra-to-include-active-relapsing-ms/ 2024-04-04T16:59:19+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2024/04/Cladribine_indication_expanded_by_MHRA_to_include_active_relapsing_MS.jpg https://hospitalpharmacyeurope.com/clinical-zones/neurology/atogepant-recommended-by-nice-as-first-oral-drug-for-chronic-and-episodic-migraine-prophylaxis/ 2024-04-12T10:37:46+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2024/04/Atogepant_recommended_by_NICE_as_first_oral_drug_for_chronic_and_episodic_migraine_prophylaxis.jpg https://hospitalpharmacyeurope.com/clinical-zones/neurology/some-progestogen-medicines-associated-with-increased-risk-of-meningioma-say-researchers/ 2024-04-15T15:27:07+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2024/04/Some_progestogen_medicines_associated_with_increased_risk_of_meningioma_say_researchers.jpg https://hospitalpharmacyeurope.com/clinical-zones/haematology/tisagenlecleucel-recommended-for-routine-nhs-rollout-to-treat-relapsed-or-refractory-b-cell-all/ 2024-04-16T08:15:22+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2024/04/Tisagenlecleucel_recommended_for_routine_NHS_rollout_to_treat_R_R_B-cell_ALL.jpg https://hospitalpharmacyeurope.com/clinical-zones/haematology/cilta-cel-approved-by-ec-as-second-line-r-r-multiple-myeloma-treatment/ 2024-04-23T12:20:30+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2024/04/Cilta-cel_approved_by_EC_as_second-line_R_R_multiple_myeloma_treatment.jpg https://hospitalpharmacyeurope.com/clinical-zones/haematology/management-of-haemophilia-a-and-b/ 2024-05-01T15:08:14+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2015/08/haematology-1.jpg https://hospitalpharmacyeurope.com/clinical-zones/haematology/switching-to-extended-half-life-prophylaxis-impacts-clinical-outcomes-in-haemophilia-a-or-b/ 2024-05-01T15:17:58+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/07/Switching-to-extended-half-life-prophylaxis-impacts-clinical-outcomes-in-haemophilia-A-or-B.jpg https://hospitalpharmacyeurope.com/clinical-zones/haematology/emicizumab-approved-in-ec-for-haemophilia-a-with-inhibitors/ 2024-05-01T15:21:49+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/06/haematology-2.jpg https://hospitalpharmacyeurope.com/clinical-zones/haematology/personalised-prophylaxis-in-haemophilia-a/ 2024-05-01T15:29:19+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/12/haematology-3.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/lipid-lowering-therapy-benefits-ethnic-patients-despite-under-representation-in-trials/ 2024-05-01T16:40:12+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/02/Lipid-lowering-therapy-benefits-ethnic-patients-despite-under-representation-in-trials.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/women-less-likely-than-men-to-be-prescribed-cholesterol-lowering-drugs-despite-identical-guidelines/ 2024-05-01T17:01:39+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2024/05/Women_less_likely_than_men_to_be_prescribed_cholesterol-lowering_drugs_despite_identical_guidelines2.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/kaftrio-approval-extended-by-ema-for-cystic-fibrosis-from-6-years-of-age/ 2024-05-04T18:02:45+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/01/GettyImages-1082582778.jpg-cystic-fibrosis-in-child.jpg https://hospitalpharmacyeurope.com/clinical-zones/neurology/statin-use-reduces-risk-of-strokes-in-atrial-fibrillation/ 2024-05-04T18:07:58+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/04/Statin-use-reduces-risk-of-strokes-in-atrial-fibrillation.jpg https://hospitalpharmacyeurope.com/clinical-zones/medicines-safety/finasteride-patient-alert-card-to-be-introduced-after-drug-safety-review/ 2024-05-08T08:56:20+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2024/05/Finasteride_patient_alert_card_to_be_introduced_after_drug_safety_review.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/5-alpha-reductase-inhibitor-use-does-not-increase-prostate-cancer-mortality/ 2024-05-08T11:22:55+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/04/5-alpha-reductase-inhibitor-use-does-not-increase-prostate-cancer-mortality.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/prenatal-leukotriene-receptor-antagonist-use-does-not-increase-neuropsychiatric-events-in-offspring/ 2024-05-08T11:25:47+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/03/Prenatal-leukotriene-receptor-antagonist-use-does-not-increase-neuropsychiatric-events-in-offspring.jpg https://hospitalpharmacyeurope.com/news/king-charles-iii-announced-as-new-patron-of-the-rps/ 2024-05-15T09:28:26+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2024/05/King_Charles_III_announced_as_new_patron_of_the_RPS.jpg https://hospitalpharmacyeurope.com/clinical-zones/haematology/pegcetacoplan-indication-extended-to-first-line-for-adults-with-pnh-in-europe/ 2024-05-15T15:45:07+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2024/05/Pegcetacoplan_indication_extended_to_first-line_for_adults_with_PNH_in_Europe.jpg https://hospitalpharmacyeurope.com/news/editors-pick/dependency-risks-with-tramadol/ 2024-05-16T13:56:30+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2018/06/mental-health-965x500-copy.jpg https://hospitalpharmacyeurope.com/news/pain-management/pain-medicine-use-doubles-in-usa/ 2024-05-16T13:57:22+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2015/07/Pain-management-1.jpg https://hospitalpharmacyeurope.com/news/editors-pick/pharmacists-slammed-over-methadone-restriction/ 2024-05-16T13:58:03+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2015/10/Mental-health-1.jpg https://hospitalpharmacyeurope.com/news/editors-pick/pharmacists-urged-to-resume-methadone-handouts/ 2024-05-16T13:59:04+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2015/10/Mental-health-1.jpg https://hospitalpharmacyeurope.com/news/editors-pick/call-to-suspend-carisoprodol-in-eu/ 2024-05-16T13:59:19+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2015/07/Pain-management-1.jpg https://hospitalpharmacyeurope.com/news/pain-management/pain-and-substance-misuse-improving-patient-care/ 2024-05-16T14:03:06+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2015/07/Pain-management-1.jpg https://hospitalpharmacyeurope.com/news/editors-pick/lundbeck-initiates-phase-iii-trial-with-nalmefene/ 2024-05-16T14:05:24+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2015/08/Antimicrobial-resistance-5.jpg https://hospitalpharmacyeurope.com/news/editors-pick/cancer-drugs-could-tackle-alcoholism/ 2024-05-16T14:05:56+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2015/10/Mental-health-1.jpg https://hospitalpharmacyeurope.com/news/editors-pick/vaccine-may-stop-cocaine-addiction/ 2024-05-16T14:06:10+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/05/GettyImages-1126063131.jpg https://hospitalpharmacyeurope.com/news/editors-pick/prescribe-heroin-to-addicts-nurse/ 2024-05-16T14:09:55+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2015/10/Mental-health-1.jpg https://hospitalpharmacyeurope.com/news/editors-pick/parkinsons-drugs-addiction-risk/ 2024-05-16T14:10:22+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/07/Neurology-4.jpg https://hospitalpharmacyeurope.com/news/editors-pick/parkinsons-drug-addiction-claim/ 2024-05-16T14:10:47+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/07/Neurology-4.jpg https://hospitalpharmacyeurope.com/news/editors-pick/addiction-drugs-aid-weight-loss/ 2024-05-16T14:11:03+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/08/gastroenterology-965x500.jpg https://hospitalpharmacyeurope.com/news/editors-pick/most-quitters-helped-by-nrt-poll/ 2024-05-16T14:13:02+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2015/10/Mental-health-1.jpg https://hospitalpharmacyeurope.com/news/editors-pick/plant-could-treat-cocaine-addiction/ 2024-05-16T14:13:22+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2015/10/Mental-health-1.jpg https://hospitalpharmacyeurope.com/news/editors-pick/sleeping-pills-raise-death-risk/ 2024-05-16T14:13:51+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/07/Neurology-4.jpg https://hospitalpharmacyeurope.com/news/editors-pick/treating-alcohol-dependence/ 2024-05-16T14:14:30+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2015/10/Mental-health-1.jpg https://hospitalpharmacyeurope.com/news/editors-pick/nalmefene-completes-clinical-phase-iii-programme/ 2024-05-16T14:15:02+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2015/10/Mental-health-1.jpg https://hospitalpharmacyeurope.com/in-depth/views/opinion-comment/lundbeck-receives-positive-opinion-for-approval-of-selincro-in-eu/ 2024-05-16T14:19:10+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2015/10/Mental-health-1.jpg https://hospitalpharmacyeurope.com/news/editors-pick/heroin-vaccine-highly-successful-in-animal-models/ 2024-05-16T14:19:33+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2015/10/Mental-health-1.jpg https://hospitalpharmacyeurope.com/clinical-zones/rheumatology/one-in-three-patients-with-rheumatic-and-msk-conditions-at-risk-from-long-term-opioid-use/ 2024-05-16T14:20:26+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/05/One_in_three_patients_with_rheumatic_and_MSK_conditions_at_risk_from_long_term_opioid_use.jpg https://hospitalpharmacyeurope.com/news/pfizer-rapped-over-drug-overdoses/ 2024-05-16T14:22:19+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2016/01/Safety-1.jpg https://hospitalpharmacyeurope.com/news/study-could-help-overdose-patients/ 2024-05-16T14:22:44+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2002/12/Pain-management-2.jpg https://hospitalpharmacyeurope.com/news/methadone-kills-leukaemia/ 2024-05-16T14:22:55+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2015/08/haematology-1.jpg https://hospitalpharmacyeurope.com/news/patches-pulled-amid-overdose-fears/ 2024-05-16T14:23:01+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2015/07/Pain-management-1.jpg https://hospitalpharmacyeurope.com/news/irish-pm-slams-chemists-over-methadone-refusal/ 2024-05-16T14:23:17+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2015/10/Mental-health-1.jpg https://hospitalpharmacyeurope.com/news/only-one-third-pharma-companies-fmd-compliant-six-months-away-from-implementation-deadline/ 2024-05-16T16:36:24+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/05/Unit-dosing-5.jpg https://hospitalpharmacyeurope.com/news/radiometers-safepico70-syringes-ensure-compliance/ 2024-05-16T16:36:51+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2016/01/Safety-1.jpg https://hospitalpharmacyeurope.com/reviews-research/knowyourdrops-eye-drop-compliance-campaign-to-achieve-medicines-optimisation-in-ophthalmology/ 2024-05-16T16:47:41+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/02/HPE_Peoples_Choice.jpg https://hospitalpharmacyeurope.com/clinical-zones/medicines-safety/the-falsified-medicines-directive/ 2024-05-16T16:54:56+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/06/Safety-2.jpg https://hospitalpharmacyeurope.com/clinical-zones/medicines-safety/eu-fmd-hospital-pharmacy-challenges-and-opportunities/ 2024-05-16T17:01:15+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/11/healthcare-worker-safety-3.jpg https://hospitalpharmacyeurope.com/reviews-research/establishing-a-clinical-pharmacy-department/ 2024-05-16T17:05:08+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2016/11/OTC-3.jpg https://hospitalpharmacyeurope.com/news/ukcpa-introduction-to-pharmaceutical-care-course-taking-place-on-20-21-february-in-manchester/ 2024-05-16T17:05:46+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2015/10/Medicines-reconciliation-3.jpg https://hospitalpharmacyeurope.com/news/fight-against-infections/ 2024-05-16T17:06:22+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2015/08/Antimicrobial-resistance-5.jpg https://hospitalpharmacyeurope.com/clinical-zones/medicines-safety/directive-on-falsified-medicines-approved/ 2024-05-16T17:07:14+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2016/11/Antimicrobial-resistance-3.jpg https://hospitalpharmacyeurope.com/clinical-zones/medicines-safety/efpia-welcome-falsified-medicines-directive/ 2024-05-16T17:07:47+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2016/01/Safety-1.jpg https://hospitalpharmacyeurope.com/news/ecuador-can-ignore-drug-patents/ 2024-05-16T17:09:01+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2016/11/Antimicrobial-resistance-3-1.jpg https://hospitalpharmacyeurope.com/news/glaxo-crack-down-on-drug-promotions/ 2024-05-16T17:09:20+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/06/Safety-2-1.jpg https://hospitalpharmacyeurope.com/news/quick-compliance-with-safety/ 2024-05-16T17:10:18+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2016/01/Safety-1.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/compliance-boosts-statins-efficacy/ 2024-05-16T17:10:47+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2016/11/HPE-statins.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/managing-metastatic-bone-disease/ 2024-05-16T17:12:31+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2018/06/cancer-cell-2-411_0.jpg https://hospitalpharmacyeurope.com/reviews-research/compliance-issues-in-transplant-patients/ 2024-05-16T17:14:16+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2004/01/Organ-transplant.jpg https://hospitalpharmacyeurope.com/news/pharmaceutical-industry-in-push-to-expose-counterfeit-drugs/ 2024-05-16T17:21:21+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/02/Safety-1.jpg https://hospitalpharmacyeurope.com/clinical-zones/paediatrics/guidelines-for-sedation-in-children-and-young-people/ 2024-05-19T16:15:05+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2013/04/Paediatrics-2.jpg https://hospitalpharmacyeurope.com/news/european-commission-authorise-sedative-dexdor/ 2024-05-19T16:18:43+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/01/Respiratory-3.jpg https://hospitalpharmacyeurope.com/clinical-zones/dexmedetomidine-for-light-to-moderate-sedation/ 2024-05-19T16:19:52+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/01/Respiratory-3.jpg https://hospitalpharmacyeurope.com/news/cocaine-free-topical-anaesthetics-may-be-effective/ 2024-05-19T16:21:32+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/01/Respiratory-3.jpg https://hospitalpharmacyeurope.com/news/anaesthesia-associated-mortality-on-the-rise/ 2024-05-19T16:22:31+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/01/Respiratory-3.jpg https://hospitalpharmacyeurope.com/clinical-zones/neurology/anti-drooling-drug-wins-approval/ 2024-05-19T16:23:46+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/07/Neurology-4.jpg https://hospitalpharmacyeurope.com/news/placental-oxytocin-does-not-work/ 2024-05-19T16:24:49+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/01/Respiratory-3.jpg https://hospitalpharmacyeurope.com/news/warning-issued-over-sedative-dosage/ 2024-05-19T16:27:31+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2002/09/Unit-dosing-3.jpg https://hospitalpharmacyeurope.com/news/anaesthetics-found-to-enhance-pain/ 2024-05-19T16:28:19+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/01/Respiratory-3.jpg https://hospitalpharmacyeurope.com/news/dutch-doctors-prefer-deep-sedation-to-euthanasia/ 2024-05-19T16:29:04+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/01/Respiratory-3.jpg https://hospitalpharmacyeurope.com/clinical-zones/gastroenterology/managing-postoperative-nausea-and-vomiting/ 2024-05-19T16:44:27+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2001/09/gastroenterology-965x500.jpg https://hospitalpharmacyeurope.com/news/new-guidance-on-patient-consent-for-anaesthesia/ 2024-05-19T16:52:36+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/01/Respiratory-3.jpg https://hospitalpharmacyeurope.com/news/orion-introduces-new-intensive-care-sedative-dexdor/ 2024-05-19T16:54:14+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/01/Respiratory-3.jpg https://hospitalpharmacyeurope.com/clinical-zones/neurology/positive-chmp-opinion-for-akcea-orphan-drug-inotersen-2/ 2024-05-19T17:00:26+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2002/03/neurology-965x500.jpg https://hospitalpharmacyeurope.com/news/orphan-drug-designation-for-first-in-class-treatment-for-c3-glomerulopathy/ 2024-05-19T17:02:21+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2018/02/Nephrology-2.jpg https://hospitalpharmacyeurope.com/news/letermovir-granted-marketing-authorisation-as-an-orphan-medicinal-product/ 2024-05-19T17:03:42+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2002/12/HPE-single-use-device.jpg https://hospitalpharmacyeurope.com/news/abeona-therapeutics-receives-orphan-drug-designation-in-eu-for-abo-102/ 2024-05-19T17:06:34+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2016/10/Rare-diseases-1.jpg https://hospitalpharmacyeurope.com/clinical-zones/rheumatology/orphan-drug-designation-granted-to-nintedanib-for-treatment-of-systemic-sclerosis/ 2024-05-19T17:09:35+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2016/09/Respiratory-4.jpg https://hospitalpharmacyeurope.com/news/dompes-rhngf-receives-orphan-drug-designation-from-the-ema/ 2024-05-19T17:11:32+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2015/12/Opthamology-2.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/adcetris-is-the-first-ultra-orphan-medicine-recommended-by-awmsg-via-the-new-assessment-process/ 2024-05-19T17:14:13+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2016/08/HPE-chemo.jpg https://hospitalpharmacyeurope.com/news/eculizumab-recommended-for-orphan-drug-status/ 2024-05-19T17:23:01+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2016/09/Nephrology-2.jpg https://hospitalpharmacyeurope.com/news/comp-adopts-applications-for-four-lipodystrophy-drugs/ 2024-05-19T17:23:16+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2016/11/Antimicrobial-resistance-3-1.jpg https://hospitalpharmacyeurope.com/news/orphan-drug-committee-proposes-new-designations/ 2024-05-19T17:25:07+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/03/infectious-disease-965x500.jpg https://hospitalpharmacyeurope.com/news/shire-expands-pipeline-to-treat-orphan-muscle-diseases-through-collaboration-with-acceleron-pharma/ 2024-05-19T17:27:46+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2016/11/Antimicrobial-resistance-3-1.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/orphan-status-for-child-cancer-drug/ 2024-05-19T17:28:33+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/08/Oncology-1.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/pixantrone-designated-orphan-drug/ 2024-05-19T17:30:01+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/08/Oncology-1.jpg https://hospitalpharmacyeurope.com/news/pfizer-licenses-taliglucerase-alfa/ 2024-05-19T17:30:53+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2015/08/Rare-diseases-1.jpg https://hospitalpharmacyeurope.com/news/biovitrum-and-swedish-orphan-will-be-combined-forming-swedish-orphan-biovitrum/ 2024-05-19T17:34:08+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2016/11/Antimicrobial-resistance-3-1.jpg https://hospitalpharmacyeurope.com/news/trial-boosts-first-attr-pn-drug-treatment/ 2024-05-19T17:36:03+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2018/02/Rare-diseases-1-1.jpg https://hospitalpharmacyeurope.com/news/shire-reveals-gbp-276m-bid-for-jerini/ 2024-05-19T17:36:46+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/06/Safety-2-1.jpg https://hospitalpharmacyeurope.com/news/orphan-drug-designation-for-rhitol/ 2024-05-19T17:37:37+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/08/Oncology-1.jpg https://hospitalpharmacyeurope.com/news/study-hope-for-early-ejaculation/ 2024-05-19T17:39:11+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2014/06/HPE-viagra.jpg https://hospitalpharmacyeurope.com/news/fda-approves-orphan-drug-for-inflammatory-syndromes/ 2024-05-19T17:39:53+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2016/11/Antimicrobial-resistance-3-1.jpg https://hospitalpharmacyeurope.com/clinical-zones/rheumatology/new-treatment-for-patients-with-rare-inflammatory-diseases/ 2024-05-24T07:33:35+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/09/Rheumatology-3.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/chmp-gives-positive-opinion-on-enhertu-for-her2-low-breast-cancer-treatment/ 2024-06-06T11:46:10+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/12/CHMP-gives-positive-opinion-on-Enhertu-for-HER2-low-breast-cancer-treatment.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/continuous-chemotherapy-improves-outcomes-and-quality-of-life-in-advanced-breast-cancer/ 2024-06-13T08:58:30+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2016/06/Oncology-breast.jpg https://hospitalpharmacyeurope.com/news/editors-pick/bleach-holds-key-to-immune-system/ 2024-06-28T15:25:15+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2018/01/Infectious-disease-2.jpg https://hospitalpharmacyeurope.com/news/editors-pick/biomerieux-to-gradually-close-site-in-netherlands/ 2024-06-28T15:27:55+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2014/06/HPE-HIV.jpg https://hospitalpharmacyeurope.com/news/medimmune-rejigs-management-team/ 2024-06-28T15:28:43+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/03/infectious-disease-965x500.jpg https://hospitalpharmacyeurope.com/clinical-zones/paediatrics/study-reveals-77-efficacy-for-vaccine-candidate-against-malaria-in-children/ 2024-06-28T16:59:27+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/04/HPE-GettyImages-1197360928.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/expert-view-investigating-de-escalation-strategies-in-ibd/ 2024-06-28T17:04:28+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2016/06/Oncology-4.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/first-in-class-mov18-ige-antibody-shows-potential-as-safe-and-effective-cancer-therapy/ 2024-07-01T14:16:47+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/07/First-in-class_MOv18_IgE_antibody_shows_potential_as_safe_and_effective_cancer_therapy.jpg https://hospitalpharmacyeurope.com/clinical-zones/dermatology/eu-reapproves-cimzia-to-treat-plaque-psoriasis/ 2024-07-01T15:04:52+00:00 https://hospitalpharmacyeurope.com/clinical-zones/mental-health/investigational-combination-xanomeline-trospium-effective-in-schizophrenia/ 2024-07-01T15:09:06+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/03/Investigational-combination-xanomeline-trospium-effective-in-schizophrenia.jpg https://hospitalpharmacyeurope.com/clinical-zones/neurology/zavegepant-nasal-spray-receives-approval-for-acute-migraine/ 2024-07-01T15:09:54+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/03/Zavegepant-nasal-spray-receives-approval-for-acute-migraine.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/oral-pcsk9-inhibitor-mk-0616-significantly-lowers-ldl-cholesterol/ 2024-07-01T15:10:04+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/03/Oral-PCSK9-inhibitor-MK-0616-significantly-lowers-LDL-cholesterol.jpg https://hospitalpharmacyeurope.com/clinical-zones/neurology/fda-approves-omaveloxolone-for-treatment-of-friedreichs-ataxia/ 2024-07-01T15:10:27+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/03/FDA-approves-omaveloxolone-for-treatment-of-Friedreichs-Ataxia.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/dapagliflozin-approved-in-eu-for-heart-failure-across-full-ejection-fraction-spectrum/ 2024-07-01T15:11:32+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/02/Dapagliflozin-approved-in-EU-for-heart-failure-across-full-ejection-fraction-spectrum.jpg https://hospitalpharmacyeurope.com/clinical-zones/haematology/efanesoctocog-alfa-effective-for-haemophilia-a/ 2024-07-01T15:11:41+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/01/Efanesoctocog-alfa-effective-for-haemophilia-A.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/angina-gene-therapy-decreases-episodes-of-chest-pain/ 2024-07-01T15:11:51+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/01/Angina-gene-therapy-decreases-episodes-of-chest-pain-1.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/bexotegrast-significantly-improves-lung-function-in-idiopathic-pulmonary-fibrosis/ 2024-07-01T15:12:02+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/01/Bexotegrast-significantly-improves-lung-function-in-idiopathic-pulmonary-fibrosis.jpg https://hospitalpharmacyeurope.com/clinical-zones/haematology/trial-suggests-fidanacogene-elaparvovec-effective-in-haemophilia-b/ 2024-07-01T15:13:22+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/01/Trial-suggests-fidanacogene-elaparvovec-effective-in-haemophilia-B.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/trastuzumab-deruxtecan-monotherapy-in-advanced-gastric-cancer-recommended-for-eu-approval/ 2024-07-01T15:14:14+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/11/Trastuzumab-deruxtecan-monotherapy-in-advanced-gastric-cancer-recommended-for-EU-approval-1.gif https://hospitalpharmacyeurope.com/clinical-zones/oncology/cancer-research-uk-tests-first-of-its-kind-vaccine-to-treat-lung-cancer-2/ 2024-07-01T15:32:36+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2018/06/cancer-cell-2-411_0.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/development-of-type-2-diabetes-reduced-most-by-eating-fish-diet/ 2024-07-01T15:50:24+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/04/Development-of-type-2-diabetes-reduced-most-by-eating-fish-diet.jpg https://hospitalpharmacyeurope.com/clinical-zones/mental-health/common-cardiovascular-and-diabetes-drugs-could-help-tackle-mental-health-issues-study-finds/ 2024-07-01T15:57:27+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2015/10/Mental-health-1.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/insulin-degludec-liraglutide-reduces-cardiovascular-risk-factors-in-people-with-type-2-diabetes/ 2024-07-01T15:58:13+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/09/Diabetes-2.jpg https://hospitalpharmacyeurope.com/clinical-zones/new-fit-diabetes-injection-golden-rules/ 2024-07-01T16:08:04+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/05/Diabetes-2.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/victoza-provides-significantly-greater-blood-sugar-reduction-than-lixisenatide-in-new-clinical-trial/ 2024-07-01T16:10:28+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2016/11/Diabetes-2.jpg https://hospitalpharmacyeurope.com/news/specialise-in-diabetes-urges-national-pharmacist-leader/ 2024-07-01T16:11:09+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2016/11/Diabetes-2.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/new-data-confirm-tresiba-u200-delivers-significantly-lower-rates-of-confirmed-hypoglycaemia/ 2024-07-01T16:12:10+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2016/11/Diabetes-2.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/new-xultophy-data-show-improvements-in-some-patient-reported-outcomes-versus-glargine/ 2024-07-01T16:12:53+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2016/11/Diabetes-2.jpg https://hospitalpharmacyeurope.com/clinical-zones/paediatrics/levemir-receives-positive-chmp-opinion-for-extended-use-in-children-as-young-as-one-year-old/ 2024-07-01T16:14:06+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2016/11/Diabetes-2.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/new-treatment-can-help-adults-with-type-ii-diabetes-achieve-better-glycaemic-control/ 2024-07-01T16:15:06+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/09/Diabetes-2.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/t2d-patients-reporting-better-communication-by-their-physician-show-improved-self-care/ 2024-07-01T16:17:19+00:00 https://hospitalpharmacyeurope.com/clinical-zones/respiratory/dupilumab-gains-world-first-approval-for-targeting-uncontrolled-copd/ 2024-07-04T13:58:20+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2024/07/Dupilumab_sees_world_first_approval_for_targeting_uncontrolled_COPD.jpg https://hospitalpharmacyeurope.com/clinical-zones/immunology/no-link-between-mmr-vaccine-and-autism-according-to-large-scale-danish-study/ 2024-07-11T10:35:39+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2018/01/HPE-single-use-device.jpg https://hospitalpharmacyeurope.com/clinical-zones/immunology/how-can-european-countries-improve-vaccination-in-the-wake-of-the-measles-outbreak/ 2024-07-11T10:39:08+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2002/09/HPE-european-community.jpg https://hospitalpharmacyeurope.com/clinical-zones/paediatrics/risk-of-allergic-disease-not-increased-by-childhood-vaccination/ 2024-07-11T10:52:35+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/07/HPE-GettyImages-1178544866-childhood-vaccination.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/jcvi-backs-rsv-routine-vaccination-for-babies-and-older-adults-in-the-uk/ 2024-07-11T16:13:31+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/06/JCVI_backs_RSV_routine_vaccination_for_babies_and_older_adults_in_the_UK.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/maternal-vaccination-shows-high-efficacy-severe-rsv-in-newborns/ 2024-07-11T16:14:09+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/04/Maternal-vaccination-shows-high-efficacy-severe-RSV-in-newborns.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/mrna-1345-effective-against-rsv-associated-lower-respiratory-tract-infections-in-older-adults/ 2024-07-11T16:17:46+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/01/mRNA-1345-effective-against-RSV-associated-lower-respiratory-tract-infections-in-older-adults.jpg https://hospitalpharmacyeurope.com/clinical-zones/mental-health/fentanyl-vaccine-shows-potential-as-opioid-use-disorder-treatment/ 2024-07-11T16:18:25+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/11/Fentanyl-vaccine-shows-potential-for-opioid-use-disorder-treatment.gif https://hospitalpharmacyeurope.com/reviews-research/the-challenges-of-influenza-vaccine-hesitancy-in-hospital-pharmacy-staff/ 2024-07-11T16:31:35+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/11/GettyImages_1308070311_965X500PX.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/cancer-research-uk-lifearc-and-ono-pharma-form-cancer-therapy-alliance/ 2024-07-11T16:45:42+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/08/Oncology-1.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/researchers-show-combination-therapy-can-enhance-ipilimumab-immunotherapy/ 2024-07-11T16:46:15+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/07/Oncology-1.jpg https://hospitalpharmacyeurope.com/clinical-zones/immunology/immune-cells-discovery-could-help-transform-vaccine-development/ 2024-07-11T16:47:22+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/06/Oncology-1.jpg https://hospitalpharmacyeurope.com/clinical-zones/immunology/patient-immune-response-could-potentially-prevent-heart-failure/ 2024-07-11T16:48:59+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2018/05/Heart-attack-4.jpg https://hospitalpharmacyeurope.com/clinical-zones/paediatrics/peanut-oral-immunotherapy-leads-to-greater-desensitisation-and-remission-in-children/ 2024-07-11T17:03:22+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/01/Peanut-oral-immunotherapy-leads-to-greater-desensitisation-and-remission-in-children.jpg https://hospitalpharmacyeurope.com/clinical-zones/paediatrics/new-drug-could-reduce-risk-of-allergic-reaction-to-peanuts-in-children-and-adolescents/ 2024-07-11T17:07:00+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2013/04/Paediatrics-2.jpg https://hospitalpharmacyeurope.com/clinical-zones/paediatrics/new-epipen-junior-validation-process-mandated-following-critical-shortages-in-uk/ 2024-07-11T17:07:16+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2018/01/HPE-single-use-device.jpg https://hospitalpharmacyeurope.com/clinical-zones/immunology/bbos-may-relieve-allergic-ocular-itching/ 2024-07-11T17:08:17+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2015/12/Opthamology-2.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/treating-allergic-rhinitis-in-secondary-care-2/ 2024-07-11T17:09:12+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2016/09/Respiratory-4.jpg https://hospitalpharmacyeurope.com/clinical-zones/immunology/nonlatex-glove-solutions-combat-allergy-risks-associated-with-natural-rubber-latex-3/ 2024-07-11T17:09:27+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2016/01/Safety-1.jpg https://hospitalpharmacyeurope.com/clinical-zones/immunology/asian-gene-linked-to-drug-allergy/ 2024-07-11T17:09:59+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/07/Neurology-4.jpg https://hospitalpharmacyeurope.com/clinical-zones/immunology/intranasal-epinephrine-offers-comparable-outcomes-to-im-auto-injector/ 2024-07-11T17:10:31+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/02/Intranasal-epinephrine-offers-comparable-outcomes-to-IM-auto-injector.jpg https://hospitalpharmacyeurope.com/clinical-zones/immunology/oral-penicillin-challenge-deemed-safe-and-effective-in-low-risk-allergy-patients/ 2024-07-11T17:10:44+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/07/Oral_penicillin_challenge_deemed_safe_and_effective_in_low-risk_allergy_patients.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/slit-liquid-significantly-reduces-asthma-onset-or-worsening-in-allergic-rhinitis-study-finds/ 2024-07-12T11:10:15+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2024/05/SLIT-liquid_significantly_reduces_asthma_onset_or_worsening_in_allergic_rhinitis_study_finds.jpg https://hospitalpharmacyeurope.com/clinical-zones/gastroenterology/etrasimod-receives-green-light-from-mhra-and-nice-for-ulcerative-colitis/ 2024-07-12T11:12:05+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2024/03/Etrasimod_receives_green_light_from_MHRA_and_NICE_for_ulcerative_colitis.jpg https://hospitalpharmacyeurope.com/clinical-zones/dermatology/secukinumab-recommended-by-nice-for-hidradenitis-suppurativa/ 2024-07-12T11:12:22+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/10/Secukinumab_recommended_by_NICE_for_hidradenitis_suppurativa.jpg https://hospitalpharmacyeurope.com/clinical-zones/medicines-safety/include-penicillin-allergy-history-in-medicines-reconciliation-to-ensure-accurate-status-says-rps/ 2024-07-12T11:13:05+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/10/Include_penicillin_allergy_history_in_medicines_reconciliation_to_ensure_accurate_status.jpg https://hospitalpharmacyeurope.com/clinical-zones/rheumatology/bimekizumab-approved-by-mhra-for-psoriatic-arthritis-and-axial-spondyloarthritis/ 2024-07-12T11:33:35+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/08/Bimekizumab_approved_by_MHRA_for_psoriatic_arthritis_and_axial_spondyloarthritis.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/nice-consults-on-virtual-wards-for-acute-respiratory-infection/ 2024-07-12T11:34:41+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/08/NICE-consults-on-virtual-wards-for-acute-respiratory-infection.jpg https://hospitalpharmacyeurope.com/clinical-zones/dermatology/eblasakimab-hailed-as-first-biologic-treatment-effective-as-monthly-dose-in-atopic-dermatitis/ 2024-07-12T11:36:26+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/07/Eblasakimab_hailed_as_first_biologic_treatment_effective_as_monthly_dose_in_atopic_dermatitis.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/repeated-and-varied-use-of-antibiotics-linked-to-severe-covid-19-side-effects/ 2024-07-12T11:37:28+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/07/Repeated_and_varied_use_of_antibiotics_linked_to_severe_Covid-19_side_effects.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/study-finds-high-dose-influenza-vaccine-candidate-safe-and-effective/ 2024-07-12T11:38:26+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/07/Study_finds_high-dose_influenza_vaccine_candidate_safe_and_effective.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/dexpramipexole-found-to-significantly-lower-absolute-eosinophil-count-in-asthma/ 2024-07-12T11:38:51+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/08/Dexpramipexole-significantly-lowers-eosinophil-count-in-asthmatics.jpg https://hospitalpharmacyeurope.com/clinical-zones/dermatology/remibrutinib-provides-clinically-meaningful-improvement-in-chronic-spontaneous-urticaria/ 2024-07-12T11:39:13+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/08/Remibrutinib-provides-clinically-meaningful-improvement-in-chronic-urticaria.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/benefits-of-ensitrelvir-in-covid-19-and-long-covid-highlighted-in-two-studies/ 2024-07-12T11:39:55+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/09/Benefits_of_ensitrelvir_in_Covid-19_and_long_Covid_highlighted_in_two_studies.jpg https://hospitalpharmacyeurope.com/clinical-zones/gastroenterology/risankizumab-shows-efficacy-when-head-to-head-with-ustekinumab-in-crohns-disease/ 2024-07-12T11:40:11+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/09/Risankizumab_shows_efficacy_when_head_to_head_with_ustekinumab_in_Crohn%E2%80%98s_disease.jpg https://hospitalpharmacyeurope.com/clinical-zones/dermatology/amlitelimab-use-in-moderate-to-severe-atopic-dermatitis-improves-disease-severity/ 2024-07-12T11:40:41+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/07/Amlitelimab_use_in_moderate_to_severe_atopic_dermatitis_improves_disease_severity.jpg https://hospitalpharmacyeurope.com/clinical-zones/dermatology/higher-adalimumab-dose-more-effective-for-obese-patients-with-hidradenitis-suppurativa/ 2024-07-12T11:41:02+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/06/Higher-adalimumab-dose-more-effective-for-obese-patients-with-hidradenitis-suppurativa.jpg https://hospitalpharmacyeurope.com/clinical-zones/dermatology/biologics-safe-for-pregnant-women-with-psoriasis-review-suggests/ 2024-07-12T11:42:02+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/06/Biologics_safe_for_pregnant_women_with_psoriasis_review_suggests.jpg https://hospitalpharmacyeurope.com/clinical-zones/immunology/oseltamivir-does-not-reduce-risk-of-hospitalisation-for-influenza-review-suggests/ 2024-07-12T11:42:36+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/06/Oseltamivir_does_not_reduce_risk_of_hospitalisation_for_influenza_review_suggests.jpg https://hospitalpharmacyeurope.com/clinical-zones/immunology/mri-scanning-reveals-benefit-of-apremilast-in-psoriatic-arthritis/ 2024-07-12T11:42:52+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/06/MRI_scanning_reveals_benefit_of_apremilast_in_psoriatic_arthritis.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/analysis-finds-increased-malignancy-risk-with-jak-inhibitors-compared-tnf-inhibitors/ 2024-07-12T11:43:49+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/04/Analysis-finds-increased-malignancy-risk-with-JAK-inhibitors-compared-TNF-inhibitors.jpg https://hospitalpharmacyeurope.com/clinical-zones/gastroenterology/faecal-transplantation-increases-clinical-remission-rate-in-ulcerative-colitis/ 2024-07-12T11:45:32+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/04/Faecal-transplantation-increases-clinical-remission-rate-in-ulcerative-colitis.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/rsv-infection-during-infancy-leads-to-higher-childhood-asthma-risk/ 2024-07-12T11:45:58+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/04/RSV-infection-during-infancy-leads-to-higher-childhood-asthma-risk.jpg https://hospitalpharmacyeurope.com/clinical-zones/gastroenterology/endocan-a-promising-biomarker-for-assessing-disease-extent-in-ulcerative-colitis/ 2024-07-12T11:46:51+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/04/Endocan-a-promising-biomarker-for-assessing-disease-extent-in-ulcerative-colitis.jpg https://hospitalpharmacyeurope.com/clinical-zones/dermatology/bimekizumab-provides-clinical-benefit-in-patients-with-moderate-to-severe-hidradenitis-suppurativa/ 2024-07-12T11:47:00+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/04/Bimekizumab-provides-clinical-benefit-in-patients-with-moderate-to-severe-hidradenitis-suppurativa.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/dupilumab-treatment-provides-greatest-decrease-in-asthma-exacerbations-among-mabs/ 2024-07-12T11:47:14+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/04/Dupilumab-treatment-provides-greatest-decrease-in-asthma-exacerbations-among-mAbs.jpg https://hospitalpharmacyeurope.com/clinical-zones/dermatology/enhanced-compared-to-reactive-treatment-in-atopic-eczema-reduces-hen-egg-allergy/ 2024-07-12T11:47:21+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/04/Enhanced-compared-to-reactive-treatment-in-atopic-eczema-reduces-hen-egg-allergy.jpg https://hospitalpharmacyeurope.com/clinical-zones/dermatology/identical-rcts-find-lebrikizumab-monotherapy-effective-in-moderate-to-severe-atopic-eczema/ 2024-07-12T11:47:34+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/03/Identical-RCTs-find-lebrikizumab-monotherapy-effective-in-moderate-to-severe-atopic-eczema.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/essential-oil-containing-nasal-spray-reduces-allergic-rhinitis-symptoms/ 2024-07-12T11:48:15+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/03/Essential-oil-containing-nasal-spray-reduces-allergic-rhinitis-symptoms.jpg https://hospitalpharmacyeurope.com/clinical-zones/dermatology/dupilumab-treatment-reduces-spontaneous-chronic-urticaria-activity-and-improves-quality-of-life/ 2024-07-12T11:48:51+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/02/Dupilumab-treatment-reduces-spontaneous-chronic-urticaria-activity-and-improves-quality-of-life.jpg https://hospitalpharmacyeurope.com/clinical-zones/dermatology/uvb-phototherapy-for-atopic-eczema-does-not-increase-skin-cancer-risk-says-study/ 2024-07-12T11:50:41+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/06/UVB_phototherapy_for_atopic_eczema_does_not_increase_skin_cancer_risk_says_study.jpg https://hospitalpharmacyeurope.com/clinical-zones/rheumatology/bimekizumab-effective-in-both-forms-of-axial-spondyloarthritis/ 2024-07-12T11:51:08+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/02/Bimekizumab-effective-in-both-forms-of-axial-spondyloarthritis.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/phase-2-trial-finds-intra-nasal-inna-051-accelerates-respiratory-virus-clearance/ 2024-07-12T11:51:56+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/02/Phase-2-trial-finds-intra-nasal-INNA-051-accelerates-respiratory-virus-clearance.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/updated-cochrane-finds-no-benefit-from-vitamin-d-on-asthma-control/ 2024-07-12T11:58:23+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/02/Updated-Cochrane-finds-no-benefit-from-vitamin-D-on-asthma-control.jpg https://hospitalpharmacyeurope.com/clinical-zones/gastroenterology/rinvoq-receives-mhra-approval-for-moderate-to-severe-crohns-disease/ 2024-07-12T11:59:18+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/02/Rinvoq-receives-MHRA-approval-for-moderate-to-severe-Crohns-disease.jpg https://hospitalpharmacyeurope.com/clinical-zones/dermatology/dupixent-approval-extended-to-treatment-of-severe-eczema-in-children-from-6-months/ 2024-07-12T12:00:32+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/01/Dupixent-approval-extended-to-treatment-of-severe-eczema-in-children-from-6-months.jpg https://hospitalpharmacyeurope.com/clinical-zones/immunology/hiv-vaccine-trial-prematurely-terminated/ 2024-07-12T12:09:45+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/01/HIV-vaccine-trial-prematurely-terminated.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/xofluza-approval-extended-for-influenza-to-children-aged-one-year-and-above/ 2024-07-12T12:10:24+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/01/Xofluza-approval-extended-for-influenza-to-children-aged-one-year-and-above.jpg https://hospitalpharmacyeurope.com/clinical-zones/dermatology/adherence-to-nice-criteria-for-initiation-and-continuation-of-treatment-with-a-biologic-in-atopic-dermatitis/ 2024-07-12T12:11:42+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/01/Adherence-to-NICE-criteria.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/tezepelumab-now-available-as-pre-filled-single-use-pen-for-severe-asthma/ 2024-07-12T12:12:38+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/01/Tezepelumab-now-available-as-pre-filled-single-use-pen-for-severe-asthma.jpg https://hospitalpharmacyeurope.com/clinical-zones/dermatology/lebrikizumab-combined-with-topical-steroids-effective-for-moderate-to-severe-atopic-eczema/ 2024-07-12T12:13:12+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/01/Lebrikizumab-combined-with-topical-steroids-effective-for-moderate-to-severe-atopic-eczema.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/intermittent-oral-steroid-use-associated-with-higher-risk-of-adverse-outcomes-in-asthmatics/ 2024-07-12T12:13:35+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/01/Intermittent-oral-steroid-use-associated-with-higher-risk-of-adverse-outcomes-in-asthmatics.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/real-world-study-finds-dupilumab-add-on-therapy-effective-for-severe-asthma/ 2024-07-12T12:13:49+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/01/Real-world-study-finds-dupilumab-add-on-therapy-effective-for-severe-asthma.jpg https://hospitalpharmacyeurope.com/clinical-zones/dermatology/early-emollient-use-prevents-atopic-eczema-in-high-risk-infants/ 2024-07-12T12:14:07+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/01/Early-emollient-use-prevents-atopic-eczema-in-high-risk-infants.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/mrna-4157-v940-personalised-cancer-vaccine-effective-in-advanced-melanoma/ 2024-07-12T12:14:38+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/12/mRNA4157V940-personalised-cancer-vaccine-effective-in-advanced-melanoma.gif https://hospitalpharmacyeurope.com/clinical-zones/respiratory/gsk3036656-demonstrates-antibacterial-action-in-pulmonary-tuberculosis-after-two-weeks/ 2024-07-12T12:17:38+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/11/GSK3036656-demonstrates-antibacterial-action-in-pulmonary-tuberculosis-after-two-weeks.gif https://hospitalpharmacyeurope.com/clinical-zones/dermatology/dupixent-recommended-for-approval-in-eu-for-treating-moderate-to-severe-prurigo-nodularis/ 2024-07-12T12:18:42+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/11/Dupixent-recommended-for-approval-in-EU-for-treating-moderate-to-severe-prurigo-nodularis.gif https://hospitalpharmacyeurope.com/clinical-zones/respiratory/point-of-care-test-helps-distinguish-bacterial-and-viral-causes-of-acute-respiratory-infections/ 2024-07-12T12:20:11+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/10/Point-of-care-test-helps-distinguish-bacterial-and-viral-causes-of-acute-respiratory-infections.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/rsv-vaccine-demonstrates-high-efficacy-in-older-adults/ 2024-07-12T12:23:08+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/10/RSV-vaccine-demonstrates-high-efficacy-in-older-adults.jpg https://hospitalpharmacyeurope.com/clinical-zones/gastroenterology/guselkumab-and-golimumab-provide-superior-clinical-remission-in-ulcerative-colitis/ 2024-07-12T12:23:48+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/10/Guselkumab-and-golimumab-provide-superior-clinical-remission-in-ulcerative-colitis.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/nirsevimab-recommended-by-ema-to-protect-infants-against-rsv/ 2024-07-12T12:24:16+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/09/Nirsevimab-recommended-by-EMA-to-protect-infants-against-RSV.jpg https://hospitalpharmacyeurope.com/clinical-zones/dermatology/dupilumab-effective-in-children-under-six-with-atopic-eczema/ 2024-07-12T12:24:30+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/09/Dupilumab-effective-in-children-under-six-with-atopic-eczema.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/rsvpref-vaccine-effective-against-respiratory-syncytial-virus/ 2024-07-12T12:25:31+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/08/RSVpreF-vaccine-effective-against-respiratory-Syncytial-Virus.jpg https://hospitalpharmacyeurope.com/clinical-zones/immunology/lyme-disease-vaccine-vla15-enters-phase-iii-trial/ 2024-07-12T12:25:45+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/08/Lyme-disease-vaccine-VLA15-enters-Phase-III-trial.jpg https://hospitalpharmacyeurope.com/clinical-zones/gastroenterology/upadacitinib-approval-for-ulcerative-colitis/ 2024-07-12T12:28:18+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/07/Upadacitinib-approval-for-ulcerative-colitis-1.jpg https://hospitalpharmacyeurope.com/clinical-zones/dermatology/gestational-cholecalciferol-supplementation-reduces-atopic-eczema-incidence/ 2024-07-12T12:28:35+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/07/Gestational-cholecalciferol-supplementation-reduces-atopic-eczema-incidence.jpg https://hospitalpharmacyeurope.com/clinical-zones/dermatology/rct-finds-emollient-formulations-equally-effective-in-childhood-eczema/ 2024-07-12T12:29:13+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/05/RCT-finds-emollient-formulations-equally-effective-in-childhood-eczema.jpg https://hospitalpharmacyeurope.com/clinical-zones/dermatology/bleach-baths-improve-disease-severity-in-atopic-eczema/ 2024-07-12T12:30:10+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/05/Bleach-baths-improve-disease-severity-in-atopic-eczema.jpg https://hospitalpharmacyeurope.com/clinical-zones/paediatrics/once-daily-inhaled-corticosteroid-use-in-asthmatic-children-increases-adherence/ 2024-07-12T13:13:33+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/02/Once-daily-inhaled-corticosteroid-use-in-asthmatic-children-increases-adherence.jpg https://hospitalpharmacyeurope.com/clinical-zones/dermatology/lirentelimab-effective-for-treatment-resistant-chronic-urticaria/ 2024-07-12T13:13:43+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/02/Lirentelimab-effective-for-treatment-resistant-chronic-urticaria.jpg https://hospitalpharmacyeurope.com/clinical-zones/mental-health/peanut-allergy-creates-huge-psychosocial-burden-for-sufferers/ 2024-07-12T13:13:57+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/02/Peanut-allergy-creates-huge-psychosocial-burden-for-sufferers.jpg https://hospitalpharmacyeurope.com/clinical-zones/rheumatology/vitamin-d-and-omega-3-fatty-acids-reduce-development-of-autoimmune-diseases/ 2024-07-12T13:15:07+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/02/Vitamin-D-and-omega-3-fatty-acids-reduce-development-of-autoimmune-diseases.jpg https://hospitalpharmacyeurope.com/clinical-zones/rheumatology/upadacitinib-approved-in-the-uk-by-nice-for-active-psoriatic-arthritis/ 2024-07-12T13:15:28+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/01/GettyImages-1182368314.jpg-Psa.jpg https://hospitalpharmacyeurope.com/clinical-zones/rheumatology/podcast-self-management-strategies-in-inflammatory-arthritis/ 2024-07-12T13:18:04+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/11/Nikiphorou_HPE-crop.jpg https://hospitalpharmacyeurope.com/clinical-zones/gastroenterology/raised-inflammatory-protein-biomarkers-identified-several-years-before-ulcerative-colitis-diagnosis/ 2024-07-12T13:23:06+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/08/HPE-GettyImages-1169810231-ulcerative-colitis.jpg https://hospitalpharmacyeurope.com/clinical-zones/rheumatology/lack-of-data-on-the-value-of-cannabinoids-in-rheumatoid-arthritis/ 2024-07-12T13:30:55+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/05/HPE-GettyImages-1283010383.jpg https://hospitalpharmacyeurope.com/clinical-zones/gastroenterology/biologic-dose-de-escalation-leads-to-variable-relapse-in-ibd/ 2024-07-12T13:36:05+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/12/HPE-GettyImages-1063752208.jpg https://hospitalpharmacyeurope.com/clinical-zones/rheumatology/brodalumab-effective-for-patients-with-psoriatic-arthritis/ 2024-07-12T13:36:22+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/11/HPE-GettyImages-1282247032.jpg https://hospitalpharmacyeurope.com/clinical-zones/paediatrics/incidence-of-coeliac-disease-could-be-reduced-by-early-introduction-of-gluten/ 2024-07-12T13:36:32+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/10/HPE-GettyImages-480975378.jpg https://hospitalpharmacyeurope.com/clinical-zones/immunology/anti-gd2-mabs-for-the-treatment-of-high-risk-neuroblastoma/ 2024-07-12T14:18:15+00:00 https://hospitalpharmacyeurope.com/clinical-zones/immunology/plans-to-commercialise-novel-cell-based-quadrivalent-influenza-vaccine-in-europe/ 2024-07-12T14:20:52+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/05/GettyImages-1126063131.jpg https://hospitalpharmacyeurope.com/clinical-zones/immunology/managing-acquired-immune-mediated-ttp/ 2024-07-12T14:25:29+00:00 http://preview.hospitalpharmacyeurope.com/wp-content/uploads/2017/12/Table_1_Symptoms_TTP_400x318px.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/first-once-daily-single-inhaler-triple-therapy-to-be-approved-in-europe/ 2024-07-12T14:28:14+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2002/09/HPE-european-community.jpg https://hospitalpharmacyeurope.com/clinical-zones/immunology/data-support-the-efficacy-and-safety-of-biosimilar-rituximab-in-autoimmune-disease-and-oncology/ 2024-07-12T14:29:22+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/09/Rheumatology-3.jpg https://hospitalpharmacyeurope.com/clinical-zones/immunology/mrsa-decolonisation-in-a-district-general-hospital/ 2024-07-12T14:34:20+00:00 http://preview.hospitalpharmacyeurope.com/wp-content/uploads/2017/05/Scott-table-1_0.JPG https://hospitalpharmacyeurope.com/clinical-zones/oncology/new-immunotherapy-trial-launched-to-test-cancer-vaccine/ 2024-07-12T14:36:50+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2018/01/HPE-single-use-device.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/european-commission-approves-amgens-imlygic-as-first-oncolytic-immunotherapy-in-europe/ 2024-07-12T14:38:17+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/06/Oncology-1.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/bristol-myers-squibb-will-win-big-with-melanoma-combination-immunotherapy/ 2024-07-12T14:39:18+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/06/Oncology-1.jpg https://hospitalpharmacyeurope.com/clinical-zones/immunology/new-european-trial-initiated-to-identify-response-to-talimogene-laherparepvec-using-intratumoural-cd8-t-lymphocytes-as-biomarker/ 2024-07-12T14:40:08+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/06/Oncology-1.jpg https://hospitalpharmacyeurope.com/clinical-zones/neurology/stem-cell-therapy-heralded-as-breakthrough-in-ms-treatment/ 2024-07-12T14:41:18+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/11/CNS-1.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/fluzone-high-dose-vaccine-data/ 2024-07-12T14:43:56+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2018/01/HPE-single-use-device.jpg https://hospitalpharmacyeurope.com/clinical-zones/gastroenterology/childhood-stomach-bug-cases-drop-by-69-since-vaccine-introduction/ 2024-07-12T14:45:32+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2015/08/Paediatrics-5.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/gardasil-hpv-vaccine-approved-for-the-prevention-of-anal-cancer/ 2024-07-12T14:46:56+00:00 https://hospitalpharmacyeurope.com/clinical-zones/immunology/vaccine-candidate-against-chikungunya-fever/ 2024-07-12T14:48:14+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/03/infectious-disease-965x500.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/patient-attitudes-and-adherence-to-treatment-across-six-chronic-inflammatory-diseases/ 2024-07-12T14:48:44+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/06/Oncology-1.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/gsk-vaccine-shown-to-reduce-pneumonia-cases-in-young-children/ 2024-07-12T14:52:31+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2014/06/HPE-asthma.jpg https://hospitalpharmacyeurope.com/clinical-zones/immunology/astrazenecas-medimmune-presents-encouraging-immunotherapy-data/ 2024-07-12T14:54:25+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2015/08/Antimicrobial-resistance-5.jpg https://hospitalpharmacyeurope.com/clinical-zones/immunology/novartis-meningitis-b-vaccine-receives-fda-breakthrough-therapy-designation/ 2024-07-12T14:56:25+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2015/08/Antimicrobial-resistance-5.jpg https://hospitalpharmacyeurope.com/clinical-zones/immunology/uk-recommends-bexsero-vaccine-to-help-protect-against-devastating-meningitis-b/ 2024-07-12T14:58:19+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2015/08/haematology-1.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/novartis-expands-cancer-immunotherapy-with-acquisition-of-costim/ 2024-07-12T14:59:02+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/06/Oncology-1.jpg https://hospitalpharmacyeurope.com/clinical-zones/immunology/nice-recommends-revolade/ 2024-07-12T14:59:57+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2015/08/Antimicrobial-resistance-5.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/roche-releases-all-trial-data-on-tamiflu-drug/ 2024-07-12T15:00:57+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/03/infectious-disease-965x500.jpg https://hospitalpharmacyeurope.com/clinical-zones/immunology/scig-replacement-for-antibody-deficiencies/ 2024-07-12T15:04:28+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/06/haematology-2.jpg https://hospitalpharmacyeurope.com/clinical-zones/immunology/imiquimod-immune-effect-explained/ 2024-07-12T15:05:24+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/06/Oncology-1.jpg https://hospitalpharmacyeurope.com/clinical-zones/immunology/ucb-accelerates-transition-to-become-patient-centric-global-biopharmaceutical-leader/ 2024-07-12T15:07:26+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/07/CNS-1.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/medimmune-announces-winners-of-cancer-research-competition/ 2024-07-12T15:08:10+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/08/Oncology-1.jpg https://hospitalpharmacyeurope.com/clinical-zones/immunology/novartis-vaccine-shows-strong-immune-response-in-clinical-trials/ 2024-07-12T15:09:13+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/05/GettyImages-1126063131.jpg https://hospitalpharmacyeurope.com/clinical-zones/immunology/ucb-collaborates-in-the-metahit-project-to-decipher-the-human-metagenome/ 2024-07-12T15:09:35+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2018/02/Neurology-1.jpg https://hospitalpharmacyeurope.com/news/ucb-plans-new-biologics-pilot-plant-in-belgium/ 2024-07-12T15:10:03+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/07/CNS-1.jpg https://hospitalpharmacyeurope.com/clinical-zones/immunology/study-reports-immune-function-boost/ 2024-07-12T15:10:44+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2015/08/Antimicrobial-resistance-5.jpg https://hospitalpharmacyeurope.com/clinical-zones/immunology/ucb-study-reaches-milestone/ 2024-07-12T15:11:12+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2015/08/haematology-1.jpg https://hospitalpharmacyeurope.com/clinical-zones/immunology/rituximab-in-the-management-of-chronic-immune-thrombocytopenic-purpura/ 2024-07-12T15:15:43+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/07/haematology-2.jpg https://hospitalpharmacyeurope.com/clinical-zones/immunology/management-of-immune-thrombocytopenia-in-adults/ 2024-07-12T15:15:52+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/06/haematology-2.jpg https://hospitalpharmacyeurope.com/clinical-zones/immunology/primary-immunodeficiencies-treatment-overview/ 2024-07-12T15:19:11+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2002/06/Conference-report-3.jpg https://hospitalpharmacyeurope.com/clinical-zones/immunology/immunosuppressant-fights-infection/ 2024-07-12T15:20:52+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2018/01/Infectious-disease-2.jpg https://hospitalpharmacyeurope.com/clinical-zones/immunology/fda-warning-on-immune-system-drugs/ 2024-07-12T15:21:39+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2016/02/Rheumatology-2.jpg https://hospitalpharmacyeurope.com/clinical-zones/immunology/antidepressants-boost-immune-system/ 2024-07-12T15:22:06+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2015/10/Mental-health-1.jpg https://hospitalpharmacyeurope.com/clinical-zones/immunology/chmp-and-fda-disagree-on-angioedema-drug/ 2024-07-12T15:22:18+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2018/02/haematology-3.jpg https://hospitalpharmacyeurope.com/clinical-zones/immunology/mmr-jab-take-up-rate-lagging/ 2024-07-12T15:22:38+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2018/01/HPE-single-use-device.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/phase-iii-enrolment-in-trovax-trial-completed/ 2024-07-12T15:23:06+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/08/Oncology-1.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/immunotherapy-helps-many-heart-patients/ 2024-07-12T15:23:25+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2018/05/Heart-attack-4.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/tamiflu-stock-to-cover-25-of-uk/ 2024-07-12T15:23:50+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2018/01/HPE-single-use-device.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/positive-data-for-immunotherapy/ 2024-07-12T15:24:00+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/08/Oncology-1.jpg https://hospitalpharmacyeurope.com/clinical-zones/immunology/primary-immunodeficiency-and-immunoglobulin-therapy/ 2024-07-12T15:25:58+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2014/06/HPE-HIV.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/cell-based-immunotherapy-for-prostate-cancer/ 2024-07-12T15:28:20+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2002/12/HPE-benign-prosatic.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/recent-advances-in-radioimmunotherapy-2/ 2024-07-12T15:30:41+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2016/06/Oncology-4.jpg https://hospitalpharmacyeurope.com/clinical-zones/immunology/new-immunosuppressive-drugs-in-transplantation/ 2024-07-12T15:36:36+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2003/11/Organ-transplant-2.jpg https://hospitalpharmacyeurope.com/clinical-zones/immunology/immunosuppressants-to-reduce-graft-rejection/ 2024-07-12T15:37:13+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2003/11/Organ-transplant-2.jpg https://hospitalpharmacyeurope.com/clinical-zones/immunology/new-therapeutic-trends-in-immunosuppression/ 2024-07-12T15:40:33+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2003/11/Organ-transplant-2.jpg https://hospitalpharmacyeurope.com/clinical-zones/medicines-safety/mhra-imposes-restricted-indications-on-esmya-for-uterine-fibroids/ 2024-07-15T08:40:10+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/08/gastroenterology-965x500.jpg https://hospitalpharmacyeurope.com/clinical-zones/gastroenterology/ec-approves-early-dose-optimisation-of-simponi-for-ulcerative-colitis-patients/ 2024-07-15T11:03:00+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/08/HPE-GettyImages-1169810231-ulcerative-colitis.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/post-approval-transcatheter-aortic-valve-implantation/ 2024-07-16T14:53:16+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2018/04/Cardiovascular_1.jpg https://hospitalpharmacyeurope.com/news/wocova-previews-needleless-bacterial-control-system/ 2024-07-16T15:03:36+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/06/haematology-2.jpg https://hospitalpharmacyeurope.com/clinical-zones/haematology/reducing-catheter-related-bloodstream-infections/ 2024-07-16T15:11:21+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/06/haematology-4.jpg https://hospitalpharmacyeurope.com/clinical-zones/haematology/asap-praises-catheter-system/ 2024-07-16T15:14:05+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/06/haematology-2.jpg https://hospitalpharmacyeurope.com/clinical-zones/haematology/iv-catheter-technology-benefits-of-closed-iv-catheter-systems/ 2024-07-16T15:15:40+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2002/03/HPE-urology.jpg https://hospitalpharmacyeurope.com/clinical-zones/firm-unveils-drug-eluting-catheter/ 2024-07-16T15:45:57+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2001/12/HPE-coronary-artery-disease.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/acuity-study-one-year-follow-up-results-published/ 2024-07-16T16:00:20+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/01/Combining-coronary-artery-calcium-score-and-cystatin-C-level-in-chest-pain-predict-MACCE.jpg https://hospitalpharmacyeurope.com/clinical-zones/antimuscarinic-drugs-to-treat-overactive-bladder/ 2024-07-16T16:09:59+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/10/Bladder-pain.jpg https://hospitalpharmacyeurope.com/clinical-zones/antibiotic-prophylaxis-in-urological-procedures/ 2024-07-16T16:11:31+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/10/Bladder-pain.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/advanced-bladder-cancer-new-drug-combinations/ 2024-07-16T16:13:13+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/08/HPE-GettyImages-902846724-bladder-cancer.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/new-chemotherapy-drugs-for-advanced-bladder-cancer/ 2024-07-16T16:14:23+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/10/HPE-GettyImages-1216471160.jpg-bladder-cancer.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/intravesical-chemo-to-treat-bladder-cancer/ 2024-07-16T16:16:58+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2002/06/HPE-bladder-cancer.jpg https://hospitalpharmacyeurope.com/in-depth/views/xviith-congress-of-the-eau-birmingham-uk/ 2024-07-16T16:18:52+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2002/03/HPE-urology.jpg https://hospitalpharmacyeurope.com/clinical-zones/recent-advances-in-therapy-for-impotence/ 2024-07-16T16:20:22+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2002/03/HPE-viagra.jpg https://hospitalpharmacyeurope.com/clinical-zones/controlling-the-overactive-bladder/ 2024-07-16T16:21:42+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2002/03/HPE-overactive-bladder.jpg https://hospitalpharmacyeurope.com/clinical-zones/urinary-incontinence-what-are-the-options/ 2024-07-16T16:23:38+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/10/Bladder-pain.jpg https://hospitalpharmacyeurope.com/clinical-zones/pharmacotherapy-of-urinary-incontinence/ 2024-07-16T16:25:08+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/10/Bladder-pain.jpg https://hospitalpharmacyeurope.com/clinical-zones/drug-therapy-in-benign-prostatic-enlargement/ 2024-07-16T16:25:12+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2002/12/HPE-benign-prosatic.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/cancer-detection-drug-approved/ 2024-07-16T16:26:07+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/08/Oncology-1.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/vinflunine-in-metastatic-bladder-cancer/ 2024-07-16T16:26:15+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/08/Oncology-1.jpg https://hospitalpharmacyeurope.com/news/24th-annual-eau-congress-key-messages/ 2024-07-16T16:26:27+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/08/HPE-urology.jpg https://hospitalpharmacyeurope.com/news/drug-watchdog-criticises-advert/ 2024-07-16T16:26:34+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/01/GettyImages-1334849440.gif-black-man.gif https://hospitalpharmacyeurope.com/news/fesoterodine-approved-by-fda/ 2024-07-16T16:26:51+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/10/Bladder-pain.jpg https://hospitalpharmacyeurope.com/news/drug-relieves-bladder-condition/ 2024-07-16T16:26:59+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/10/Bladder-pain.jpg https://hospitalpharmacyeurope.com/news/maa-submitted-for-premature-ejaculation-treatment/ 2024-07-16T16:27:09+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/12/EU_treatment_milestone_as_dostarlimab_approved_for_eligible_patients_with_endometrial_cancer.jpg https://hospitalpharmacyeurope.com/clinical-zones/drug-treatment-of-overactive-bladder/ 2024-07-16T16:27:27+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/10/Bladder-pain.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/prostate-cancer-saliva-test-to-start-trials/ 2024-07-16T16:28:39+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/09/HPE-GettyImages-498813697-prostate-cancer.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/nice-approves-new-advanced-bladder-cancer-immunotherapy/ 2024-07-16T16:28:47+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2018/05/HPE-bladder-cancer.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/first-major-treatment-advance-in-bladder-cancer-in-three-decades-reimbursed-for-patient-use/ 2024-07-16T16:28:55+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/11/HPE-bladder-cancer.jpg https://hospitalpharmacyeurope.com/clinical-zones/bene-arzneimittel-receives-orphan-drug-status-for-pentosan-polysulphate/ 2024-07-16T16:29:07+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/10/Bladder-pain.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/msd-announces-presentation-of-data-on-investigational-use-of-pembrolizumab-in-advanced-bladder-cancer/ 2024-07-16T16:29:20+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/06/Oncology-1.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/chemoradiotherapy-helps-control-bladder-cancer/ 2024-07-16T16:29:27+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/06/Oncology-1.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/ema-updates-on-pioglitazone-and-bladder-cancer/ 2024-07-16T16:29:34+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/06/Oncology-1.jpg https://hospitalpharmacyeurope.com/news/botox-approved-for-urinary-incontinence-treatment/ 2024-07-16T16:29:44+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/10/Bladder-pain.jpg https://hospitalpharmacyeurope.com/clinical-zones/drugs-for-treatment-of-urinary-incontinence/ 2024-07-16T16:29:51+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2002/03/HPE-overactive-bladder.jpg https://hospitalpharmacyeurope.com/clinical-zones/wake-up-to-nocturia/ 2024-07-16T16:30:09+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/10/Bladder-pain.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/could-existing-drug-offer-new-hope-for-people-with-secondary-breast-cancer/ 2024-07-19T08:53:49+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/10/HPE-GettyImages-1344309408-breast-cancer-now.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/capivasertib-approved-by-mhra-for-advanced-breast-cancer-following-eu-green-light/ 2024-07-25T08:49:29+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2024/07/Capivasertib_approved_by_MHRA_for_advanced_breast_cancer_following_EU_green_light.gif https://hospitalpharmacyeurope.com/clinical-zones/rheumatology/skyrizi-cleared-by-ema-for-treatment-of-active-psoriatic-arthritis/ 2024-07-26T10:16:06+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/11/GettyImages-995967580.gif-Skyrizi.gif https://hospitalpharmacyeurope.com/clinical-zones/gastroenterology/risankizumab-gains-fourth-approved-indication-as-ec-gives-nod-for-ulcerative-colitis/ 2024-07-26T10:43:21+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2024/07/Risankizumab_gains_fourth_approved_indication_as_EC_gives_nod_for_ulcerative_colitis.jpg https://hospitalpharmacyeurope.com/clinical-zones/gastroenterology/biologics-and-biosimilars-in-ibd/ 2024-07-26T10:48:14+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/03/StClair-table-1.JPG http://preview.hospitalpharmacyeurope.com/wp-content/uploads/2017/03/StClair-table-1.JPG https://hospitalpharmacyeurope.com/clinical-zones/haematology/efanesoctocog-alfa-receives-positive-chmp-opinion-for-haemophilia-a/ 2024-07-26T14:28:47+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2024/05/Efanesoctocog_alfa_receives_positive_CHMP_opinion_for_haemophilia_A.jpg https://hospitalpharmacyeurope.com/clinical-zones/immunology/gsk-announces-eu-regulatory-submission-of-candidate-vaccine-shingrix/ 2024-07-26T15:41:37+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2016/11/Infectious-disease-4.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/herpes-zoster-infection-increases-risk-of-stroke-and-coronary-heart-disease/ 2024-07-26T16:05:46+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/01/Herpes-zoster-infection-increases-risk-of-stroke-and-coronary-heart-disease.jpg https://hospitalpharmacyeurope.com/clinical-zones/haematology/tisagenlecleucel-effective-beyond-3-years-in-paediatric-leukaemia/ 2024-08-06T14:02:40+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/12/Tisagenlecleucel-effective-beyond-3-years-in-paediatric-leukaemia.gif https://hospitalpharmacyeurope.com/clinical-zones/oncology/ec-approves-adding-overall-survival-data-to-blincyto-label/ 2024-08-07T15:39:39+00:00 https://hospitalpharmacyeurope.com/clinical-zones/oncology/blincyto-significantly-improved-overall-survival-in-b-cell-precursor-all-vs-chemotherapy/ 2024-08-07T16:38:12+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/03/HPE-chemo.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/ide-cel-in-r-r-multiple-myeloma-lowers-risk-of-progression-or-death-by-51/ 2024-08-07T16:41:36+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/03/Ide-cel-in-R-R-multiple-myeloma-lowers-risk-of-progression-or-death-by-51.jpg https://hospitalpharmacyeurope.com/clinical-zones/emergency-and-critical-care/ketamine-and-etomidate-have-similar-effect-on-first-pass-success-rate-for-rapid-sequence-intubation-in-trauma/ 2024-08-08T14:20:42+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/05/Ketamine_and_etomidate_have_similar_effect_on_first-pass_success_rate_for_rapid_sequence_intubation.jpg https://hospitalpharmacyeurope.com/clinical-zones/emergency-and-critical-care/inhaled-isopropyl-alcohol-a-possible-treatment-for-nausea-and-vomiting-in-ed/ 2024-08-08T14:23:06+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/04/Inhaled-isopropyl-alcohol-a-possible-nausea-and-vomiting-treatment-in-ED.jpg https://hospitalpharmacyeurope.com/clinical-zones/emergency-and-critical-care/iv-diazepam-offers-similar-relief-of-acute-low-back-to-methocarbamol-in-ed/ 2024-08-08T14:24:42+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/04/IV-diazepam-offers-similar-relief-of-acute-low-back-to-methocarbamol-in-ED.jpg https://hospitalpharmacyeurope.com/clinical-zones/paediatrics/temperature-threshold-for-hypothermic-infant-infection-screening-remains-unclear/ 2024-08-08T14:38:15+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/11/Temperature-threshold-for-hypothermic-infant-infection-screening-remains-unclear.gif https://hospitalpharmacyeurope.com/clinical-zones/rheumatology/similar-musculoskeletal-pain-relief-provided-by-opiates-and-nsaids-in-ed-patients/ 2024-08-08T14:40:50+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/10/Similar-musculoskeletal-pain-relief-provided-by-opiates-and-NSAIDs-in-ED-patients.gif https://hospitalpharmacyeurope.com/clinical-zones/emergency-and-critical-care/incidental-findings-detected-in-nearly-a-third-of-emergency-department-ct-scans/ 2024-08-08T14:42:24+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/06/Incidental-findings-detected-in-nearly-a-third-of-emergency-department-CT-scans.jpg https://hospitalpharmacyeurope.com/clinical-zones/emergency-and-critical-care/medication-reconciliation-in-the-emergency-department/ 2024-08-08T14:48:03+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2015/10/Medicines-reconciliation-3.jpg https://hospitalpharmacyeurope.com/clinical-zones/emergency-and-critical-care/vitamin-d-administration-associated-with-improved-mortality-in-critical-care-patients/ 2024-08-08T14:51:35+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/09/Vitamin-D-administration-associated-with-improved-mortality-in-critical-care-patients.jpg https://hospitalpharmacyeurope.com/news/ukcpa-appoints-new-chair-of-critical-care-group/ 2024-08-08T14:57:20+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2002/03/Safety-2.jpg https://hospitalpharmacyeurope.com/clinical-zones/emergency-and-critical-care/ready-to-use-infusion-preparations-in-critical-care/ 2024-08-08T15:03:26+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/06/IV-therapy-1.jpg https://hospitalpharmacyeurope.com/clinical-zones/emergency-and-critical-care/the-nature-of-prescribing-in-the-emergency-department/ 2024-08-08T15:04:41+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/03/HPE-emergency-dept.jpg https://hospitalpharmacyeurope.com/clinical-zones/neurology/increased-cholinesterase-activity-associated-with-delirium-during-critical-illness/ 2024-08-08T15:12:07+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/12/Increased-cholinesterase-activity-associated-with-delirium-during-critical-illness.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/cancer-diagnoses-often-made-after-emergency-department-visits/ 2024-08-08T15:32:31+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/04/Cancer-diagnoses-often-made-after-emergency-department-visits.jpg https://hospitalpharmacyeurope.com/clinical-zones/emergency-and-critical-care/pharmacist-led-antimicrobial-stewardship-improves-appropriateness-of-ed-prescribing/ 2024-08-08T15:32:49+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/02/Pharmacist-led-antimicrobial-stewardship-improves-appropriateness-of-ED-prescribing-1.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/campaign-leads-to-higher-level-of-acs-patients-arriving-at-ed-via-emergency-services/ 2024-08-08T15:33:25+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/11/GettyImages-1168364048.gif-ACS.gif https://hospitalpharmacyeurope.com/clinical-zones/paediatrics/non-urgent-attendance-by-children-account-for-a-fifth-of-ed-visits/ 2024-08-08T15:33:41+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/11/GettyImages-700828364.gif-children-emergency-care.gif https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/an-ed-anticoagulant-pathway-for-af-patients-shown-to-be-safe-and-effective/ 2024-08-08T15:42:16+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/09/An-ED-anticoagulant-pathway-for-AF-patients-shown-to-be-safe-and-effective.jpg https://hospitalpharmacyeurope.com/clinical-zones/emergency-and-critical-care/emergency-department-quality-of-medicine-use-improved-with-a-pharmacist/ 2024-08-08T15:45:05+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/08/Pharmacist-in-the-ED.jpg https://hospitalpharmacyeurope.com/clinical-zones/emergency-and-critical-care/cannabis-use-not-linked-to-increased-respiratory-related-hospital-visits/ 2024-08-08T15:48:27+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/06/Cannabis-use-not-linked-to-increased-respiratory-related-hospital-visits.jpg https://hospitalpharmacyeurope.com/clinical-zones/medicines-safety/standardising-paediatric-infusions-and-supporting-use-of-smart-pump-technology-in-ireland/ 2024-08-08T16:14:00+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2024/06/Standardising_paediatric_infusions_and_supporting_use_of_smart-pump_technology_in_Ireland2.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/mechanism-responsible-for-antimicrobial-resistance-identified-as-mixed-strain-pathogens/ 2024-08-08T16:17:34+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/07/Mechanism_responsible_for_antimicrobial_resistance_identified_as_mixed_strain_pathogens.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/recreational-drug-use-responsive-for-1-in-10-intensive-cardiac-care-unit-admissions/ 2024-08-08T16:25:36+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/08/Recreational-drug-use-responsive-for-1-in-10-intensive-cardiac-care-unit-admissions.jpg https://hospitalpharmacyeurope.com/clinical-zones/emergency-and-critical-care/skeletal-muscle-loss-approaches-2-each-day-upon-admission-to-intensive-care/ 2024-08-09T06:47:54+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/01/Skeletal-muscle-loss-approaches-2-each-day-upon-admission-to-intensive-care.jpg https://hospitalpharmacyeurope.com/clinical-zones/paediatrics/diagnostic-aid-fast-and-reliable-for-respiratory-pathogen-identification-in-critically-ill-children/ 2024-08-09T06:54:56+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/01/Diagnostic-aid-fast-and-reliable-for-respiratory-pathogen-identification-in-critically-ill-children.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/hypothermic-temperature-control-following-in-hospital-cardiac-arrest-fails-to-improve-survival/ 2024-08-09T06:57:32+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/10/Hypothermic-temperature-control-following-in-hospital-cardiac-arrest-fails-to-improve-survival.jpg https://hospitalpharmacyeurope.com/clinical-zones/emergency-and-critical-care/study-finds-intravenous-vitamin-c-use-in-sepsis-linked-to-greater-mortality-risk/ 2024-08-09T07:04:45+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/06/Study-finds-intravenous-vitamin-C-use-in-sepsis-linked-to-greater-mortality-risk.jpg https://hospitalpharmacyeurope.com/news/iv-fluid-therapy-nutrition/iv-fluid-restriction-has-no-mortality-impact-compared-to-standard-fluid-therapy-in-septic-shock/ 2024-08-09T07:06:37+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/06/IV-fluid-restriction-has-no-mortality-impact-compared-to-standard-fluid-therapy-in-septic-shock.jpg https://hospitalpharmacyeurope.com/clinical-zones/emergency-and-critical-care/blood-lactate-levels-together-with-qsofa-or-news-offers-better-predictive-value-of-28-day-in-hospital-mortality-for-those-at-risk-of-sepsis/ 2024-08-09T07:13:25+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/04/Blood-lactate-levels-together-with-qSOFA-or-NEWS-offers-better-predictive-value-of-28-day-in-hospital-mortality-for-those-at-risk-of-sepsis.jpg https://hospitalpharmacyeurope.com/clinical-zones/emergency-and-critical-care/vital-sign-risk-stratification-levels-used-in-ed-patients-questioned/ 2024-08-09T07:16:34+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/02/Vital-sign-risk-stratification-levels-used-in-ED-patients-questioned.jpg https://hospitalpharmacyeurope.com/clinical-zones/emergency-and-critical-care/amino-acids-supplement-reduces-muscle-wasting-and-improves-gut-function-in-critically-ill/ 2024-08-09T07:21:29+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/12/Amino-acids-supplement-reduces-muscle-wasting-and-improves-gut-function-in-critically-ill.jpg https://hospitalpharmacyeurope.com/clinical-zones/emergency-and-critical-care/the-impact-of-ready-to-use-fentanyl-vials/ 2024-08-09T07:36:58+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/05/Cavell-pic-1.JPG http://preview.hospitalpharmacyeurope.com/wp-content/uploads/2017/05/Cavell-pic-1.JPG http://preview.hospitalpharmacyeurope.com/wp-content/uploads/2017/05/Cavell-table-1.JPG http://preview.hospitalpharmacyeurope.com/wp-content/uploads/2017/05/Cavell-fig-1.JPG http://preview.hospitalpharmacyeurope.com/wp-content/uploads/2017/05/Cavell-pic-2.JPG https://hospitalpharmacyeurope.com/clinical-zones/gastroenterology/therapeutic-monitoring-of-adalimumab-invaluable-for-children-with-crohns-disease/ 2024-08-12T11:32:03+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/06/HPE-GettyImages-1313152158.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/particulate-matter-in-air-pollution-might-cause-lung-cancer-in-non-smokers/ 2024-08-14T08:04:54+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/09/Particulate-matter-in-air-pollution-might-cause-lung-cancer-in-non-smokers.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/higher-particulate-matter-exposure-increases-infant-all-cause-and-respiratory-infection-related-ed-visits/ 2024-08-14T08:06:20+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/03/Higher-particulate-matter-exposure-increases-infant-all-cause-and-infection-related-ED-visits.jpg https://hospitalpharmacyeurope.com/in-depth/views/influence-of-nutrition-in-allergic-disease/ 2024-08-14T08:35:28+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/11/Fruit_vegetables_GettyImages_1142841178_965x500px.jpg https://hospitalpharmacyeurope.com/news/rps-calls-for-mandatory-training-on-learning-disabilities-and-autism-for-pharmacists/ 2024-08-14T09:12:47+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/09/RPS_calls_for_mandatory_training_on_learning_disabilities_and_autism_for_pharmacists.jpg https://hospitalpharmacyeurope.com/news/industry-news/pharmacists-in-great-britain-accessing-mental-health-support-sees-three-fold-increase/ 2024-08-14T09:13:03+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/07/Pharmacists_in_Great_Britain_accessing_mental_health_support_sees_three-fold_increase.jpg https://hospitalpharmacyeurope.com/news/crucial-role-of-pharmacists-in-safe-and-effective-healthcare-celebrated-on-world-pharmacists-day/ 2024-08-14T09:13:12+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/09/Crucial_role_of_pharmacists_in_safe_and_effective_healthcare_celebrated_on_World_Pharmacists_Day.jpg https://hospitalpharmacyeurope.com/news/impact-of-pharmacist-independent-prescribing-on-uk-hospital-practice-highlighted-by-cpho/ 2024-08-14T09:13:40+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/11/Impact_of_pharmacist_independent_prescribing_on_UK_hospital_practice_highlighted_by_CPhO.jpg https://hospitalpharmacyeurope.com/news/calls-for-pharmacists-to-embrace-amr-leadership-in-updated-fip-policy-statement/ 2024-08-14T09:13:49+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/11/Calls_for_pharmacists_to_embrace_AMR_leadership_in_updated_FIP_policy_statement.jpg https://hospitalpharmacyeurope.com/news/nhs-workforce-plan-further-delayed-over-cost-concerns/ 2024-08-14T09:14:16+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/05/NHS_workforce_plan_further_delayed_over_cost_concerns.jpg https://hospitalpharmacyeurope.com/news/eu-pharmacists-joining-nhs-workforce-to-have-automatic-recognition-for-at-least-five-more-years/ 2024-08-14T09:14:57+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/07/EU_pharmacists_joining_NHS_workforce_to_have_automatic_recognition_for_at_least_five_more_years.jpg https://hospitalpharmacyeurope.com/news/clinical-services-provision-and-workforce-capacity-require-improvement-in-hospital-pharmacy-eahp-finds/ 2024-08-14T09:15:17+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/11/Clinical_services_provision_and_workforce_capacity_require_improvement_in_hospital_pharmacy.jpg https://hospitalpharmacyeurope.com/news/optional-guidance-published-by-nhs-england-to-address-pharmacist-workforce-issues/ 2024-08-14T09:15:24+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/12/Optional_guidance_published_by_NHS_England_to_address_pharmacist_workforce_issues.jpg https://hospitalpharmacyeurope.com/news/industry-news/new-and-expanded-routes-for-pharmacist-training-detailed-in-long-awaited-nhs-england-workforce-plan/ 2024-08-14T09:15:32+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/06/New_and_expanded_routes_for_pharmacist_training_detailed_in_long-awaited_NHS_England_workforce_plan.jpg https://hospitalpharmacyeurope.com/news/calls-for-urgent-action-to-tackle-burnout-across-uk-pharmacy-sector/ 2024-08-14T09:15:41+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/10/Calls_for_urgent_action_to_tackle_burnout_across_UK_pharmacy_sector.jpg https://hospitalpharmacyeurope.com/reviews-research/optimising-medication-adherence-health-literacy-and-the-role-of-the-hospital-pharmacist/ 2024-08-14T09:25:27+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/03/the_role_of_the_hospital_pharmacist.jpg https://hospitalpharmacyeurope.com/reviews-research/pharmacy-workforce-matching-staffing-resource-to-service-demand/ 2024-08-14T09:35:51+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/03/Pharmacy_workforce.jpg https://hospitalpharmacyeurope.com/reviews-research/electronic-prescribing-phased-rollout-vs-big-bang/ 2024-08-14T09:38:52+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/03/doctor_at_desk_GettyImages_599779470_965x500px.jpg https://hospitalpharmacyeurope.com/news/chief-pharmacist-role-should-be-mandatory-for-hospitals-rps-says/ 2024-08-14T09:50:28+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2024/04/Chief_pharmacist_role_should_be_mandatory_for_hospitals_RPS_says.jpg https://hospitalpharmacyeurope.com/news/gphc-issues-advice-on-supporting-children-and-young-people-with-gender-identity-issues/ 2024-08-14T09:50:39+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2024/04/GPhC_issues_advice_on_supporting_children_and_young_people_with_gender_identity_issues.jpg https://hospitalpharmacyeurope.com/news/scotlands-first-consultant-pharmacist-appointed-to-support-cancer-outcomes-and-survival/ 2024-08-14T09:50:53+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2024/03/Scotlands_first_consultant_pharmacist_appointed_to_support_cancer_outcomes_and_survival.jpg https://hospitalpharmacyeurope.com/news/research-grant-for-pharmacist-specialisation-and-advanced-practice-topics-opens-for-applications/ 2024-08-14T09:51:21+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2024/03/Research_grant_for_pharmacist_specialisation_and_advanced_practice_topics_opens_for_applications.jpg https://hospitalpharmacyeurope.com/news/vast-majority-of-hospital-pharmacists-at-risk-of-burnout-new-rps-wellbeing-survey-shows/ 2024-08-14T09:51:48+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2024/02/Vast_majority_of_hospital_pharmacists_at_risk_of_burnout_new_RPS_wellbeing_survey_shows.jpg https://hospitalpharmacyeurope.com/news/rps-welcomes-recent-progress-in-pharmacy-practice-but-highlights-further-opportunity/ 2024-08-14T09:52:08+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2024/02/RPS_welcomes_recent_progress_in_pharmacy_practice_but_highlights_further_opportunity.jpg https://hospitalpharmacyeurope.com/news/rps-launches-consultations-on-critical-care-and-mental-health-curricula-for-advanced-pharmacist-practice/ 2024-08-14T09:52:19+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2024/02/RPS_launches_consultations_on_critical_care_and_mental_health_curricula.jpg https://hospitalpharmacyeurope.com/news/new-fip-guide-outlines-pharmacists-role-in-managing-iron-deficiency-anaemia/ 2024-08-14T09:53:09+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2024/02/New_FIP_guide_outlines_pharmacists_role_in_managing_iron_deficiency_anaemia.jpg https://hospitalpharmacyeurope.com/news/professional-standards-for-homecare-services-updated-by-rps/ 2024-08-14T09:53:39+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2024/02/Professional_Standards_for_Homecare_Services_updated_by_RPS.jpg https://hospitalpharmacyeurope.com/news/vision-for-consultant-pharmacists-by-2030-unveiled-by-rps/ 2024-08-14T09:53:46+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2024/01/Vision_for_consultant_pharmacists_by_2030_unveiled_by_RPS.jpg https://hospitalpharmacyeurope.com/news/consultation-on-draft-standards-for-chief-pharmacists-launched-by-gphc/ 2024-08-14T09:53:54+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2024/01/Consultation_on_draft_Standards_for_Chief_Pharmacists_launched_by_GPhC.jpg https://hospitalpharmacyeurope.com/news/industry-news/rotational-roles-for-uk-pharmacists-helping-with-workforce-issues-and-career-development/ 2024-08-14T10:17:16+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/06/Rotational_roles_for_UK_pharmacists_helping_with_workforce_issues_and_career_development.jpg https://hospitalpharmacyeurope.com/news/rps-manifesto-outlines-key-pharmacy-priorities-ahead-of-upcoming-uk-general-election/ 2024-08-14T13:15:13+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2024/01/RPS_manifesto_outlines_key_pharmacy_priorities_ahead_of_upcoming_UK_general_election.jpg https://hospitalpharmacyeurope.com/news/fip-calls-for-strengthening-of-education-on-antimicrobial-resistance-and-stewardship/ 2024-08-14T13:16:45+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/11/FIP_calls_for_strengthening_of_education_on_antimicrobial_resistance_and_stewardship.jpg https://hospitalpharmacyeurope.com/news/newly-appointed-health-secretary-calls-for-partnership-across-settings-in-england/ 2024-08-14T13:17:28+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/11/Newly_appointed_health_secretary_calls_for_partnership_across_settings_in_England.jpg https://hospitalpharmacyeurope.com/news/ecpha-established-as-pan-european-body-for-accrediting-lifelong-pharmacy-learning/ 2024-08-14T13:18:12+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/10/ECPhA_established_as_pan-European_body_for_accrediting_lifelong_pharmacy_learning.jpg https://hospitalpharmacyeurope.com/news/key-drivers-for-future-pandemic-preparedness-in-pharmacy-outlined-by-fip/ 2024-08-14T13:19:29+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/08/Key_drivers_for_future_pandemic_preparedness_in_pharmacy_outlined_by_FIP_.jpg https://hospitalpharmacyeurope.com/news/industry-news/medicines-optimisation-teams-lack-capacity-to-drive-transformation-says-nhs-confed/ 2024-08-14T13:20:44+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/06/Medicines_optimisation_teams_lack_capacity_to_drive_transformation_says_NHS_Confed.jpg https://hospitalpharmacyeurope.com/news/recommendations-for-pharmacists-in-disaster-and-emergency-management-outlined-by-fip/ 2024-08-14T13:24:43+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/10/Recommendations_for_pharmacists_in_disaster_and_emergency_management_outlined_by_FIP.jpg https://hospitalpharmacyeurope.com/news/eahp-welcomes-eu-measures-to-tackle-medicines-shortages-including-new-critical-list/ 2024-08-14T13:24:57+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/12/EAHP_welcomes_EU_measures_to_tackle_medicines_shortages_including_new_critical_list2.jpg https://hospitalpharmacyeurope.com/news/ema-launches-medicines-supply-support-measures-as-part-of-wider-ec-initiative/ 2024-08-14T13:25:04+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/10/EMA_launches_medicines_supply_support_measures_as_part_of_wider_EC_initiative.jpg https://hospitalpharmacyeurope.com/clinical-zones/emergency-and-critical-care/pharmacists-in-ae/ 2024-08-14T13:36:48+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2018/01/HPE-emergency-dept.jpg https://hospitalpharmacyeurope.com/news/the-pharmacist-apprentice-plans-show-everything-thats-wrong-with-the-profession/ 2024-08-14T13:37:45+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/07/mi-48379.jpeg https://hospitalpharmacyeurope.com/clinical-zones/emergency-and-critical-care/pharmacists-have-wider-clinical-role-in-ae-concludes-study/ 2024-08-14T13:46:09+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2018/01/HPE-emergency-dept.jpg https://hospitalpharmacyeurope.com/in-depth/views/what-will-become-of-medicines-supplies-in-brexit-britain/ 2024-08-14T13:53:30+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2014/11/Drug-Shortage-3.jpg https://hospitalpharmacyeurope.com/news/64-of-uk-primary-care-workers-predict-brexit-will-make-shortages-worse/ 2024-08-14T13:56:08+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2001/09/European-conferences-2.jpg https://hospitalpharmacyeurope.com/clinical-zones/neurology/shortage-alert-epanutin-50mg-infatabs-out-of-stock-until-november-in-uk/ 2024-08-14T14:00:15+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/07/mi-48359.jpeg https://hospitalpharmacyeurope.com/clinical-zones/oncology/esmo-drives-eu-level-action-to-tackle-shortages-of-essential-medicines/ 2024-08-14T14:02:10+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2014/11/Drug-Shortage-3.jpg https://hospitalpharmacyeurope.com/news/shortages-uk-pharma-warns-against-no-deal-after-week-of-brexit-chaos/ 2024-08-14T14:05:10+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2018/04/Drug-Shortage-1.jpg https://hospitalpharmacyeurope.com/news/uk-government-to-spend-11m-preventing-medicine-shortages-in-preparation-for-no-deal-brexit/ 2024-08-14T14:07:13+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/06/GettyImages-871424916.jpg https://hospitalpharmacyeurope.com/news/refrigeration-capacity-for-no-deal-brexit-cold-storage-medicines-to-cost-uk-1m-government-reveals/ 2024-08-14T14:16:30+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/06/GettyImages-871424916.jpg https://hospitalpharmacyeurope.com/clinical-zones/gastroenterology/volanesorsen-receives-conditional-marketing-authorisation-from-the-european-commission/ 2024-08-14T14:29:41+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2002/09/HPE-european-community.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/will-a-simple-test-for-pancreatic-cancer-really-solve-the-late-diagnosis-crisis-2/ 2024-08-14T14:30:04+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/07/mi-48358.jpeg https://hospitalpharmacyeurope.com/news/sponsored-helapet-puts-a-cap-on-contamination/ 2024-08-14T15:09:17+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/03/Pharmapack_Sterile_Multi_pack_Capped_Syringes_965x500px.jpg https://hospitalpharmacyeurope.com/wp-content/uploads/2020/03/Pharmapack_Sterile_Multi_pack_Capped_Syringes_1500x1000px.jpg https://hospitalpharmacyeurope.com/wp-content/uploads/2020/03/Combi_Cap_Only_IV2102_500x500px.jpg https://hospitalpharmacyeurope.com/wp-content/uploads/2020/03/Sterile_IV_Cap_IV5750R_500x500px.jpg https://hospitalpharmacyeurope.com/wp-content/uploads/2020/03/Syringe_Cap_Thunder1201173113_500x500px-1.jpg https://hospitalpharmacyeurope.com/clinical-zones/excessive-duration-of-antibiotic-therapy-in-transition-care-an-opportunity-for-pharmacists/ 2024-08-14T15:36:05+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/06/HPE-GettyImages-1186408288.jpg https://hospitalpharmacyeurope.com/in-depth/views/key-commentary/hospital-pharmacist-led-medicine-optimisation-clinics-reduces-re-admission-rates/ 2024-08-14T15:36:17+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/06/HPE-GettyImages-182172308.jpg https://hospitalpharmacyeurope.com/clinical-zones/paediatrics/vitamin-d-has-little-impact-on-asthma-exacerbations-in-high-risk-children/ 2024-08-15T08:19:45+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/09/HPE-GettyImages-655371326.jpg https://hospitalpharmacyeurope.com/clinical-zones/dermatology/discovery-of-s-aureus-protein-key-to-triggering-eczema-flare/ 2024-08-15T08:21:40+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/10/HPE-GettyImages-509659221.jpg https://hospitalpharmacyeurope.com/clinical-zones/rheumatology/large-placebo-response-in-subjective-and-objective-measures-in-ra-trials/ 2024-08-15T08:29:59+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/10/HPE-GettyImages-959377006.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/doing-more-vigorous-physical-activity-linked-to-greater-health-benefits/ 2024-08-15T09:59:26+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/11/HPE-GettyImages-1231564358.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/ticagrelor-aspirin-combination-superior-to-aspirin-in-ischaemic-stroke/ 2024-08-15T10:01:34+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/11/HPE-GettyImages-1088968180.jpg https://hospitalpharmacyeurope.com/clinical-zones/haematology/vitamin-c-supplemented-with-iron-has-no-effect-on-haemoglobin-levels/ 2024-08-15T10:01:59+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/11/HPE-GettyImages-185062032.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/advances-in-the-treatment-of-paediatric-neuroblastoma/ 2024-08-15T10:03:08+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/11/neuroblastoma_GettyImages_512803988_965x500px.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/heart-failure-patients-at-greater-risk-of-cancer-and-cancer-related-mortality/ 2024-08-15T10:07:42+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/01/Heart-failure-patients-at-greater-risk-of-cancer-and-cancer-related-mortality-1.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/higher-olive-oil-intake-linked-with-lower-cardiovascular-and-all-cause-mortality/ 2024-08-15T10:08:43+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/01/Higher-olive-oil-intake-linked-with-lower-cardiovascular-and-all-cause-mortality-1.jpg https://hospitalpharmacyeurope.com/ophthalmology/wet-amd-drug-changed-by-italy-government/ 2024-08-15T10:08:56+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2015/12/Opthamology-2.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/prolonged-tv-viewing-linked-with-higher-venous-thromboembolism-risk/ 2024-08-15T10:10:01+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/01/Prolonged-TV-viewing-linked-with-higher-venous-thromboembolism-risk.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/breastfeeding-associated-with-reduced-maternal-risk-of-cardiovascular-disease/ 2024-08-15T10:13:16+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/01/GettyImages-1282686132.jpg-breastfeeding.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/mallinckrodt-will-promote-and-distribute-rapiscan-in-france-italy-belgium-and-spain/ 2024-08-15T10:13:17+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2018/04/Cardiovascular_1.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/sodium-glucose-cotransporter-2-inhibitors-reduce-cardiovascular-mortality/ 2024-08-15T10:13:42+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/01/Sodium-glucose-cotransporter-2-inhibitors-reduce-cardiovascular-mortality.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/colchicine-use-reduces-mace-in-percutaneous-coronary-interventions/ 2024-08-15T10:14:05+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/01/Colchicine-use-reduces-MACE-in-percutaneous-coronary-interventions.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/relatlimab-nivolumab-combination-effective-for-advanced-metastatic-melanoma/ 2024-08-15T10:15:36+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/01/GettyImages-1260533084.jpg-melanoma.jpg https://hospitalpharmacyeurope.com/clinical-zones/mental-health/co-treatment-with-opiates-and-benzodiazepines-increases-mortality-risk/ 2024-08-15T10:15:48+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/12/HPE-GettyImages-497526115.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/neoplasia-found-in-a-third-of-under-50s-undergoing-colorectal-screening/ 2024-08-15T10:16:19+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/01/Neoplasia-found-in-a-third-of-under-50s-undergoing-colorectal-screening.jpg https://hospitalpharmacyeurope.com/clinical-zones/dermatology/real-world-evidence-suggests-psoriasis-biologics-are-less-effective-in-practice/ 2024-08-15T10:16:59+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/12/HPE-GettyImages-168510711.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/smoking-cessation-around-time-of-lung-cancer-diagnosis-improves-survival/ 2024-08-15T10:17:14+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/01/GettyImages-1042650426.jpg-smoking-cessation.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/nebulised-magnesium-sulfate-fails-to-prevent-admission-to-hospital-in-those-with-acute-refractory-asthma/ 2024-08-15T10:18:01+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/11/HPE-GettyImages-1167752754.jpg https://hospitalpharmacyeurope.com/clinical-zones/neurology/stroke-risk-after-tia-in-ed-higher-compared-with-rapid-access-tia-clinics/ 2024-08-15T10:18:48+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/01/HPE-GettyImages-1088968180.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/radiomics-nomogram-predicts-lymph-node-metastases-in-pancreatic-cancer/ 2024-08-15T10:19:01+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/01/GettyImages-805551162.jpg-pancreatic-cancer.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/standalone-ai-reader-could-reduce-radiologist-workload-in-lung-cancer-screening/ 2024-08-15T10:19:44+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/01/GettyImages-1324669080.jpg-lung-cancer.jpg https://hospitalpharmacyeurope.com/clinical-zones/dermatology/small-increased-risk-of-osteoporotic-fracture-with-long-term-use-of-some-topical-steroids/ 2024-08-15T10:21:48+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/01/HPE-GettyImages-506252614.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/ultrasonography-superior-to-clinical-assessment-for-ln-metastases-in-scc-but-with-more-false-positives/ 2024-08-15T10:22:11+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/01/Ultrasonography-superior-to-clinical-assessment-for-LN-metastases-in-SCC-but-with-more-false-positives.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/sex-related-mortality-from-heart-failure-linked-to-left-ventricular-ejection-fraction/ 2024-08-15T10:24:05+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/01/GettyImages-1331257445.jpg-heart-failure.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/aspirin-use-associated-with-improved-survival-in-bladder-and-breast-cancer/ 2024-08-15T10:24:43+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/01/HPE-GettyImages-1199493454.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/nmr-based-metabolomic-diagnostics-identifies-cancer-in-patients-with-non-specific-symptoms/ 2024-08-15T10:24:47+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/01/GettyImages-1218798167.jpg-blood-testing-for-cancer.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/alcoholic-spirit-intake-linked-to-greater-risk-of-ventricular-arrhythmias/ 2024-08-15T10:25:55+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/01/Alcoholic-spirit-intake-linked-to-greater-risk-of-ventricular-arrhythmias.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/just-one-alcoholic-drink-per-day-linked-to-greater-risk-of-atrial-fibrillation/ 2024-08-15T10:26:41+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/01/HPE-GettyImages-1294993946.jpg https://hospitalpharmacyeurope.com/clinical-zones/rheumatology/long-term-bisphosphonate-therapy-not-associated-with-reduced-risk-of-hip-fracture/ 2024-08-15T10:27:12+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/01/HPE-GettyImages-488520012.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/low-dose-aspirin-given-to-nearly-half-of-over-70-year-olds-for-primary-prevention/ 2024-08-15T10:29:01+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/01/Low-dose-aspirin-given-to-nearly-half-of-over-70-year-olds-for-primary-prevention.jpg https://hospitalpharmacyeurope.com/clinical-zones/haematology/intrathoracic-bleeding-incidence-after-rib-fracture-similar-for-doacs-and-vkas/ 2024-08-15T10:32:33+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/01/GettyImages-1201674251.gif-oral-anticoagulants.gif https://hospitalpharmacyeurope.com/clinical-zones/mental-health/potential-biomarker-for-depression-and-response-to-treatment-identified/ 2024-08-15T10:33:47+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/01/GettyImages-1179626266.gif-major-depression.gif https://hospitalpharmacyeurope.com/clinical-zones/oncology/black-men-in-prostate-cancer-trials-have-more-aggressive-disease-but-better-outcomes/ 2024-08-15T10:34:06+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/01/GettyImages-1334849440.gif-black-man.gif https://hospitalpharmacyeurope.com/clinical-zones/oncology/dietary-supplements-taken-by-40-of-patients-living-with-cancer/ 2024-08-15T10:34:22+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/01/GettyImages-1213645504.gif-dietary-supplements.gif https://hospitalpharmacyeurope.com/clinical-zones/oncology/convincing-evidence-for-protective-role-of-high-intake-of-dietary-fibre-in-colorectal-cancer/ 2024-08-15T10:36:11+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/02/HPE-GettyImages-1138392391.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/semaglutide-leads-to-significant-weight-loss-in-obese-patients-without-diabetes/ 2024-08-15T10:49:36+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/02/HPE-GettyImages-1097281014.jpg https://hospitalpharmacyeurope.com/clinical-zones/paediatrics/ppi-use-in-children-associated-with-an-increased-risk-of-asthma/ 2024-08-15T10:53:28+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/02/HPE-GettyImages-1011129540.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/breast-cancer-surpasses-lung-cancer-as-most-common-form-worldwide/ 2024-08-15T10:54:01+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/02/HPE-GettyImages-1184194742.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/higher-intake-of-raw-rather-than-cooked-vegetables-lower-cvd-risk/ 2024-08-15T10:54:12+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/02/Higher-intake-of-raw-rather-than-cooked-vegetables-lower-CVD-risk.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/darolutamide-combination-therapy-improves-overall-survival-in-metastatic-prostate-cancer/ 2024-08-15T10:55:11+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/02/Darolutamide-improves-overall-survival-in-metastatic-prostate-cancer.jpg https://hospitalpharmacyeurope.com/reviews-research/implementing-an-automated-dispensing-system-for-the-safe-management-of-controlled-drugs/ 2024-08-15T10:56:07+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/02/Oxycodone_drug_molecule_SPL_SUO_965x500px.jpg https://hospitalpharmacyeurope.com/wp-content/uploads/2021/02/Figure1_Driver_diagram_500x380px.png https://hospitalpharmacyeurope.com/wp-content/uploads/2021/02/Figure2_SPC_I_chart_500x380px.png https://hospitalpharmacyeurope.com/wp-content/uploads/2021/02/Figure3_SPC_I_chart_500x380px.png https://hospitalpharmacyeurope.com/clinical-zones/mental-health/synaptic-density-reductions-correlate-with-cognitive-scores-in-alzheimers-disease/ 2024-08-15T10:57:57+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/02/Synaptic-density-reductions-correlate-with-cognitive-scores-in-Alzheimers-disease.jpg https://hospitalpharmacyeurope.com/clinical-zones/dermatology/spironolactone-use-does-not-increase-cancer-risk/ 2024-08-15T10:58:22+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/02/Spironolactone-use-does-not-increase-cancer-risk.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/radio-frequency-ablation-useful-for-low-risk-thyroid-papillary-micro-carcinoma/ 2024-08-15T10:58:42+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/02/Radio-frequency-ablation-useful-for-low-risk-thyroid-papillary-micro-carcinoma.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/physical-activity-in-the-elderly-for-just-20-minutes-day-decreases-cardiovascular-risk/ 2024-08-15T10:59:04+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/02/Physical-activity-in-the-elderly-for-just-20-minutes-day-decreases-cardiovascular-risk.jpg https://hospitalpharmacyeurope.com/in-depth/views/adaptation-after-heart-transplantation-a-framework-for-the-future/ 2024-08-15T11:00:53+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/02/heart_transplant_GettyImages_1208716584_965x500px.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/statin-side-effects-affect-less-than-10-of-patients/ 2024-08-15T11:01:01+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/02/Statin-side-effects-affect-less-than-10-of-patients.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/aromatase-inhibitors-reduce-breast-cancer-recurrence-risk-more-than-tamoxifen/ 2024-08-15T11:01:29+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/02/Aromatase-inhibitors-reduce-breast-cancer-recurrence-risk-more-than-tamoxifen.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/anti-hypertensive-drug-use-and-healthy-lifestyle-lowers-risk-of-death/ 2024-08-15T11:01:42+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/02/Anti-hypertensive-drug-use-and-healthy-lifestyle-lowers-risk-of-death.jpg https://hospitalpharmacyeurope.com/clinical-zones/paediatrics/sponsored-iv-ibuprofen-for-perioperative-pain-in-children/ 2024-08-15T11:03:10+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/02/child_with_uv_GettyImages_182696527_965x500px.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/breast-cancer-scans-identifies-tumours-in-40-of-women-with-no-risk-factors/ 2024-08-15T11:03:49+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/02/Breast-cancer-scans-identifies-tumours-in-40-of-women-with-no-risk-factors.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/generalised-and-visceral-body-fat-seen-on-mri-associated-with-lower-cognitive-scores/ 2024-08-15T11:04:02+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/02/Generalised-and-visceral-body-fat-seen-on-MRI-associated-with-lower-cognitive-scores.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/around-40000-fewer-patients-starting-cancer-treatment-in-the-uk-during-the-pandemic/ 2024-08-15T11:04:13+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/02/HPE-GettyImages-1242482746.jpg https://hospitalpharmacyeurope.com/clinical-zones/gastroenterology/probiotics-added-to-peanut-oral-immunotherapy-do-not-increase-remission-rates-but-reduce-gi-symptoms/ 2024-08-15T11:04:26+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/02/Probiotics-added-to-peanut-oral-immunotherapy-do-not-increase-remission-rates-but-reduce-GI-symptoms.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/sleep-extension-reduces-energy-expenditure-and-could-help-with-weight-loss/ 2024-08-15T11:04:36+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/02/Sleep-extension-reduces-energy-expenditure-and-could-help-with-weight-loss.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/mortality-in-heart-disease-patients-lowest-for-bmi-values-between-25-and-35/ 2024-08-15T11:04:53+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/02/Mortality-in-heart-disease-patients-lowest-for-BMI-values-between-25-and-35.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/improvements-in-survival-with-nivolumab-in-patients-with-mesothelioma/ 2024-08-15T11:05:17+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/02/HPE-GettyImages-1133973940.jpg https://hospitalpharmacyeurope.com/clinical-zones/early-intravenous-fluid-use-in-sepsis-enhanced-through-a-range-of-interventions/ 2024-08-15T11:05:38+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/02/Early-intravenous-fluid-use-in-sepsis-enhanced-through-a-range-of-interventions.jpg https://hospitalpharmacyeurope.com/clinical-zones/delayed-inpatient-admission-by-longer-than-5-hours-associated-with-higher-30-day-mortality/ 2024-08-15T11:06:35+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/02/Delayed-inpatient-admission-by-longer-than-5-hours-associated-with-higher-30-day-mortality.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/mri-guided-thermoseed-potential-therapy-for-brain-tumour-ablation/ 2024-08-15T11:06:49+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/02/MRI-guided-thermoseed-potential-therapy-for-brain-tumour-ablation.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/lipoprotein-a-levels-associated-with-greater-risk-of-prostate-cancer/ 2024-08-15T11:07:00+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/02/Lipoprotein-A-levels-associated-with-greater-risk-of-prostate-cancer.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/french-study-suggests-slight-increased-cancer-risk-with-artificial-sweeteners/ 2024-08-15T11:07:49+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/03/French-study-suggests-slight-increased-cancer-risk-with-artificial-sweeteners.jpg https://hospitalpharmacyeurope.com/clinical-zones/mental-health/music-interventions-linked-to-improved-mental-and-physical-aspects-of-health-related-qol/ 2024-08-15T11:08:03+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/03/Music-interventions-linked-to-improved-mental-but-not-physical-aspects-of-health-related-QOL.jpg https://hospitalpharmacyeurope.com/clinical-zones/dermatology/cochrane-systematic-review-provides-some-answers-on-the-use-of-topical-steroids/ 2024-08-15T11:09:22+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/03/Cochrane-systematic-review-provides-some-answers-on-the-use-of-topical-steroids.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/test-can-personalise-use-of-immunotherapy-and-chemotherapy-for-head-and-neck-cancer/ 2024-08-15T11:09:34+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/03/Test-can-personalise-use-of-immunotherapy-and-chemotherapy-for-head-and-neck-cancer.jpg https://hospitalpharmacyeurope.com/clinical-zones/mental-health/medical-marijuana-card-use-increases-incidence-of-cannabis-use-disorder-without-improving-clinical-symptoms/ 2024-08-15T11:10:13+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/03/Medical-marijuana-card-use-increases-incidence-of-cannabis-use-disorder-without-improving-of-clinical-symptoms.jpg https://hospitalpharmacyeurope.com/reviews-research/fetal-alcohol-spectrum-disorders-a-brief-overview/ 2024-08-15T11:10:53+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/03/Fetal_alcohol_spectrum_disorders.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/cumulative-excess-weight-more-important-than-bmi-as-risk-factor-in-colorectal-cancer/ 2024-08-15T11:11:44+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/03/Cumulative-excess-weight-more-important-than-BMI-as-risk-factor-in-colorectal-cancer.jpg https://hospitalpharmacyeurope.com/clinical-zones/dermatology/risk-of-squamous-cell-cancer-higher-in-those-with-prior-actinic-keratoses/ 2024-08-15T11:11:58+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/03/HPE-GettyImages-902349882.jpg https://hospitalpharmacyeurope.com/reviews-research/improving-competencies-in-behaviour-change-support-in-chronic-disease-the-case-of-medication-adherence/ 2024-08-15T11:12:04+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/03/behaviour-change_support_in_chronic_disease.jpg https://hospitalpharmacyeurope.com/in-depth/views/always-great-to-start-the-day-with-a-celebration/ 2024-08-15T11:13:35+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/03/Always-great-to-start-the-day-with-a-celebration%E2%80%A6.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/no-calorie-sweeteners-replacement-for-sugar-sweetened-drinks-reduces-cardiometabolic-risk/ 2024-08-15T11:14:19+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/03/No-calorie-sweeteners-replacement-for-sugar-sweetened-drinks-reduces-cardiometabolic-risk.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/faecal-microbiota-unique-signature-potential-screening-tool-for-pancreatic-adenocarcinoma/ 2024-08-15T11:15:28+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/03/Faecal-microbiota-unique-signature-potential-screening-tool-for-pancreatic-adenocarcinoma.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/statin-absolute-risk-reduction-benefit-for-cardiovascular-outcomes-only-modest/ 2024-08-15T11:16:01+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/03/Statin-absolute-risk-reduction-in-cardiovascular-outcomes-only-modest.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/meat-eaters-at-increased-risk-of-some-types-of-cancer/ 2024-08-15T11:16:13+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/03/Meat-eaters-at-increased-risk-of-some-types-of-cancer.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/machine-learning-models-appear-to-add-little-to-mortality-risk-prediction-after-heart-attacks/ 2024-08-15T11:17:34+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/03/HPE-GettyImages-974694162.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/doacs-superior-to-lmw-heparins-in-venous-thromboembolism/ 2024-08-15T11:18:10+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/03/DOACs-superior-to-LMW-heparins-in-venous-thromboembolism.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/radiotherapy-use-for-cancer-increases-the-risk-of-death-from-cardiovascular-disease/ 2024-08-15T11:18:19+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/03/Radiotherapy-use-for-cancer-increases-cardiovascular-disease-deaths.jpg https://hospitalpharmacyeurope.com/clinical-zones/dermatology/psoriasis-patients-report-higher-analgesic-use-due-to-joint-pain/ 2024-08-15T11:18:37+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/03/Psoriasis-patients-report-higher-analgesic-use-due-to-joint-pain.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/breast-density-on-mammography-linked-with-family-history-of-breast-cancer-in-premenopausal-women/ 2024-08-15T11:18:48+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/03/Breast-density-on-mammography-linked-with-family-history-of-breast-cancer-in-premenopausal-women.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/mortality-benefit-from-increased-step-count-per-day-plateaus/ 2024-08-15T11:18:56+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/03/Mortality-benefit-from-increased-step-count-per-day-plateaued.jpg https://hospitalpharmacyeurope.com/clinical-zones/neurology/higher-tau-levels-linked-to-psychosis-and-cognitive-decline-in-alzheimers-disease/ 2024-08-15T11:19:13+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/03/Higher-tau-levels-linked-to-psychosis-and-cognitive-decline-in-Alzheimers-disease.jpg https://hospitalpharmacyeurope.com/clinical-zones/neurology/pilocarpine-drops-effective-for-presbyopia/ 2024-08-15T11:19:31+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/03/Pilocarpine-drops-effective-for-presbyopia.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/muscle-strengthening-activities-without-aerobics-reduce-cvd-cancer-and-all-cause-mortality-risk/ 2024-08-15T11:19:48+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/03/Muscle-strengthening-activities-without-aerobics-reduce-CVD-cancer-and-all-cause-mortality-risk.jpg https://hospitalpharmacyeurope.com/clinical-zones/paediatrics/anaesthetic-methods-used-in-forearm-reduction-lack-evidence-to-guide-clinician-choice/ 2024-08-15T11:20:14+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/03/Anaesthetic-methods-used-in-forearm-reduction-lack-evidence-to-guide-clinician-choice.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/sodium-intake-from-soluble-paracetamol-linked-to-higher-cvd-and-mortality-risk/ 2024-08-15T11:20:47+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/03/Sodium-intake-from-soluble-paracetamol-linked-to-higher-CVD-and-mortality-risk.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/empagliflozin-effective-when-initiated-at-hospital-for-acute-heart-failure/ 2024-08-15T11:21:05+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/03/Empagliflozin-effective-when-initiated-at-hospital-for-acute-heart-failure.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/lifestyle-intervention-advice-for-patients-with-cardiovascular-risk-factors-appears-limited/ 2024-08-15T11:21:18+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/02/Lifestyle-intervention-advice-for-patients-with-cardiovascular-risk-factors-appears-limited.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/neurofilament-light-best-for-predicting-neurological-outcomes-after-cardiac-arrest/ 2024-08-15T11:21:36+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/03/Neurofilament-light-best-for-predicting-neurological-outcomes-after-cardiac-arrest.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/caffeine-lowers-ldl-cholesterol-through-blockage-of-hepatic-regulators-to-mitigate-cardiovascular-risk/ 2024-08-15T11:21:54+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/02/Caffeine-lowers-LDL-cholesterol-through-blockage-of-hepatic-regulators-to-mitigate-cardiovascular-risk-1.jpg https://hospitalpharmacyeurope.com/clinical-zones/mental-health/dexmedetomidine-use-significantly-reduces-agitation-scores-in-bipolar-disorder/ 2024-08-15T11:22:05+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/02/Dexmedetomidine-use-significantly-reduces-agitation-scores-in-bipolar-disorder.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/magnetic-stimulation-potentially-useful-for-ventricular-storm/ 2024-08-15T11:22:24+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/02/Magnetic-stimulation-potentially-useful-for-ventricular-storm.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/study-shows-atrial-fibrillation-successfully-detected-in-older-patients-via-a-wearable-device/ 2024-08-15T11:23:04+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/02/HPE-GettyImages-1285935490.jpg https://hospitalpharmacyeurope.com/clinical-zones/paediatrics/severe-psoriasis-in-children-effectively-treated-with-fumaric-acid-esters/ 2024-08-15T11:24:20+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/02/HPE-GettyImages-494339020.jpg https://hospitalpharmacyeurope.com/clinical-zones/dermatology/atopic-eczema-increases-risk-of-developing-alzheimers-disease/ 2024-08-15T11:25:03+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/04/Atopic-eczema-increases-risk-of-developing-Alzheimers-disease.jpg https://hospitalpharmacyeurope.com/clinical-zones/paediatrics/study-shows-increase-in-recorded-uk-hospital-admissions-for-food-allergies/ 2024-08-15T11:25:16+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/02/HPE-GettyImages-537629482.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/higher-avocado-intake-associated-with-a-lower-risk-of-cardiovascular-disease/ 2024-08-15T11:25:51+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/04/Higher-avocado-intake-associated-with-a-lower-risk-of-cardiovascular-disease.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/omega-3-supplements-reduce-stress-related-inflammatory-markers/ 2024-08-15T11:26:49+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/04/HPE-GettyImages-1202888974.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/nitrate-and-pde5-inhibitors-concomitant-use-not-associated-with-adverse-cv-events/ 2024-08-15T11:26:51+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/04/Nitrate-and-PDE5-inhibitors-concomitant-use-not-associated-with-adverse-CV-events.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/early-computed-tomography-rules-out-subarachnoid-haemorrhage-in-patients-with-sudden-onset-severe-headache/ 2024-08-15T11:27:29+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/04/Early-computed-tomography-rules-out-subarachnoid-haemorrhage-in-patients-with-sudden-onset-severe-headache.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/increased-risk-of-skin-cancer-with-thiazide-diuretics-in-older-adults/ 2024-08-15T11:28:02+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/04/HPE-GettyImages-1312815696.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/early-glycaemic-control-in-type-2-diabetes-lowers-risk-of-adverse-cv-outcomes/ 2024-08-15T11:28:05+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/04/Early-glycaemic-control-in-type-2-diabetes-lowers-risk-of-adverse-CV-outcomes.jpg https://hospitalpharmacyeurope.com/clinical-zones/neurology/healthy-lifestyle-linked-to-reduced-risk-of-alzheimers-disease-in-later-life/ 2024-08-15T11:28:24+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/04/Healthy-lifestyle-linked-to-reduced-risk-of-Alzheimers-disease-in-later-life-1.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/cardiac-data-from-smartwatches-potentially-less-accurate-in-darker-skinned-individuals/ 2024-08-15T11:28:39+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/04/Cardiac-data-from-smartwatches-potentially-less-accurate-in-darker-skinned-individuals.jpg https://hospitalpharmacyeurope.com/clinical-zones/rheumatology/use-of-beta-blockers-associated-with-analgesic-effect-in-osteoarthritis/ 2024-08-15T11:29:42+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/04/HPE-GettyImages-956015576.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/sodium-glucose-co-transporter-2-inhibitors-lower-adverse-cv-outcomes-in-acute-decompensated-heart-failure/ 2024-08-15T11:29:42+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/04/Sodium-glucose-co-transporter-2-inhibitors-lower-adverse-CV-outcomes-in-acute-decompensated-heart-failure.jpg https://hospitalpharmacyeurope.com/clinical-zones/mental-health/review-finds-depression-risk-significantly-reduced-by-low-levels-of-physical-activity/ 2024-08-15T11:30:06+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/04/Review-finds-depression-risk-significantly-reduced-by-low-levels-of-physical-activity.jpg https://hospitalpharmacyeurope.com/clinical-zones/gastroenterology/simple-dietary-changes-could-reduce-intestinal-inflammation/ 2024-08-15T11:30:08+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/04/HPE-GettyImages-1279892613.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/fenofibrate-use-associated-with-lower-risk-of-vision-threatening-diabetic-retinopathy/ 2024-08-15T11:30:34+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/04/Fenofibrate-use-associated-with-lower-risk-of-vision-threatening-diabetic-retinopathy.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/study-identifies-how-aerobic-exercise-might-reduce-risk-of-colon-cancer/ 2024-08-15T11:30:49+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/04/Study-identifies-how-aerobic-exercise-might-reduce-risk-of-colon-cancer.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/the-presence-of-residual-ctdna-enables-prediction-of-relapse-in-lung-cancer/ 2024-08-15T11:31:14+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/04/The-presence-of-residual-ctDNA-enables-prediction-of-relapse-in-lung-cancer.jpg https://hospitalpharmacyeurope.com/clinical-zones/mental-health/bipolar-disorder-associated-with-increased-risk-of-osteoporosis-but-reduced-by-lithium-therapy/ 2024-08-15T11:31:34+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/04/Bipolar-disorder-associated-with-increased-risk-of-osteoporosis-but-reduced-by-lithium-therapy.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/breast-tomosynthesis-lowers-false-positive-rate-in-comparison-to-traditional-mammography/ 2024-08-15T11:31:43+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/04/Breast-tomosynthesis-lowers-false-positive-rate-in-comparison-to-traditional-mammography.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/daily-coffee-intake-should-be-part-of-a-healthy-diet/ 2024-08-15T11:31:52+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/04/Daily-coffee-intake-should-be-part-of-a-healthy-diet.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/a-reduced-sodium-intake-has-no-effect-on-clinical-events-in-heart-failure-patients/ 2024-08-15T11:32:06+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/04/A-reduced-sodium-intake-has-no-effect-on-clinical-events-in-heart-failure-patients.jpg https://hospitalpharmacyeurope.com/clinical-zones/neurology/mri-based-deep-learning-allows-identification-of-prodromal-alzheimers-disease/ 2024-08-15T11:32:20+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/04/MRI-based-deep-learning-allows-identification-of-prodromal-Alzheimers-disease.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/combing-immune-checkpoint-inhibitors-and-radiotherapy-provides-no-survival-benefit-in-melanoma/ 2024-08-15T11:32:34+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/04/Combing-immune-checkpoint-inhibitors-and-radiotherapy-provides-no-survival-benefit-in-melanoma.jpg https://hospitalpharmacyeurope.com/clinical-zones/rheumatology/rates-of-fracture-detection-found-to-be-comparable-between-ai-and-clinicians/ 2024-08-15T11:32:43+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/04/Rates-of-fracture-detection-found-to-be-comparable-between-AI-and-clinicians.jpg https://hospitalpharmacyeurope.com/clinical-zones/mental-health/long-term-antibiotic-use-in-midlife-women-linked-to-minor-decrease-in-cognition-scores-7-years-later/ 2024-08-15T11:33:11+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/04/Long-term-antibiotic-use-in-midlife-women-linked-to-minor-decrease-in-cognition-scores-7-years-later.jpg https://hospitalpharmacyeurope.com/clinical-zones/gastroenterology/suspected-acute-appendicitis-can-be-initially-assessed-with-ultrasound/ 2024-08-15T11:33:24+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/04/Suspected-acute-appendicitis-can-be-initially-assessed-with-ultrasound.jpg https://hospitalpharmacyeurope.com/clinical-zones/paediatrics/preconception-paternal-use-of-metformin-associated-with-major-birth-defects/ 2024-08-15T11:33:46+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/04/Preconception-paternal-use-of-metformin-associated-with-major-birth-defects.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/non-harmful-dysnatraemia-and-dyskalemia-commonly-seen-in-patients-with-acute-copd-exacerbations/ 2024-08-15T11:34:17+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/03/Non-harmful-dysnatraemia-and-dyskalemia-commonly-seen-in-patients-with-acute-COPD-exacerbations.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/lower-doses-of-pioglitazone-provide-superior-cardiovascular-risk-reduction-and-less-adverse-effects/ 2024-08-15T11:34:26+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/03/Lower-doses-of-pioglitazone-provide-superior-cardiovascular-risk-reduction-and-less-adverse-effects.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/analysis-finds-screening-endoscopy-before-age-50-in-women-linked-to-lower-risk-of-crc-diagnosis/ 2024-08-15T11:35:23+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/05/Analysis-finds-screening-endoscopy-before-age-50-in-women-linked-to-lower-risk-of-CRC-diagnosis.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/metformin-added-to-breast-cancer-chemotherapy-not-beneficial/ 2024-08-15T11:35:57+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/05/Metformin-added-to-breast-cancer-chemotherapy-not-beneficial.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/study-finds-apatinib-therapy-promising-for-thymic-epithelial-tumours/ 2024-08-15T11:36:08+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/05/Study-finds-apatinib-therapy-promising-for-thymic-epithelial-tumours.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/time-restricted-eating-pattern-lowers-cvd-risk-in-breast-cancer-survivors/ 2024-08-15T11:36:19+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/05/Time-restricted-eating-pattern-lowers-CVD-risk-in-breast-cancer-survivors.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/probiotic-mixture-found-to-reduce-incidence-of-wheezing-in-preschool-asthmatics/ 2024-08-15T11:36:29+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/05/Probiotic-mixture-found-to-reduce-incidence-of-wheezing-in-preschool-asthmatics.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/kailuan-study-shows-elevated-arterial-stiffness-best-predictor-of-subsequent-diabetes-in-hypertensives/ 2024-08-15T11:36:54+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/05/Kailuan-study-shows-elevated-arterial-stiffness-best-predictor-of-subsequent-diabetes-in-hypertensives.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/alirocumab-combined-with-statins-stabilises-coronary-artery-plaques-following-acute-mi/ 2024-08-15T11:37:08+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/05/Alirocumab-combined-with-statins-stabilises-coronary-artery-plaques-following-acute-MI.jpg https://hospitalpharmacyeurope.com/clinical-zones/haematology/study-finds-systemic-corticosteroid-use-increases-risk-of-hospitalisation-for-vaso-occlusive-episodes-in-sickle-cell-disease/ 2024-08-15T11:37:21+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/05/Study-finds-systemic-corticosteroid-use-increases-risk-of-hospitalisation-for-vaso-occlusive-episodes-in-sickle-cell-disease.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/analysis-finds-espresso-coffee-increases-total-serum-cholesterol-levels/ 2024-08-15T11:37:30+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/05/Analysis-finds-espresso-coffee-increases-total-serum-cholesterol-levels.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/pcsk9-inhibitors-and-ezetimibe-added-to-statins-only-reduce-non-fatal-mi-and-stroke-in-high-risk-patients-but-not-death/ 2024-08-15T11:37:52+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/05/PCSK9-inhibitors-and-ezetimibe-added-to-statins-only-reduce-non-fatal-MI-and-stroke-in-high-risk-patients-but-not-death.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/ai-based-breast-cancer-screening-could-reduce-radiologist-workload/ 2024-08-15T11:38:02+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/05/AI-based-breast-cancer-screening-could-reduce-radiologist-workload.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/higher-body-fat-levels-associated-with-increased-risk-of-prostate-cancer-death/ 2024-08-15T11:38:10+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/05/Higher-body-fat-levels-associated-with-increased-risk-of-prostate-cancer-death.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/coronary-artery-calcium-scores-add-little-to-cvd-risk-assessment/ 2024-08-15T11:38:19+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/05/Coronary-artery-calcium-scores-add-little-to-CVD-risk-assessment.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/cancer-patients-with-covid-19-at-increased-risk-of-hospitalisation-and-death/ 2024-08-15T11:38:29+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/05/Cancer-patients-with-COVID-19-at-increased-risk-of-hospitalisation-and-death.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/study-finds-tirzepatide-reduces-body-weight-by-over-20-in-obese-patients/ 2024-08-15T11:39:13+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/05/Study-finds-tirzepatide-reduces-body-weight-by-over-20-in-obese-patients.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/less-than-two-thirds-of-patients-alive-10-years-after-out-of-hospital-cardiac-arrest/ 2024-08-15T11:39:30+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/05/Less-than-two-thirds-of-patients-alive-10-years-after-out-of-hospital-cardiac-arrest.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/short-interfering-rna-able-to-lower-elevated-levels-of-lipoprotein-a/ 2024-08-15T11:39:49+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/04/Short-interfering-RNA-able-to-lower-elevated-levels-of-lipoprotein-a.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/increased-risk-of-second-cancer-among-breast-cancer-survivors-linked-to-higher-bmi/ 2024-08-15T11:39:59+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/05/HPE-GettyImages-1172601251.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/adult-asthmatics-have-increased-risk-of-developing-obesity/ 2024-08-15T11:41:03+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/04/Adult-asthmatics-have-increased-risk-of-developing-obesity.jpg https://hospitalpharmacyeurope.com/clinical-zones/paediatrics/high-dose-vitamin-d-not-associated-with-serious-adverse-events-in-young-children/ 2024-08-15T11:41:43+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/04/High-dose-vitamin-D-not-associated-with-serious-adverse-events-in-young-children.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/first-pass-success-rate-similar-for-inclined-and-supine-positioning-during-endotracheal-intubation/ 2024-08-15T11:41:53+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/04/First-pass-success-rate-similar-for-inclined-and-supine-positioning-during-endotracheal-intubation.jpg https://hospitalpharmacyeurope.com/clinical-zones/mental-health/increased-activity-of-specific-neural-network-predictive-of-stress-response/ 2024-08-15T11:42:08+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/04/HPE-GettyImages-1207080509.jpg https://hospitalpharmacyeurope.com/reviews-research/high-output-stomas-a-background/ 2024-08-15T11:43:15+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/06/Stomas_Getty_1084120504_965x500px.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/hospital-discharge-smoking-cessation-programs-found-to-be-equivalent/ 2024-08-15T11:43:43+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/06/Hospital-discharge-smoking-cessation-programs-found-to-be-equivalent.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/multi-cancer-early-detection-test-validated-in-study/ 2024-08-15T11:44:17+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/06/GettyImages-1219696566-HPE-cancer.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/bariatric-surgery-reduces-obesity-related-cancer-risk/ 2024-08-15T11:44:24+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/06/Bariatric-surgery-reduces-obesity-related-cancer-risk.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/review-questions-benefit-of-adding-intranasal-antihistamines-to-inhaled-steroids-in-allergic-rhinitis/ 2024-08-15T11:45:32+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/06/Review-questions-benefit-of-adding-intranasal-antihistamines-to-inhaled-steroids-in-allergic-rhinitis.jpg https://hospitalpharmacyeurope.com/clinical-zones/rheumatology/walking-associated-with-significant-reduction-in-new-frequent-knee-pain-in-osteoarthritis/ 2024-08-15T11:45:58+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/06/Walking-associated-with-significant-reduction-in-new-frequent-knee-pain-in-osteoarthritis.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/ema-recommends-olaparib-for-treatment-of-high-risk-early-breast-cancer/ 2024-08-15T11:46:30+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/06/EMA-recommends-olaparib-for-treatment-of-high-risk-early-breast-cancer.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/paracetamol-use-found-to-increase-systolic-blood-pressure/ 2024-08-15T11:47:09+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/06/Paracetamol-use-found-to-increase-systolic-blood-pressure.jpg https://hospitalpharmacyeurope.com/news/infectious-disease/commonly-used-sepsis-model-fails-to-identify-over-two-thirds-of-patients-with-the-condition/ 2024-08-15T11:47:13+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/06/GettyImages-812951444-sepsis.jpg https://hospitalpharmacyeurope.com/clinical-zones/dermatology/green-tea-extract-reduces-severity-of-radiation-induced-dermatitis/ 2024-08-15T11:47:35+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/06/Green-tea-extract-reduces-severity-of-radiation-induced-dermatitis.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/weekly-tirzepatide-produces-significant-weight-in-obese-patients/ 2024-08-15T11:47:45+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/06/Weekly-tirzepatide-produces-significant-weight-in-obese-patients.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/polq-inhibitors-identified-as-a-new-class-of-targeted-cancer-drugs/ 2024-08-15T11:47:58+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/06/HPE-GettyImages-1224079626.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/cvd-risk-after-prolonged-sitting-more-prominent-in-lower-income-countries/ 2024-08-15T11:48:04+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/06/HPE-CVD-risk-from-prolonged-sitting-higher-in-lower-income-countries.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/combing-pomegranate-juice-with-aerobic-training-improves-risk-factors-in-type-2-diabetes/ 2024-08-15T11:48:13+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/06/Combing-pomegranate-juice-with-aerobic-training-improves-risk-factors-in-type-2-diabetes.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/meta-analysis-shows-all-cause-mortality-risk-reduced-in-chd-by-keeping-physically-active/ 2024-08-15T11:48:22+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/06/Meta-analysis-shows-all-cause-mortality-risk-reduced-in-CHD-by-keeping-physically-active.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/analysis-shows-heart-failure-exercise-based-cardiac-rehabilitation-programs-equally-beneficial/ 2024-08-15T11:48:30+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/06/Analysis-shows-heart-failure-exercise-based-cardiac-rehabilitation-programs-equally-beneficial.jpg https://hospitalpharmacyeurope.com/clinical-zones/dermatology/study-finds-higher-fish-intake-linked-to-increased-melanoma-risk/ 2024-08-15T11:49:01+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/06/Study-finds-higher-fish-intake-linked-to-increased-melanoma-risk.jpg https://hospitalpharmacyeurope.com/clinical-zones/paediatrics/rct-finds-multiplex-pcr-point-of-care-testing-fails-to-reduce-antibiotic-use-in-acutely-ill-children/ 2024-08-15T11:49:17+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/06/RCT-finds-multiplex-PCR-point-of-care-testing-fails-to-reduce-antibiotic-use-in-acutely-ill-children.jpg https://hospitalpharmacyeurope.com/clinical-zones/mental-health/meta-analysis-suggests-omega-3-supplements-not-effective-for-depression-in-cardiometabolic-disease/ 2024-08-15T11:50:19+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/06/Meta-analysis-suggests-omega-3-supplements-not-effective-for-depression-in-cardiometabolic-disease.jpg https://hospitalpharmacyeurope.com/clinical-zones/neurology/fda-approves-aducanumab-a-first-in-class-drug-for-alzheimers-disease/ 2024-08-15T11:51:40+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/06/HPE-GettyImages-151645089.jpg https://hospitalpharmacyeurope.com/clinical-zones/mental-health/transcranial-magnetic-stimulation-brain-connectivity-changes-in-major-depression-visible-on-mri-scan/ 2024-08-15T11:52:05+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/06/Transcranial-magnetic-stimulation-brain-connectivity-changes-in-major-depression-visible-on-MRI-scan.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/study-finds-similar-mortality-benefit-for-unsweetened-and-coffee-sweetened-with-sugar/ 2024-08-15T11:52:23+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/05/Study-finds-similar-mortality-benefit-for-unsweetened-and-coffee-sweetened-with-sugar.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/post-mi-mortality-risk-lower-among-overweight-obese-but-increased-for-underweight-individuals/ 2024-08-15T11:52:34+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/05/Post-MI-mortality-risk-lower-among-overweightobese-but-increased-for-underweight-individuals.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/metformin-or-lifestyle-interventions-unable-to-reduce-adverse-cv-outcome-risk-in-pre-diabetics/ 2024-08-15T11:52:48+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/05/Metformin-or-lifestyle-interventions-unable-to-reduce-adverse-CV-outcome-risk-in-pre-diabetics.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/sglt-2-inhibitors-and-metformin-first-line-in-type-2-diabetes-produce-similar-cardiovascular-outcomes/ 2024-08-15T11:53:04+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/05/SGLT-2-inhibitors-and-metformin-first-line-in-type-2-diabetes-produce-similar-cardiovascular-outcomes.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/urothelial-carcinoma-detectable-with-biomarker-keratin-17/ 2024-08-15T11:54:41+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/06/HPE-GettyImages-1291123737.jpg https://hospitalpharmacyeurope.com/clinical-zones/neurology/additional-mri-with-ct-scan-has-no-does-not-affect-clinical-outcomes-in-acute-ischaemic-stroke/ 2024-08-15T11:55:11+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/07/No-effect-on-outcome-from-additional-MRI-with-CT-scan-in-acute-ischaemic-stroke.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/intensity-modulated-radiation-therapy-effective-without-chemotherapy-in-nasopharyngeal-cancer/ 2024-08-15T13:53:35+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/08/Intensity-modulated-radiation-therapy-without-chemotherapy-effective-for-nasopharyngeal-cancer.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/risk-of-open-angle-glaucoma-increased-for-hypertensives-with-a-high-salt-intake/ 2024-08-15T13:55:16+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/08/Risk-of-open-angle-glaucoma-increased-for-hypertensives-with-a-high-salt-intake.jpg https://hospitalpharmacyeurope.com/clinical-zones/mental-health/first-nmda-receptor-antagonist-approved-for-major-depression-by-fda/ 2024-08-15T13:56:04+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/08/First-NMDA-receptor-antagonist-approved-for-major-depression-by-FDA.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/machine-learning-mri-model-offers-enhanced-prediction-of-liver-cancer-recurrence/ 2024-08-15T13:56:40+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/08/Machine-learning-MRI-model-offers-enhanced-prediction-of-liver-cancer-recurrence.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/male-cancer-incidence-higher-and-only-partly-accounted-for-by-known-risk-factors/ 2024-08-15T13:57:41+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/08/Male-cancer-incidence-higher-and-only-partly-accounted-for-by-known-risk-factors.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/genetic-risk-score-could-enhance-triaging-of-men-with-suspected-prostate-cancer/ 2024-08-15T13:57:50+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/08/Genetic-risk-score-could-enhance-triaging-of-men-with-suspected-prostate-cancer.jpg https://hospitalpharmacyeurope.com/clinical-zones/neurology/increased-leisure-activities-associated-with-lower-risk-of-all-cause-dementia/ 2024-08-15T13:58:33+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/08/Increased-leisure-activities-associated-with-lower-risk-of-all-cause-dementia.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/canakinumab-trial-data-in-non-small-cell-lung-cancer-released/ 2024-08-15T13:58:59+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/08/Canakinumab-trial-data-in-non-small-cell-lung-cancer-released.jpg https://hospitalpharmacyeurope.com/clinical-zones/malarial-monoclonal-antibody-highly-protective-against-controlled-infection/ 2024-08-15T14:03:03+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/08/Malarial-monoclonal-antibody-highly-protective-against-controlled-infection.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/cancer-survivors-at-greater-risk-of-cardiovascular-disease/ 2024-08-15T14:03:56+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/08/Cancer-survivors-at-greater-risk-of-cardiovascular-disease.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/resistant-starch-decreases-non-crc-risk-in-lynch-syndrome/ 2024-08-15T14:04:09+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/08/Resistant-starch-decreases-non-CRC-risk-in-Lynch-syndrome.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/high-lung-cancer-risk-for-those-in-non-recommended-screening-groups/ 2024-08-15T14:05:46+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/08/High-lung-cancer-risk-for-those-in-non-recommended-screening-groups.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/daily-insulin-use-increases-cancer-risk-in-type-1-diabetics/ 2024-08-15T14:06:05+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/08/Daily-insulin-use-increases-cancer-risk-in-type-1-diabetics.jpg https://hospitalpharmacyeurope.com/clinical-zones/rheumatology/higher-vitamin-k-levels-reduce-knee-oa-symptoms/ 2024-08-15T14:07:31+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/08/Higher-vitamin-K-levels-reduce-knee-OA-symptoms.jpg https://hospitalpharmacyeurope.com/clinical-zones/dermatology/dietary-elimination-has-minimal-effect-on-childrens-atopic-eczema/ 2024-08-15T14:09:54+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/08/Dietary-elimination-has-minimal-effect-on-childrens-atopic-eczema.jpg https://hospitalpharmacyeurope.com/clinical-zones/haematology/gene-therapy-normalises-factor-ix-in-haemophilia-b/ 2024-08-15T14:12:10+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/07/Gene-therapy-normalises-factor-IX-in-haemophilia-B.jpg https://hospitalpharmacyeurope.com/clinical-zones/dermatology/ruxolitinib-cream-approved-by-fda-for-vitiligo/ 2024-08-15T14:12:33+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/07/Ruxolitinib-cream-approved-by-FDA-for-vitiligo.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/chmp-recommends-conditional-marketing-authorisation-for-teclistamab-monotherapy/ 2024-08-15T14:12:51+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/07/CHMP-recommends-conditional-marketing-authorisation-for-teclistamab-monotherapy.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/moderate-intensity-statin-therapy-with-ezetimibe-non-inferior-to-high-intensity-mono-therapy/ 2024-08-15T14:13:37+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/07/Moderate-intensity-statin-therapy-with-ezetimibe-non-inferior-to-high-intensity-mono-therapy.jpg https://hospitalpharmacyeurope.com/clinical-zones/emergency-and-critical-care/severe-vitamin-d-deficiency-linked-with-higher-mortality-and-longer-hospital-stay-in-sepsis/ 2024-08-15T14:14:28+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/07/Severe-vitamin-D-deficiency-linked-with-higher-mortality-and-longer-hospital-stay-in-sepsis.jpg https://hospitalpharmacyeurope.com/clinical-zones/neurology/antihistamines-superior-to-benzodiazepines-in-vertigo/ 2024-08-15T14:14:59+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/07/Antihistamines-superior-to-benzodiazepines-in-vertigo.jpg https://hospitalpharmacyeurope.com/clinical-zones/rheumatology/hyaluronic-acid-of-limited-value-in-knee-osteoarthritis/ 2024-08-15T14:15:10+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/07/Hyaluronic-acid-of-limited-value-in-knee-osteoarthritis.jpg https://hospitalpharmacyeurope.com/clinical-zones/haematology/use-of-ravulizumab-for-pnh-extended-to-children/ 2024-08-15T14:15:30+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/07/HP-GettyImages-1138888803-PNH.jpg https://hospitalpharmacyeurope.com/clinical-zones/emergency-and-critical-care/low-dose-methoxyflurane-provides-superior-pain-relief-in-trauma-patients/ 2024-08-15T14:16:26+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/07/Low-dose-methoxyflurane-provides-superior-pain-relief-in-trauma-patients.jpg https://hospitalpharmacyeurope.com/clinical-zones/neurology/noradrenergic-drugs-improve-global-cognition-and-apathy-in-alzheimers-disease/ 2024-08-15T14:17:02+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/07/Noradrenergic-drugs-improve-global-cognition-and-apathy-in-Alzheimers-disease.jpg https://hospitalpharmacyeurope.com/clinical-zones/haematology/topical-tranexamic-acid-reduces-need-for-anterior-nasal-packing-in-epistaxis/ 2024-08-15T14:17:15+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/07/Topical-tranexamic-acid-reduces-need-for-anterior-nasal-packing-in-epistaxis.jpg https://hospitalpharmacyeurope.com/clinical-zones/mental-health/eszopiclone-and-lemborexant-show-favourable-profile-for-management-of-insomnia/ 2024-08-15T14:17:24+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/07/Eszopiclone-and-lemborexant-show-favourable-profile-for-management-of-insomnia.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/daily-avocado-intake-has-no-significant-effect-on-visceral-adiposity/ 2024-08-15T14:17:41+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/07/Daily-avocado-intake-has-no-significant-effect-on-visceral-adiposity.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/frequently-adding-salt-to-food-increases-the-risk-of-premature-death/ 2024-08-15T14:17:51+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/07/Frequently-adding-salt-to-food-increases-the-risk-of-premature-death.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/weekend-warriors-and-regularly-active-have-similar-mortality/ 2024-08-15T14:17:59+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/07/Weekend-warriors-and-regularly-active-have-similar-mortality.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/arterial-stiffness-progresses-more-slowly-in-statin-users/ 2024-08-15T14:18:09+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/07/Arterial-stiffness-progresses-more-slowly-in-statin-users.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/nice-approves-pemigatinib-for-patients-with-advanced-cholangiocarcinoma/ 2024-08-15T14:20:16+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/07/HPE-GettyImages-619381256-cholangiocarcinoma.jpg https://hospitalpharmacyeurope.com/clinical-zones/paediatrics/early-biologic-use-in-systemic-juvenile-idiopathic-arthritis-reduces-need-for-steroids/ 2024-08-15T14:22:00+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/07/HPE-GettyImages-935947672-SJIA.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/tepotinib-granted-early-access-for-advanced-non-small-cell-lung-cancer/ 2024-08-15T14:22:45+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/07/HPE-GettyImages-1183311083-topinib.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/apatinib-neoadjuvant-therapy-effective-for-advanced-gastric-cancer/ 2024-08-15T14:23:20+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/07/HPE-GettyImages-1168181167-Stomach-cancer.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/both-tamoxifen-and-tumour-size-best-predictors-of-long-term-survival-in-breast-cancer/ 2024-08-15T14:24:41+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/07/HPE-GettyImages-1223164082.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/combination-therapy-increases-progression-free-survival-in-advanced-prostate-cancer/ 2024-08-15T14:25:10+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/07/HPE-GettyImages-865378008.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/higher-coffee-intake-inversely-related-to-ihd-mortality-over-last-20-years/ 2024-08-15T14:26:00+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/07/Higher-coffee-intake-inversely-related-to-IHD-mortality-over-last-20-years.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/cml-real-world-suggests-higher-level-of-second-cancers-and-comorbidities/ 2024-08-15T14:27:09+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/07/CML-real-world-suggests-higher-level-of-second-cancers-and-comorbidities.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/next-day-car-t-cells-process-effective-in-acute-lymphoblastic-leukaemia/ 2024-08-15T14:27:22+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/07/Next-day-CAR-T-cells-process-effective-in-acute-lymphoblastic-leukaemia.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/electronic-noses-found-to-have-good-diagnostic-accuracy-for-cancer-detection/ 2024-08-15T14:29:05+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/07/Electronic-noses-found-to-have-good-diagnostic-accuracy-for-cancer-detection.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/study-shows-heart-failure-associated-with-increased-incidence-of-cancer/ 2024-08-15T14:29:46+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/07/HPE-GettyImages-1271878579-HF.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/apatinib-addition-to-doxorubicin-improves-outcomes-in-platinum-resistant-recurrent-ovarian-cancer/ 2024-08-15T14:29:54+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/07/Apatinib-addition-to-doxorubicin-improves-outcomes-in-platinum-resistant-recurrent-ovarian-cancer.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/rct-finds-cocoa-flavanol-supplement-failed-to-reduce-cardiovascular-events/ 2024-08-15T14:30:03+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/07/RCT-finds-cocoa-flavanol-supplement-failed-to-reduce-cardiovascular-events.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/ability-to-stand-on-one-leg-for-10s-associated-with-reduced-mortality-risk/ 2024-08-15T14:31:04+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/06/Ability-to-stand-on-one-leg-for-10s-associated-with-reduced-mortality-risk.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/neoadjuvant-therapy-before-surgery-extremely-effective-in-dmmr-colon-cancer/ 2024-08-15T14:33:38+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/09/Neoadjuvant-therapy-before-surgery-extremely-effective-in-dMMR-colon-cancer.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/rp2-oncolytic-hsv-therapy-a-promising-approach-for-advanced-unresponsive-cancer/ 2024-08-15T14:33:45+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/09/RP2-oncolytic-HSV-therapy-a-promising-approach-for-advanced-unresponsive-cancer.jpg https://hospitalpharmacyeurope.com/reviews-research/management-of-high-output-stomas/ 2024-08-15T14:33:49+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/06/Intestine_Getty_1225227338_965x500px.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/single-caffeine-genotype-associated-with-longer-prostate-cancer-survival/ 2024-08-15T14:34:15+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/09/Single-caffeine-genotype-associated-with-longer-prostate-cancer-survival.jpg https://hospitalpharmacyeurope.com/clinical-zones/dermatology/tumour-infiltrating-lymphocyte-therapy-in-advanced-melanoma-superior-to-ipilimumab/ 2024-08-15T14:35:00+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/09/Tumour-infiltrating-lymphocyte-therapy-in-advanced-melanoma-superior-to-ipilimumab.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/use-of-anti-hypertensives-associated-with-reduced-risk-of-colorectal-cancer-mortality/ 2024-08-15T14:35:31+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/08/HPE-GettyImages-1289386618-antihypertensives-and-cancer.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/inspiratory-muscle-strength-training-reduces-blood-pressure/ 2024-08-15T14:35:35+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/09/Inspiratory-muscle-strength-training-reduces-blood-pressure.jpg https://hospitalpharmacyeurope.com/clinical-zones/dermatology/risk-of-atopic-eczema-reduced-by-probiotics/ 2024-08-15T14:35:56+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/08/HPE-GettyImages-85652515-probiotics.jpg https://hospitalpharmacyeurope.com/clinical-zones/neurology/tofersen-reduces-levels-of-sod1-protein-in-als-patients/ 2024-08-15T14:36:38+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/09/Tofersen-reduces-levels-of-SOD1-protein-in-ALS-patients.jpg https://hospitalpharmacyeurope.com/clinical-zones/paediatrics/nearly-half-of-paediatric-opioid-prescriptions-high-risk/ 2024-08-15T14:36:53+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/08/HPE-GettyImages-696830780-opioids-young-people.jpg https://hospitalpharmacyeurope.com/clinical-zones/neurology/multivitamins-improve-global-cognition-more-than-cocoa-extract/ 2024-08-15T14:37:02+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/09/Multivitamins-improve-global-cognition-more-than-cocoa-extract.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/sotorasib-and-panitumumab-effective-for-treatment-resistant-metastatic-colorectal-cancer/ 2024-08-15T14:37:17+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/09/Sotorasib-and-panitumumab-effective-for-treatment-resistant-metastatic-colorectal-cancer.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/cardiac-biomarkers-do-not-aid-cv-risk-stratification-in-patients-with-psoriasis-disease/ 2024-08-15T14:38:00+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/03/Cardiac-biomarkers-do-not-aid-CV-risk-stratification-in-patients-with-psoriasis-disease.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/low-vitamin-d-levels-associated-with-lower-overall-survival-in-invasive-melanoma/ 2024-08-15T14:38:39+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/09/Low-vitamin-D-levels-associated-with-lower-overall-survival-in-invasive-melanoma.jpg https://hospitalpharmacyeurope.com/clinical-zones/dermatology/first-in-class-oral-interleukin-23-inhibitor-jnj-77242113-effective-in-moderate-to-severe-psoriasis/ 2024-08-15T14:38:42+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/07/First-in-class_oral_interleukin-23_inhibitor_JNJ-77242113_effective_in_moderate_to_severe_psoriasis.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/dietary-changes-provide-greatest-reduction-in-cvd-events-for-stage-1-hypertensives/ 2024-08-15T14:38:50+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/09/Dietary-changes-have-greatest-reduction-in-CVD-events-for-stage-1-hypertensives.jpg https://hospitalpharmacyeurope.com/clinical-zones/dermatology/tapinarof-cream-effective-in-mild-to-moderate-plaque-psoriasis/ 2024-08-15T14:39:00+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/12/GettyImages-1277131346.gif-psoriasis.gif https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/statin-therapy-offers-life-long-benefit-against-cardiovascular-disease/ 2024-08-15T14:39:17+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/09/Statin-therapy-offers-life-long-benefit-against-cardiovascular-disease.jpg https://hospitalpharmacyeurope.com/clinical-zones/dermatology/survey-finds-many-europeans-fail-to-heed-sun-awareness-measures/ 2024-08-15T14:40:35+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/09/Survey-finds-many-Europeans-fail-to-heed-sun-awareness-measures.jpg https://hospitalpharmacyeurope.com/clinical-zones/neurology/dementia-risk-lowered-by-higher-and-more-intense-daily-steps/ 2024-08-15T14:40:55+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/09/Dementia-risk-lowered-by-higher-and-more-intense-daily-steps.jpg https://hospitalpharmacyeurope.com/clinical-zones/dermatology/bimekizumab-approved-in-eu-for-moderate-to-severe-psoriasis/ 2024-08-15T14:41:06+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/08/HPE-GettyImages-1221711786-bimekizumab.jpg https://hospitalpharmacyeurope.com/clinical-zones/dermatology/basal-cell-carcinoma-diagnosis-improved-upon-with-novel-imaging-technique/ 2024-08-15T14:41:10+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/09/Basal-cell-carcinoma-diagnosis-improved-upon-with-novel-imaging-technique.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/new-onset-arrhythmia-risk-greater-in-patients-prescribed-cannabis-for-chronic-pain/ 2024-08-15T14:42:56+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/09/New-onset-arrhythmia-risk-greater-in-patients-prescribed-cannabis-for-chronic-pain.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/asundexian-potentially-useful-novel-oral-anticoagulant/ 2024-08-15T14:43:08+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/09/Asundexian-potentially-useful-novel-oral-anticoagulant.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/higher-tisagenlecleucel-doses-more-effective-in-children-with-relapsed-lymphoblastic-leukaemia/ 2024-08-15T14:43:17+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/09/Higher-tisagenlecleucel-doses-more-effective-in-children-with-relapsed-lymphoblastic-leukaemia.jpg https://hospitalpharmacyeurope.com/clinical-zones/dermatology/abrocitinib-and-topical-therapy-effective-in-moderate-to-severe-atopic-eczema/ 2024-08-15T14:43:28+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/08/HPE-GettyImages-155137492-abrocitinib.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/autoimmune-thyroiditis-linked-to-increased-risk-of-thyroid-cancer-in-children/ 2024-08-15T14:43:43+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/09/Autoimmune-thyroiditis-linked-to-increased-risk-of-thyroid-cancer-in-children.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/atrial-fibrillation-detection-improved-with-smartphone-app/ 2024-08-15T14:44:03+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/09/Atrial-Fibrillation-detection-improved-with-smartphone-app.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/early-onset-colorectal-cancer-diagnosis-possible-with-mirna-plasma-signature/ 2024-08-15T14:44:19+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/08/Early-onset-colorectal-cancer-diagnosis-possible-with-miRNA-plasma-signature.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/polypill-effective-strategy-for-secondary-prevention/ 2024-08-15T14:44:30+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/08/Polypill-effective-strategy-for-secondary-prevention.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/car-t-cells-and-focused-ultrasound-suppress-tumour-growth/ 2024-08-15T14:45:52+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/08/HPE-GettyImages-537528872-ultrasound-cancer.jpg https://hospitalpharmacyeurope.com/clinical-zones/immunology/addition-of-dupilumab-to-immunotherapy-offers-no-benefit-in-seasonal-allergic-rhinitis/ 2024-08-15T14:46:52+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/08/HPE-GettyImages-1088395848-dupilumab-and-AR.jpg https://hospitalpharmacyeurope.com/clinical-zones/haematology/thin-film-and-rapid-diagnostic-test-an-effective-screen-for-malaria/ 2024-08-15T14:50:17+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/08/HPE-GettyImages-822664896-malaria.jpg https://hospitalpharmacyeurope.com/clinical-zones/neurology/physical-activity-slows-cognitive-decline-in-those-with-high-tau-levels/ 2024-08-15T14:53:39+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/08/HPE-GettyImages-1064220756-cognitive-decline.jpg https://hospitalpharmacyeurope.com/news/iv-fluid-therapy-nutrition/no-mortality-advantage-for-balanced-fluids-over-saline-in-critically-ill-patients/ 2024-08-15T14:54:47+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/08/HPE-GettyImages-1261298735-IV-fluids.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/avelumab-approved-by-smc-as-maintenance-therapy-for-urothelial-cancer/ 2024-08-15T14:56:04+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/08/HPE-GettyImages-902846724-bladder-cancer.jpg https://hospitalpharmacyeurope.com/clinical-zones/haematology/sutimlimab-receives-eu-approval-for-cold-agglutinin-haemolytic-anaemia/ 2024-08-15T14:56:29+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/11/Sutimlimab-receives-EU-approval-for-cold-agglutinin-haemolytic-anaemia.gif https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/higher-olive-oil-intake-reduces-cvd-and-all-cause-mortality-risk/ 2024-08-15T14:56:38+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/11/Higher-olive-oil-intake-reduces-CVD-and-all-cause-mortality-risk.gif https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/statin-induced-muscle-symptoms-not-helped-by-vitamin-d/ 2024-08-15T14:56:48+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/11/Statin-induced-muscle-symptoms-not-helped-by-vitamin-D.gif https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/hdl-cholesterol-cardioprotective-role-questioned/ 2024-08-15T14:57:11+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/11/HDL-cholesterol-cardioprotective-role-questioned.gif https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/milrinone-and-dobutamine-equally-effective-in-cardiogenic-shock/ 2024-08-15T14:57:18+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/08/HPE-GettyImages-867502090-cardiogenic-shock.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/honey-intake-improves-cardiometabolic-risk/ 2024-08-15T14:57:23+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/11/Honey-intake-improves-cardiometabolic-risk.gif https://hospitalpharmacyeurope.com/clinical-zones/neurology/multiple-sclerosis-risk-from-anti-diabetic-medication-dependent-on-patient-age/ 2024-08-15T14:57:36+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/11/Multiple-sclerosis-risk-from-anti-diabetic-medication-dependent-on-patient-age.gif https://hospitalpharmacyeurope.com/clinical-zones/dermatology/upadacitinib-superior-to-dupilumab-in-atopic-eczema/ 2024-08-15T14:58:04+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/08/HPE-GettyImages-1270933857-atopic-eczema.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/continued-radiotherapy-reduces-localised-breast-cancer-recurrence-but-not-overall-survival/ 2024-08-15T14:59:15+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/11/Continued-radiotherapy-reduces-localised-breast-cancer-recurrence-but-not-overall-survival.gif https://hospitalpharmacyeurope.com/clinical-zones/neurology/gantenerumab-unable-to-achieve-primary-outcome-in-alzheimers-disease/ 2024-08-15T14:59:25+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/11/Gantenerumab-unable-to-achieve-primary-outcome-in-Alzheimers-disease.gif https://hospitalpharmacyeurope.com/clinical-zones/neurology/anticoagulation-reversal-agents-show-similar-efficacy-following-an-intracranial-haemorrhage/ 2024-08-15T14:59:35+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/11/Anticoagulation-reversal-agents-show-similar-efficacy-following-an-intracranial-haemorrhage.gif https://hospitalpharmacyeurope.com/clinical-zones/paediatrics/palforzia-efficacy-in-childhood-peanut-allergy-improves-over-time/ 2024-08-15T15:00:18+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/08/HPE-GettyImages-470795190-Peanut-allergy.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/ai-software-to-aid-detection-of-prostate-cancer-approved-by-fda/ 2024-08-15T15:04:25+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/09/HPE-GettyImages-498813697-prostate-cancer.jpg https://hospitalpharmacyeurope.com/clinical-zones/mental-health/treatment-resistant-depression-trials-have-large-placebo-response/ 2024-08-15T15:05:03+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/09/HPE-GettyImages-1272795673-treatment-resistant-depression.jpg https://hospitalpharmacyeurope.com/clinical-zones/gastroenterology/probiotic-yogurt-with-antibiotics-restores-gut-microbiota/ 2024-08-15T15:11:23+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/09/HPE-GettyImages-178051394-Probiotics.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/prostate-cancer-screening-using-mri-after-psa-test-a-cost-effective-strategy/ 2024-08-15T15:11:31+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/11/Prostate-cancer-screening-using-MRI-after-PSA-test-a-cost-effective-strategy.gif https://hospitalpharmacyeurope.com/clinical-zones/oncology/ai-less-accurate-than-radiologists-in-breast-cancer-screening/ 2024-08-15T15:12:48+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/09/HPEGettyImages-1191028832-breast-cancer.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/reduction-in-low-density-lipoprotein-from-daily-intake-of-walnuts/ 2024-08-15T15:13:09+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/09/HPE-GettyImages-531948065-walnuts.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/on-line-mammography-self-assessment-test-successfully-completed-by-less-than-half-of-radiologists/ 2024-08-15T15:13:41+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/09/HEP-GettyImages-1180810314-mammogram-test.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/ecg-and-radiomics-model-improves-the-detection-of-af-in-women/ 2024-08-15T15:14:00+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/11/ECG-and-radiomics-model-improves-the-detection-of-AF-in-women.gif https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/baxdrostat-effective-for-patients-with-treatment-resistant-hypertension/ 2024-08-15T15:14:10+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/11/Baxdrostat-effective-for-patients-with-treatment-resistant-hypertension.gif https://hospitalpharmacyeurope.com/clinical-zones/oncology/adding-durvalumab-to-chemotherapy-effective-for-extensive-stage-small-cell-lung-cancer/ 2024-08-15T15:14:32+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/09/HPE-GettyImages-1168178985-lung-cancer.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/olpasiran-therapy-significantly-lowers-lipoprotein-a-levels-in-cardiovascular-disease-patients/ 2024-08-15T15:15:10+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/11/Olpasiran-therapy-significantly-lowers-lipoprotein-A-levels-in-cardiovascular-disease-patients.gif https://hospitalpharmacyeurope.com/clinical-zones/oncology/stage-4-breast-cancer-trial-to-examine-avelumab-and-radium-223/ 2024-08-15T15:15:14+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/09/HPE-GettyImages-1033239842-avelumab-for-BC.jpg https://hospitalpharmacyeurope.com/clinical-zones/rheumatology/low-dose-aspirin-use-associated-with-higher-risk-of-serious-falls-in-elderly/ 2024-08-15T15:15:27+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/11/Low-dose-aspirin-use-associated-with-higher-risk-of-serious-falls-in-elderly.gif https://hospitalpharmacyeurope.com/clinical-zones/respiratory/oral-anti-diabetic-agents-reduce-copd-exacerbation-risk/ 2024-08-15T15:15:36+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/11/Oral-anti-diabetic-agents-reduce-COPD-exacerbation-risk.gif https://hospitalpharmacyeurope.com/clinical-zones/only-small-improvement-in-chronic-pain-from-medical-cannabis/ 2024-08-15T15:15:42+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/09/HPE-GettyImages-1188357744-medical-cannabis.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/lung-cancer-mortality-reduced-by-single-low-dose-ct-scan/ 2024-08-15T15:16:20+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/09/HPE-GettyImages-511802196-CT-scan-smokers.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/improved-outcomes-for-asthma-and-copd-patients-with-pharmacy-inhaler-technique-service/ 2024-08-15T15:17:58+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/09/HPE-GettyImages-81175058-inhaler-service.jpg https://hospitalpharmacyeurope.com/clinical-zones/immunology/nice-approves-berotralstat-for-recurrent-attacks-of-hereditary-angioedema/ 2024-08-15T15:19:51+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/09/HPE-GettyImages-1211553912-HAE.jpg https://hospitalpharmacyeurope.com/clinical-zones/emergency-and-critical-care/sepsis-notification-system-monitored-by-pharmacists-improves-patient-outcomes/ 2024-08-15T15:20:17+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/09/HPE-GettyImages-860848242-sepsis.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/pemafibrate-similar-to-placebo-for-adverse-cardiovascular-event-reduction-in-type-2-diabetes/ 2024-08-15T15:20:53+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/11/Pemafibrate-similar-to-placebo-for-adverse-cardiovascular-event-reduction-in-type-2-diabetes.gif https://hospitalpharmacyeurope.com/clinical-zones/mental-health/full-spectrum-cannabidiol-reduces-anxiety-and-improves-cognition/ 2024-08-15T15:21:33+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/11/Full-spectrum-cannabidiol-reduces-anxiety-and-improves-cognition.gif https://hospitalpharmacyeurope.com/clinical-zones/oncology/combing-polygenic-risk-score-and-family-history-improves-prostate-cancer-risk-stratification/ 2024-08-15T15:21:55+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/11/Combing-polygenic-risk-score-and-family-history-improves-prostate-cancer-risk-stratification.gif https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/only-7000-10000-steps-day-required-among-middle-aged-adults-for-a-70-lower-all-cause-mortality-benefit/ 2024-08-15T15:22:45+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/09/HPE-GettyImages-92975825-steps-per-day.jpg https://hospitalpharmacyeurope.com/clinical-zones/emergency-and-critical-care/live-video-improves-medical-dispatchers-assessment-of-patients/ 2024-08-15T15:23:14+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/09/HPE-GettyImages-1334182678-live-videol-stream.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/higher-prevalence-of-non-traditional-cardiovascular-risk-factors-in-women/ 2024-08-15T15:23:50+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/09/HPE-GettyImages-966795460-risk-factors-heart-disease.jpg https://hospitalpharmacyeurope.com/clinical-zones/neurology/ischaemic-stroke-risk-no-higher-with-continued-anti-platelet-therapy/ 2024-08-15T15:24:37+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/09/HPE-GettyImages-1256626089-ischaemic-stroke.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/regular-breakfast-and-fibre-intake-associated-with-a-lower-overall-mortality-risk/ 2024-08-15T15:25:06+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/09/HPEGettyImages-619244172-healthy-breakfasr.jpg https://hospitalpharmacyeurope.com/clinical-zones/dermatology/cosentyx-approved-for-children-and-young-people-with-psoriasis/ 2024-08-15T15:26:24+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/09/HPE-GettyImages-815939442-cosentyx.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/intensive-control-of-elderly-blood-pressure-reduces-cardiovascular-outcomes/ 2024-08-15T15:30:01+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/09/HPE-GettyImages-1177942982-intensive-blood-pressure-control.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/nirsevimab-receives-ema-approval-for-rsv-in-newborns-and-infants/ 2024-08-15T15:54:16+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/11/Nirsevimab-receives-EMA-approval-for-RSV-in-newborns-and-infants.gif https://hospitalpharmacyeurope.com/ophthalmology/glaucoma-risk-elevated-by-suboptimal-sleep-behaviours/ 2024-08-15T15:56:56+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/11/Glaucoma-risk-elevated-by-suboptimal-sleep-behaviours.gif https://hospitalpharmacyeurope.com/clinical-zones/oncology/thyroid-cancer-increases-coronary-heart-disease-risk/ 2024-08-15T15:57:41+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/11/Thyroid-cancer-increases-coronary-heart-disease-risk.gif https://hospitalpharmacyeurope.com/ophthalmology/need-for-cataract-surgery-not-reduced-after-long-term-high-dose-vitamin-d/ 2024-08-15T15:58:46+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/11/Need-for-cataract-surgery-not-reduced-after-long-term-high-dose-vitamin-D.gif https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/elevated-plant-omega-3-levels-reduce-death-and-hospitalisation-risk-in-heart-failure/ 2024-08-15T15:59:27+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/11/Elevated-plant-omega-3-levels-reduce-death-and-hospitalisation-risk-in-heart-failure.gif https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/raised-c-reactive-protein-and-lipoproteina-linked-to-worse-outcomes-after-pci/ 2024-08-15T15:59:47+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/10/Raised-C-reactive-protein-and-Lipoproteina-linked-to-worse-outcomes-after-PCI.gif https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/smoking-cessation-not-cutting-down-reduces-adverse-cardiovascular-outcomes/ 2024-08-15T16:00:49+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/09/HPE-GettyImages-1237976675-smoking-cessation.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/influenza-vaccination-given-soon-after-mi-reduces-cardiovascular-mortality/ 2024-08-15T16:01:21+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/09/HPE-GettyImages-1183046723-influenza-and-MI.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/use-of-salt-substitutes-reduces-risk-of-future-strokes/ 2024-08-15T16:01:53+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/09/HPE-GettyImages-1214752515-salt-substitute.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/nice-approves-injectable-cholesterol-lowering-drug/ 2024-08-15T16:02:28+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/09/HPE-GettyImages-514466676-high-cholesterol.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/expert-panel-defines-remission-for-type-2-diabetes/ 2024-08-15T16:02:57+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/09/HPE-GettyImages-1256337506-type-2-diabetes.jpg https://hospitalpharmacyeurope.com/news/infectious-disease/malarial-monoclonal-antibody-highly-effective-at-6-months/ 2024-08-15T16:04:18+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/11/Malarial-monoclonal-antibody-highly-effective-at-6-months.gif https://hospitalpharmacyeurope.com/clinical-zones/oncology/malignant-mesothelioma-survival-increased-with-nivolumab/ 2024-08-15T16:04:32+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/10/GettyImages-1295482916.jpg-mesothelioma.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/prophylactic-irradiation-of-asymptomatic-bone-metastases-reduces-adverse-events/ 2024-08-15T16:05:23+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/10/Prophylactic-irradiation-of-asymptomatic-bone-metastases-reduces-adverse-events.gif https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/illicit-substance-misuse-increases-risk-of-incident-atrial-fibrillation/ 2024-08-15T16:05:35+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/10/Illicit-substance-misuse-increases-risk-of-incident-atrial-fibrillation.gif https://hospitalpharmacyeurope.com/ophthalmology/susvimo-approved-by-fda-for-wet-age-related-macular-degeneration/ 2024-08-15T16:05:45+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/10/GettyImages-1217908833.jpg-macular-degeneration.jpg https://hospitalpharmacyeurope.com/clinical-zones/dermatology/identical-rcts-confirm-topical-ruxolitinib-effective-in-non-segmental-vitiligo/ 2024-08-15T16:05:46+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/10/Identical-RCTs-confirm-topical-ruxolitinib-effective-in-non-segmental-vitiligo.gif https://hospitalpharmacyeurope.com/clinical-zones/oncology/deep-learning-algorithm-detects-metastatic-spread-of-head-and-neck-cancer/ 2024-08-15T16:06:02+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/10/Deep-learning-algorithm-detects-metastatic-spread-of-head-and-neck-cancer.jpg https://hospitalpharmacyeurope.com/in-depth/views/why-patient-empowerment-should-be-at-the-heart-of-organ-transplantation/ 2024-08-15T16:07:45+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/10/Why-patient-empowerment-should-be-at-the-heart-of-organ-transplantation.jpg https://hospitalpharmacyeurope.com/clinical-zones/fracture-incidence-a-third-in-lower-elderly-with-high-dairy-intake/ 2024-08-15T16:08:07+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/10/GettyImages-1078078826.jpg-dairy-foods.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/iv-magnesium-and-potassium-increase-chance-of-sinus-rhythm-return-in-af/ 2024-08-15T16:08:20+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/10/IV-magnesium-and-potassium-increase-chance-of-sinus-rhythm-return-in-AF.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/atezolizumab-anti-drug-antibodies-reduce-survival-in-hepatocellular-carcinoma/ 2024-08-15T16:08:51+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/10/Atezolizumab-anti-drug-antibodies-reduce-survival-in-hepatocellular-carcinoma.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/screening-colonoscopy-invitees-have-lower-10-year-risk-of-colorectal-cancer/ 2024-08-15T16:09:17+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/10/Screening-colonoscopy-invitees-have-lower-10-year-risk-of-colorectal-cancer.jpg https://hospitalpharmacyeurope.com/clinical-zones/dermatology/ruxolitinib-cream-improves-outcomes-in-patient-with-atopic-dermatitis/ 2024-08-15T16:09:28+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/08/HPE-GettyImages-1270933857-atopic-eczema.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/ga-pet-ct-scan-radiomics-model-enables-identification-of-prostate-cancer/ 2024-08-15T16:09:32+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/10/Ga-PET-CT-scan-radiomics-model-enables-identification-of-prostate-cancer.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/hypertension-self-management-feasible-with-mobile-technology/ 2024-08-15T16:09:46+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/10/GettyImages-1317964339.jpg-smartphone-hypertension.jpg https://hospitalpharmacyeurope.com/clinical-zones/mental-health/fluoroquinolone-use-not-associated-with-higher-hospital-admission-or-ed-visits-for-suicidality/ 2024-08-15T16:09:51+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/10/Fluoroquinolone-use-not-associated-with-higher-hospital-admission-or-ED-visits-for-suicidality.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/cannabis-use-common-for-symptom-relief-in-women-with-breast-cancer/ 2024-08-15T16:10:05+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/10/GettyImages-1271218024.jpg-cannabis-use.jpg https://hospitalpharmacyeurope.com/clinical-zones/neurology/aspects-helps-decision-making-for-endovascular-therapy-use-in-acute-ischaemic-stroke/ 2024-08-15T16:10:13+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/10/ASPECTS-helps-decision-making-for-endovascular-therapy-use-in-acute-ischaemic-stroke.jpg https://hospitalpharmacyeurope.com/clinical-zones/neurology/arb-therapy-linked-with-lower-risk-of-developing-epilepsy/ 2024-08-15T16:10:25+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/10/ARB-therapy-linked-with-lower-risk-of-developing-epilepsy.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/blood-pressure-medicine-administration-time-has-no-effect-on-adverse-cv-outcomes/ 2024-08-15T16:10:41+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/10/Blood-pressure-medicine-administration-time-has-no-effect-on-adverse-CV-outcomes.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/remote-radiation-oncology-consultations-more-likely-in-the-future/ 2024-08-15T16:10:51+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/10/GettyImages-1307011132-2.jpg-radiation-oncology-remote-consult-2.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/high-ala-dietary-intake-associated-with-lower-risk-of-all-cause-mortality/ 2024-08-15T16:11:31+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/10/HPE-GettyImages-683349134.jpg-ALA.jpg https://hospitalpharmacyeurope.com/clinical-zones/neurology/review-finds-clopidogrel-monotherapy-not-linked-to-higher-risk-of-brain-bleed-after-head-injury/ 2024-08-15T16:11:48+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/10/Review-finds-clopidogrel-monotherapy-not-linked-to-higher-risk-of-brain-bleed-after-head-injury.jpg https://hospitalpharmacyeurope.com/clinical-zones/emergency-and-critical-care/reviews-suggests-digital-pcr-faster-than-blood-cultures-for-pathogen-identification-in-sepsis/ 2024-08-15T16:12:53+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/10/Reviews-suggests-digital-PCR-faster-than-blood-cultures-for-pathogen-identification-in-sepsis.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/prenatal-high-dose-folic-acid-and-childhood-cancer-risk-in-epilepsy/ 2024-08-15T16:13:26+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/10/Prenatal-high-dose-folic-acid-and-childhood-cancer-risk-in-epilepsy.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/shift-workers-use-of-time-restricted-eating-affects-cardiometabolic-health/ 2024-08-15T16:13:39+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/10/Shift-workers-use-of-time-restricted-eating-affects-cardiometabolic-health.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/ai-guided-screening-improves-detection-of-high-risk-atrial-fibrillation/ 2024-08-15T16:14:00+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/10/AI-guided-screening-improves-detection-of-high-risk-atrial-fibrillation.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/effect-of-weight-lifting-on-cardiovascular-disease-mortality-risk/ 2024-08-15T16:14:20+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/09/Effect-of-weight-lifting-on-cardiovascular-disease-mortality-risk.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/bionic-pancreas-provides-superior-glycated-haemoglobin-control-type-1-diabetics/ 2024-08-15T16:14:31+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/10/Bionic-pancreas-provides-superior-glycated-haemoglobin-control-type-1-diabetics.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/fish-oil-supplement-use-and-incident-atrial-fibrillation/ 2024-08-15T16:14:51+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/09/Fish-oil-supplement-use-and-incident-atrial-fibrillation.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/coffee-drinking-associated-with-significant-cardiovascular-and-mortality-benefits/ 2024-08-15T16:15:30+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/09/Coffee-drinking-associated-with-significant-cardiovascular-and-mortality-benefits.jpg https://hospitalpharmacyeurope.com/clinical-zones/rheumatology/mri-study-finds-nsaids-worsen-arthritis-inflammation-with-long-term-use/ 2024-08-15T16:16:20+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/12/MRI-study-finds-NSAIDs-worsen-arthritis-inflammation-with-long-term-use.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/guideline-discordant-antibiotic-prescribing-for-severe-cap-within-ed-increases-mortality/ 2024-08-15T16:16:50+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/10/HPE-GettyImages-943418088.jpg-CAP-prescribiing.jpg https://hospitalpharmacyeurope.com/clinical-zones/neurology/deutetrabenazine-no-better-than-placebo-in-children-and-adolescents-with-tourette-syndrome/ 2024-08-15T16:18:08+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/10/HPE-GettyImages-490049148.jpg-tourettes.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/systolic-bp-does-not-affect-cardiovascular-outcomes-in-heart-failure-treated-with-empagliflozin/ 2024-08-15T16:19:00+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/10/HPE-GettyImages-1226146707.jpg-heart-failure.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/elranatamab-provides-durable-clinical-response-in-relapsed-multiple-myeloma/ 2024-08-15T16:20:49+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/12/Elranatamab-provides-durable-clinical-response-in-relapsed-multiple-myeloma.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/drinking-both-coffee-and-tea-lowers-cardiovascular-disease-mortality-risk/ 2024-08-15T16:21:01+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/12/Drinking-both-coffee-and-tea-lowers-cardiovascular-disease-mortality-risk.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/no-effect-from-early-ctca-on-clinical-outcomes-in-intermediate-risk-patients-with-suspected-acs/ 2024-08-15T16:21:01+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/10/HPR-GettyImages-1148013840.jpg-CTCA.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/zanubrutinib-provides-superior-progression-free-survival-in-relapsed-lymphocytic-leukaemia/ 2024-08-15T16:21:20+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/12/Zanubrutinib-provides-superior-progression-free-survival-in-relapsed-lymphocytic-leukaemia.jpg https://hospitalpharmacyeurope.com/clinical-zones/neurology/enlarged-perivascular-spaces-seen-on-mri-in-migraine-sufferers/ 2024-08-15T16:21:33+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/12/Enlarged-perivascular-spaces-seen-on-MRI-in-migraine-sufferers.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/a-palliative-care-intervention-by-nurses-failed-to-improve-patients-quality-of-life/ 2024-08-15T16:21:49+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/10/HEP-GettyImages-1313904456.jpg-nurse-led-palliative.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/ai-model-uses-single-chest-radiograph-to-predict-cvd-risk/ 2024-08-15T16:22:54+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/12/AI-model-uses-single-chest-radiograph-to-predict-CVD-risk.jpg https://hospitalpharmacyeurope.com/clinical-zones/neurology/atogepant-approved-by-fda-for-episodic-migraine/ 2024-08-15T16:23:26+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/10/HPE-GettyImages-1238998148.jpg-migraine.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/resistant-hypertension-helped-by-diet-and-exercise/ 2024-08-15T16:23:54+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/10/HPE-GettyImages-1137749016.jpg-hypertension.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/tepotinib-approved-by-mrha-for-advanced-non-small-cell-lung-cancer-with-metex14-skipping/ 2024-08-15T16:24:24+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/10/HPE-GettyImages-676198374.jpg-lung-cancer.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/quad-pill-gives-better-control-than-initial-mono-therapy-in-hypertension/ 2024-08-15T16:24:53+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/10/HPE-GettyImages-1325251634.jpg-quadpill.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/metastatic-breast-cancer-survival-improved-by-trastuzumab-deruxtecan/ 2024-08-15T16:25:05+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/09/HPE-GettyImages-1221770065.jpg-breast-cancer.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/af-linked-to-a-range-of-cerebrovascular-pathologies/ 2024-08-15T16:25:17+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/09/HPE-GettyImages-1217258922.jpg-atrial-fib.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/aspirin-use-associated-with-increased-risk-of-heart-failure/ 2024-08-15T16:27:30+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/11/GettyImages-681696976.gif-heart-failure.gif https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/inclisiran-effective-in-familial-hypercholesterolaemia-and-high-cvd-risk-irrespective-of-bmi/ 2024-08-15T16:28:01+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/11/GettyImages-503756084.gif-cholesterol-lowering.gif https://hospitalpharmacyeurope.com/clinical-zones/mental-health/cbt-for-insomnia-superior-to-sleep-education-at-reducing-risk-of-depression-in-older-adults/ 2024-08-15T16:29:14+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/11/GettyImages-1201208643.gif-cbt-and-insomnia.gif https://hospitalpharmacyeurope.com/clinical-zones/mental-health/byannli-twice-yearly-dosing-in-schizophrenia-approved-by-ema/ 2024-08-15T16:29:42+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/11/GettyImages-648705754.gif-byannli.gif https://hospitalpharmacyeurope.com/clinical-zones/easevrx-approved-by-fda-for-chronic-lower-back-pain/ 2024-08-15T16:30:02+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/11/GettyImages-1313461597.gif-VR-system.gif https://hospitalpharmacyeurope.com/in-depth/views/not-just-small-adults/ 2024-08-15T16:30:06+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/12/GettyImages-487669765-cropped.jpg https://hospitalpharmacyeurope.com/clinical-zones/rheumatology/strong-opiates-no-better-than-paracetamol-and-codeine-for-post-orthopaedic-pain/ 2024-08-15T16:31:42+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/11/GettyImages-168533336.gif-strong-opiates-and-fracture.gif https://hospitalpharmacyeurope.com/news/metabolic-disorders/review-indicates-glp1-agonists-offer-similar-glycaemic-control-to-bariatric-surgery/ 2024-08-15T16:32:30+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/12/Review-indicates-how-GLP1-agonists-offer-similar-glycaemic-control-to-bariatric-surgery.gif https://hospitalpharmacyeurope.com/clinical-zones/oncology/cancer-diagnoses-in-young-people-reduced-and-icu-admissions-increased-in-first-wave-of-pandemic/ 2024-08-15T16:32:41+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/11/GettyImages-1307768283.gif-young-people-and-cancer.gif https://hospitalpharmacyeurope.com/clinical-zones/oncology/hrt-use-associated-with-greater-risk-of-disease-recurrence-in-breast-cancer-survivors/ 2024-08-15T16:33:08+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/11/GettyImages-182052944.gif-hrt.gif https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/pcsk9-inhibitor-persistence-high-in-patients-with-fh/ 2024-08-15T16:34:26+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/12/PCSK9-inhibitor-persistence-high-in-patients-with-FH.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/endovascular-treatment-outcomes-not-improved-with-alteplase-in-stroke-patients/ 2024-08-15T16:35:14+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/11/GettyImages-1168179082.gif-endovascular-treatment.gif https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/highly-purified-epa-decreases-adverse-cardiovascular-events-in-patients-with-cad/ 2024-08-15T16:35:50+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/12/Highly-purified-EPA-decreases-adverse-cardiovascular-events-in-patients-with-CAD.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/medical-marijuana-decreases-opiate-use-in-patients-with-cancer/ 2024-08-15T16:36:20+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/12/Medical-marijuana-decreases-opiate-use-in-patients-with-cancer.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/racial-and-ethnic-disparities-apparent-in-referral-for-prostate-mri-in-men/ 2024-08-15T16:36:25+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/11/GettyImages-857094856.gif-prostate-MRI.gif https://hospitalpharmacyeurope.com/clinical-zones/neurology/donanemab-shows-greater-brain-amyloid-reduction-compared-to-aducanumab-in-early-alzheimers/ 2024-08-15T16:36:37+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/12/Donanemab-shows-greater-brain-amyloid-reduction-compared-to-aducanumab-in-early-Alzheimers.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/dark-field-x-ray-identifies-emphysema-in-copd-patients/ 2024-08-15T16:36:58+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/11/GettyImages-1152018663.gif-dark-xray.gif https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/morning-physical-activity-associated-with-lowest-risk-of-cardiovascular-disease/ 2024-08-15T16:37:28+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/11/Morning-physical-activity-associated-with-lowest-risk-of-cardiovascular-disease.gif https://hospitalpharmacyeurope.com/clinical-zones/neurology/subcutaneous-foslevodopa-foscarbidopa-infusion-improves-symptom-control-in-parkinsons-disease/ 2024-08-15T16:37:38+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/11/Subcutaneous-foslevodopa-foscarbidopa-infusion-improves-symptom-control-in-Parkinsons-disease.gif https://hospitalpharmacyeurope.com/clinical-zones/haematology/extending-rivaroxaban-treatment-course-reduces-risk-of-recurrent-venous-thromboembolism/ 2024-08-15T16:37:51+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/11/Extending-rivaroxaban-treatment-course-reduces-risk-of-recurrent-venous-thromboembolism.gif https://hospitalpharmacyeurope.com/pharmacy-practice/delayed-transfer-of-care-model-70-accurate/ 2024-08-15T16:38:01+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/11/GettyImages-1147980110.gif-delayed-discharge.gif https://hospitalpharmacyeurope.com/in-depth/views/podcast-blood-purification-strategies-in-sepsis/ 2024-08-15T16:39:44+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/11/Prof_Claudio_Ronco_965x500px.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/risankizumab-of-no-value-in-patients-with-severe-asthma/ 2024-08-15T16:41:15+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/11/GettyImages-1140415736.gif-severe-asthma.gif https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/sustained-weight-loss-leads-to-a-reduced-risk-of-adverse-cardiometabolic-outcomes/ 2024-08-15T16:41:47+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/11/GettyImages-1347115960.gif-obesity.gif https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/acute-myocarditis-associated-with-higher-90-day-mortality-and-adverse-cardiac-outcomes/ 2024-08-15T16:42:13+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/11/GettyImages-1345605293.gif-acute-myocarditis.gif https://hospitalpharmacyeurope.com/in-depth/views/preparing-for-the-upcoming-academic-year/ 2024-08-15T16:43:06+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/11/GettyImages-1190548731.jpg https://hospitalpharmacyeurope.com/reviews-research/initial-observations-on-the-implementation-of-a-clinical-pharmacy-service-in-a-rural-hospital-in-austria/ 2024-08-15T16:43:45+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/11/GettyImages_468439768_Austria_965x500px.jpg https://hospitalpharmacyeurope.com/in-depth/views/dermatology-pharmacy-coming-of-age/ 2024-08-15T16:44:28+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/11/GettyImages-956478432-cropped.jpg https://hospitalpharmacyeurope.com/ophthalmology/vuity-pilocarpine-approved-by-fda-for-presbyopia/ 2024-08-15T16:45:37+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/11/GettyImages-1173896865.gif-vuity-eye-drops.gif https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/non-fatal-mi-not-a-valid-surrogate-for-all-cause-or-cv-mortality/ 2024-08-15T16:47:53+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/11/GettyImages-148442899.gif-nonfatal-MI.gif https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/triglyceridehdl-cholesterol-ratio-and-cta-risk-score-predict-heart-disease-risk-in-stable-angina/ 2024-08-15T16:48:13+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/11/GettyImages-1167803819.gif-high-triglycerides.gif https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/vasopressin-and-methylprednisolone-for-in-hospital-cardiac-arrest/ 2024-08-15T16:48:32+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/11/GettyImages-1301595211.gif-cardiac-arrest.gif https://hospitalpharmacyeurope.com/clinical-zones/oncology/physical-inactivity-could-lead-to-over-46000-cancer-cases-in-the-us/ 2024-08-15T16:48:51+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/11/GettyImages-1126468805.gif-physical-inactivity.gif https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/prior-heart-disease-improves-survival-after-out-of-hospital-cardiac-arrest/ 2024-08-15T16:49:42+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/12/GettyImages-PHD692589702.jpg https://hospitalpharmacyeurope.com/clinical-zones/mental-health/long-term-marine-omega-3-fatty-acid-use-leads-to-slight-increased-risk-of-depression-in-older-adults/ 2024-08-15T16:50:15+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/12/GettyImages-177039677.gif-fish-oils.gif https://hospitalpharmacyeurope.com/clinical-zones/dermatology/atopic-eczema-patient-outcomes-improved-by-dupilumab-in-everyday-clinical-practice/ 2024-08-15T16:52:04+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/08/HPE-GettyImages-1270933857-atopic-eczema.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/telephone-based-management-of-chemotherapy-toxicities-fail-to-reduce-hospital-visits-in-early-breast-cancer/ 2024-08-15T16:52:42+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/12/GettyImages-1275072681.gif-nurse-on-phone.gif https://hospitalpharmacyeurope.com/clinical-zones/respiratory/dupilumab-add-on-therapy-decreases-asthma-exacerbations-in-children-with-moderate-to-severe-disease/ 2024-08-15T16:53:19+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/12/GettyImages-649745714.gif-asthmatic-child.gif https://hospitalpharmacyeurope.com/clinical-zones/oncology/apatinib-enhances-progression-free-survival-in-iodine-refractory-thyroid-cancer/ 2024-08-15T16:53:42+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/12/GettyImages-1150284930.gif-thyroid-cancer.gif https://hospitalpharmacyeurope.com/clinical-zones/neurology/convolutional-neural-network-provides-similar-level-of-ich-diagnosis-to-radiologists/ 2024-08-15T16:55:36+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/12/GettyImages-1178123409.gif-CNN-networks.gif https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/higher-lipoprotein-a-in-hypertensive-patients-raises-adverse-cardiovascular-event-risk/ 2024-08-15T16:55:36+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/12/Higher-lipoprotein-A-in-hypertensive-patients-raises-adverse-cardiovascular-event-risk.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/tafasitamab-has-best-efficacy-in-refractory-diffuse-large-b-cell-lymphoma/ 2024-08-15T16:55:54+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/12/Tafasitamab-has-best-efficacy-in-refractory-diffuse-large-B-cell-lymphoma.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/isatuximab-added-to-chemotherapy-increases-minimal-residual-disease-negativity-in-patients-with-multiple-myeloma/ 2024-08-15T16:56:48+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/12/GettyImages-680297896.gif-multiple-myeloma-cells.gif https://hospitalpharmacyeurope.com/clinical-zones/dermatology/psoriasis-associated-with-an-increased-risk-of-vte-and-pvd/ 2024-08-15T17:01:28+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/08/HPE-GettyImages-1332113456-clotting-disorder.jpg https://hospitalpharmacyeurope.com/clinical-zones/mental-health/opioid-treatment-after-suspected-overdose-visit-to-ed-rarely-initiated/ 2024-08-15T17:02:28+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/12/GettyImages-851502186.gif-opioid-overdose.gif https://hospitalpharmacyeurope.com/clinical-zones/immunology/allergen-immunotherapy-effectiveness-shown-in-long-term-real-world-study/ 2024-08-15T17:03:21+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/12/GettyImages-1177382388.gif-AIT-therapy.gif https://hospitalpharmacyeurope.com/clinical-zones/rheumatology/skyrizi-risankizumab-approved-by-mhra-for-active-psoriatic-arthritis/ 2024-08-15T17:04:26+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/11/GettyImages-995967580.gif-Skyrizi.gif https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/metformin-use-in-pre-diabetics-with-a-bmi-35-lowered-incident-cardiovascular-disease/ 2024-08-15T17:05:16+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/11/GettyImages-1163190719.gif-prediabetes-and-metformin.gif https://hospitalpharmacyeurope.com/news/world-aids-day-calls-for-an-end-to-inequality/ 2024-08-15T17:05:57+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/12/GettyImages-1283732782.gif-world-aids-day.gif https://hospitalpharmacyeurope.com/clinical-zones/oncology/targit-iort-as-effective-as-standard-treatment-in-early-breast-cancer/ 2024-08-16T08:04:35+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/08/HPE-GettyImages-613327714.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/virtual-consultations-for-cardiology-services-the-new-norm/ 2024-08-16T08:17:58+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/08/HPE-GettyImages-1141061959.jpg https://hospitalpharmacyeurope.com/reviews-research/peri-operative-pharmacy-services-and-the-enhanced-recovery-pathway/ 2024-08-16T08:21:02+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/11/GettyImages_619511730_male_patient_768x748px.jpg https://hospitalpharmacyeurope.com/reviews-research/medicines-storage-and-disposal-practices-and-outpatient-pharmacy-services-in-spain/ 2024-08-16T08:21:29+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/07/outpatients_GettyImages_135877746_965x500px.jpg https://hospitalpharmacyeurope.com/news/editors-pick/new-pactosafe-from-paxxo/ 2024-08-16T08:22:33+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/01/Medical-waste.jpg https://hospitalpharmacyeurope.com/reviews-research/optimising-medicines-for-the-frail-older-person/ 2024-08-16T08:47:59+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/07/elderly_patient_care_home_GettyImages_923216834_965x500px.jpg https://hospitalpharmacyeurope.com/reviews-research/diagnosis-and-management-of-adhd-summary-of-nice-guidance/ 2024-08-16T08:48:51+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/07/ADHD_GettyImages_941190144_965x500px.jpg https://hospitalpharmacyeurope.com/clinical-zones/dermatology/cosentyx-receives-approval-as-first-line-system-for-paediatric-psoriasis/ 2024-08-16T08:52:39+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/08/HPE-GettyImages-1141458954.jpg https://hospitalpharmacyeurope.com/clinical-zones/rotigotine-fails-to-improve-cognitive-functions-in-alzheimers-disease/ 2024-08-16T08:53:39+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/08/HPE-GettyImages-1015290888.jpg https://hospitalpharmacyeurope.com/news/vitamin-d-and-omega-3-fatty-acid-supplements-ineffective-for-chronic-knee-pain/ 2024-08-16T08:54:17+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/08/HPE-GettyImages-1191879923.jpg https://hospitalpharmacyeurope.com/clinical-zones/immunology/first-oral-therapy-for-peanut-allergy-approved-in-the-us/ 2024-08-16T09:03:49+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/07/HPE-GettyImages-920181276.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/prediabetes-linked-to-an-increased-risk-of-all-cause-mortality/ 2024-08-16T09:04:12+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/07/HPE-GettyImages-686885696.jpg https://hospitalpharmacyeurope.com/clinical-zones/rheumatology/minor-differences-in-efficacy-between-biologics-for-rheumatoid-arthritis/ 2024-08-16T09:05:19+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/07/HPE-GettyImages-184964326.jpg https://hospitalpharmacyeurope.com/news/patient-care/limited-evidence-that-polypharmacy-causes-problems-in-the-uk/ 2024-08-16T09:06:43+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/07/HPE-GettyImages-676742914.jpg https://hospitalpharmacyeurope.com/unit-dosing/automated-dispensing-systems-clinically-and-economically-effective/ 2024-08-16T09:07:42+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/07/HPE-GettyImages-896211758.jpg https://hospitalpharmacyeurope.com/clinical-zones/patients-value-hospital-pharmacy-medicine-helpline-service/ 2024-08-16T09:08:02+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/07/HPE-GettyImages-1162392872.jpg https://hospitalpharmacyeurope.com/clinical-zones/neurology/small-amounts-of-alcohol-may-help-to-ward-off-cognitive-decline/ 2024-08-16T09:10:14+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/07/HPE-GettyImages-1126205433.jpg https://hospitalpharmacyeurope.com/news/medicines-reconciliation/hospital-discharge-deprescribing-intervention-effectively-reduces-medication-burden/ 2024-08-16T09:11:55+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/02/Hospital-discharge-deprescribing-intervention-effectively-reduces-medication-burden.jpg https://hospitalpharmacyeurope.com/pharmacy-practice/why-dont-confused-patients-call-medicines-helplines-after-discharge-from-hospital/ 2024-08-16T09:13:24+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/07/HPE-GettyImages-1189755045.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/combination-therapy-with-metformin-reduces-all-cause-mortality-in-type-2-diabetes/ 2024-08-16T09:13:38+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/07/HPE-GettyImages-157693561.jpg https://hospitalpharmacyeurope.com/in-depth/views/key-commentary/increased-physical-activity-equals-reduced-cancer-risk-in-older-adults/ 2024-08-16T10:03:50+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/06/HPE-GettyImages-1044153994.jpg https://hospitalpharmacyeurope.com/in-depth/views/key-commentary/health-outcomes-in-cardiovascular-disease-better-for-women-than-men/ 2024-08-16T10:04:41+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/06/HPE-GettyImages-469758500.jpg https://hospitalpharmacyeurope.com/in-depth/views/should-opioids-be-used-to-manage-acute-pain-after-a-dental-extraction/ 2024-08-16T10:30:21+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/04/HPE-GettyImages-1061328994.jpg https://hospitalpharmacyeurope.com/in-depth/views/can-a-technology-based-approach-help-those-who-struggle-to-take-their-medicines/ 2024-08-16T10:38:17+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/03/HPE-GettyImages-1097792846.jpg https://hospitalpharmacyeurope.com/reviews-research/sponsored-under-dosing-of-small-volume-intravenous-drugs-an-overlooked-patient-safety-issue/ 2024-08-16T10:51:40+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/03/HPE-GettyImages-465902758.jpg https://hospitalpharmacyeurope.com/reviews-research/delivering-stomp-in-a-community-learning-disability-treatment-team/ 2024-08-16T10:52:03+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/03/capsuls_GettyImages_1138134665_965x500px.jpg https://hospitalpharmacyeurope.com/reviews-research/pharmacy-technicians-adding-value-to-mental-health-services-a-personal-perspective/ 2024-08-16T10:52:33+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/03/heads_GettyImages_509934728_965x500px.jpg https://hospitalpharmacyeurope.com/reviews-research/improving-timely-medicines-administration-to-parkinsons-patients-in-the-inpatient-setting/ 2024-08-16T10:53:19+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/03/parkinsons_patient_GettyImages_1157136381_965x500px.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/nhs-data-reveals-gap-in-care-for-heart-failure-patients/ 2024-08-16T10:55:03+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/03/HPE-GettyImages-673751110.jpg https://hospitalpharmacyeurope.com/in-depth/views/pharmaceutical-care-the-present-and-the-future/ 2024-08-16T10:58:42+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/03/HPE-GettyImages-867682686.jpg https://hospitalpharmacyeurope.com/clinical-zones/dermatology/could-regular-emollient-use-from-birth-prevent-the-development-of-atopic-eczema/ 2024-08-16T11:00:23+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/03/HPE-GettyImages-503250284.jpg https://hospitalpharmacyeurope.com/in-depth/views/clinical-trial-data-and-real-world-effectiveness-the-experience-with-empagliflozin/ 2024-08-16T11:02:08+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/03/HPE-GettyImages-966874060.jpg https://hospitalpharmacyeurope.com/in-depth/views/key-commentary/commentary-clinical-pharmacist-and-pharmaceutical-interventions-in-an-hbh-unit/ 2024-08-16T11:03:05+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/03/HPE-GettyImages-181644503.jpg https://hospitalpharmacyeurope.com/news/researchers-develop-new-coating-to-reduce-pain-and-risk-of-infection-for-catheter-users/ 2024-08-16T11:03:45+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/03/HPE-GettyImages-670796606.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/new-treatment-combination-available-for-previously-treated-follicular-lymphoma-patients/ 2024-08-16T11:06:14+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/02/HPE-GettyImages-181146339.jpg https://hospitalpharmacyeurope.com/in-depth/views/key-commentary/commentary-the-role-of-the-clinical-pharmacist-in-an-irish-university-teaching-hospital/ 2024-08-16T11:06:34+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/02/HPE-GettyImages-1039025652.jpg https://hospitalpharmacyeurope.com/in-depth/views/key-commentary/key-commentary-improving-patient-safety-through-a-pharmacist-led-medication-reconciliation-programme-in-nursing-homes-for-the-elderly-in-spain/ 2024-08-16T11:07:36+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/02/HPE-GettyImages-957709964.jpg https://hospitalpharmacyeurope.com/news/patient-safety/new-line-of-hazardous-drug-bags-announced/ 2024-08-16T11:08:03+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/02/HPE-PRD2020-HDB-HazardousDrugBags-01.jpg https://hospitalpharmacyeurope.com/in-depth/views/key-commentary/key-commentary-hospital-pharmacists-roles-and-responsibilities-with-car-t-medicines/ 2024-08-16T11:09:14+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/02/HPE-GettyImages-1176637281.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/scientists-show-how-the-complex-cancer-landscape-varies-between-and-within-tumours/ 2024-08-16T11:10:09+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/02/HPE-GettyImages-1180568434.jpg https://hospitalpharmacyeurope.com/clinical-zones/neurology/promising-molecule-offers-hope-for-a-treatment-that-could-stop-or-slow-parkinsons/ 2024-08-16T11:10:25+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/02/HPE-GettyImages-1125856520.jpg https://hospitalpharmacyeurope.com/in-depth/views/drinking-tea-a-simple-health-intervention-that-is-largely-ignored/ 2024-08-16T11:10:51+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/02/HPE-GettyImages-183870186.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/scottish-medicines-consortium-says-yes-to-targeted-combination-therapy/ 2024-08-16T11:11:27+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/02/HPE-GettyImages-1085157836-2.jpg https://hospitalpharmacyeurope.com/clinical-zones/paediatrics/children-with-adhd-more-likely-to-receive-medication-if-they-live-in-poorer-areas/ 2024-08-16T11:12:41+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/02/HPE-GettyImages-1181567582.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/vaccine-could-boost-the-effectiveness-of-cancer-immunotherapy/ 2024-08-16T11:13:19+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/02/HPE-GettyImages-1168199832.jpg https://hospitalpharmacyeurope.com/in-depth/views/vitamin-d-and-calcium-for-fracture-prevention-how-robust-is-the-evidence/ 2024-08-16T11:13:50+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/02/HPE-GettyImages-819647362.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/pancreatic-cancer-survival-rate-increases-but-still-the-lowest-of-all-major-cancers/ 2024-08-16T11:14:06+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/02/HPE-GettyImages-821903334.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/survey-indicate-gaps-in-cancer-risk-awareness-between-higher-and-lower-socioeconomic-groups/ 2024-08-16T11:14:20+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/02/HPE-GettyImages-946699738.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/positive-opinion-for-venetoclax-combination-in-previously-untreated-cll/ 2024-08-16T11:18:04+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/02/HPE-GettyImages-1182926623.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/formal-recommendation-on-early-screening-for-lung-cancer-in-scotland-acknowledged/ 2024-08-16T11:18:46+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/02/HPE-GettyImages-139539366.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/study-finds-that-highly-innovative-drugs-take-longer-to-reach-nhs-patients-than-more-conventional-treatments/ 2024-08-16T11:21:08+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/01/HPE-GettyImages-944882704.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/latest-approval-for-apalutamide-could-benefit-a-population-of-more-than-100000-people/ 2024-08-16T11:23:30+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/01/HPE-GettyImages-516185934.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/new-treatment-kills-infection-that-can-be-deadly-to-cystic-fibrosis-patients/ 2024-08-16T11:24:18+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/01/HPE-GettyImages-831149000.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/people-in-england-could-miss-out-on-early-bowel-cancer-screening/ 2024-08-16T11:24:53+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/01/HPE-GettyImages-1168181180.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/shortness-of-breath-and-cough-as-potential-predictors-of-lung-cancer/ 2024-08-16T11:25:17+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/01/HPE-GettyImages-1183311083.jpg https://hospitalpharmacyeurope.com/clinical-zones/mental-health/poor-mental-health-both-cause-and-effect-of-school-exclusion/ 2024-08-16T11:25:28+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/01/HPE-GettyImages-502573906.jpg https://hospitalpharmacyeurope.com/in-depth/views/catching-up-with-cannabis/ 2024-08-16T11:25:36+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/01/HPE-GettyImages-1070574788.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/immune-cell-health-and-optimising-cancer-therapies/ 2024-08-16T11:26:04+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/01/HPE-GettyImages-1163687230.jpg https://hospitalpharmacyeurope.com/clinical-zones/dermatology/sunbed-use-and-melanoma-is-there-really-a-link/ 2024-08-16T11:26:34+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/01/HPE-GettyImages-1060201294.jpg https://hospitalpharmacyeurope.com/reviews-research/developing-medicines-pictogram-stickers-via-feedback-from-the-pharmacy-patient-forum-group/ 2024-08-16T11:27:15+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/01/HPE-Ishrat_Hospital.jpg https://hospitalpharmacyeurope.com/reviews-research/environmental-monitoring-programmes-suitable-for-sterile-compounding/ 2024-08-16T11:27:33+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/01/HPE-930_H0C0503_5616x3744.jpg https://hospitalpharmacyeurope.com/in-depth/views/opinion-comment/what-next-for-dupilumab/ 2024-08-16T11:28:49+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/01/Speechbubble_GettyImages_1017048820_965x500px.jpg https://hospitalpharmacyeurope.com/news/study-shows-pharmacists-positively-influence-hospital-care-transitions/ 2024-08-16T11:31:10+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/12/HPE-GettyImages-522305556.jpg https://hospitalpharmacyeurope.com/in-depth/views/opinion-comment/the-ebmt-pharmacist-committee/ 2024-08-16T11:31:21+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/12/pharmacist_committee_GettyImages_157479983_965x500px.jpg https://hospitalpharmacyeurope.com/news/expanded-line-of-auxiliary-labels-for-neuromuscular-blocking-agents-announced/ 2024-08-16T11:32:34+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/12/HPE-PRD2019-NeuromuscularBlockingAgentWarningLabel-MINI-02.jpg https://hospitalpharmacyeurope.com/wp-content/uploads/2019/12/HHE-PRD2019-NeuromuscularBlockingAgentWarningLabelButterfly-TL-AXC107-01.jpg https://hospitalpharmacyeurope.com/news/pharmacy-service-expected-to-save-nhs-651-million/ 2024-08-16T11:32:52+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/12/HPE-GettyImages-495736665.jpg https://hospitalpharmacyeurope.com/clinical-zones/medicines-safety/three-in-10-british-drug-related-deaths-in-acute-care-due-to-omitted-medicines-research-reveals/ 2024-08-16T11:45:10+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/07/CNS-1.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/new-cancer-drugs-taking-longer-for-nhs-patients-to-access/ 2024-08-16T11:45:34+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/08/Oncology-1.jpg https://hospitalpharmacyeurope.com/news/uk-health-data-research-alliance-formed-to-support-future-medical-research/ 2024-08-16T11:46:37+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2002/06/Conference-report-2.jpg https://hospitalpharmacyeurope.com/clinical-zones/immunology/make-vegetarian-and-vegan-alternatives-to-vaccines-charity-urges/ 2024-08-16T11:47:39+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2018/01/HPE-single-use-device.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/a-revolution-in-the-diagnosis-of-prostate-cancer/ 2024-08-16T13:24:50+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/11/HPE-GettyImages-466222852.jpg https://hospitalpharmacyeurope.com/in-depth/views/expert-view-status-epilepticus-treatment-should-be-fast-well-dosed-and-with-the-right-drugs/ 2024-08-16T13:26:09+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/11/HPE-GettyImages-1124398452.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/prostate-cancer-super-responders-benefit-from-immunotherapy/ 2024-08-16T13:26:31+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/11/HPE-GettyImages-1162086466.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/pharmacist-led-interventions-may-be-pivotal-in-preventing-cv-disease/ 2024-08-16T13:28:05+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/11/HPE-GettyImages-1150732840.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/expert-view-prioritising-pancreatic-cancer/ 2024-08-16T13:29:17+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/11/HPE-GettyImages-1136507405.jpg https://hospitalpharmacyeurope.com/wp-content/uploads/2019/11/HHE-Pancreatic-Cancer-2.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/immunotherapy-combined-with-a-vegf-inhibitor-improves-survival-in-hcc/ 2024-08-16T13:30:09+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/11/HPE-GettyImages-1094961588.jpg https://hospitalpharmacyeurope.com/clinical-zones/neurology/novartis-receives-positive-chmp-opinion-for-mayzent/ 2024-08-16T13:32:49+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/11/HPE-GettyImages-1175284545.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/ec-approves-combination-therapy-for-transplant-ineligible-multiple-myeloma/ 2024-08-16T13:34:26+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/11/HPE-GettyImages-680297890.jpg https://hospitalpharmacyeurope.com/clinical-zones/international-hiv-experts-call-for-focus-on-quality-of-life-beyond-viral-suppression/ 2024-08-16T13:34:45+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/11/HPE-GettyImages-918202038.jpg https://hospitalpharmacyeurope.com/news/nice-recommends-elmiron-for-bladder-pain-syndrome/ 2024-08-16T13:35:09+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/11/HPE-GettyImages-612751364.jpg https://hospitalpharmacyeurope.com/clinical-zones/rheumatology/biologics-offer-similar-disease-activity-improvement-in-elderly-and-early-onset-ra/ 2024-08-16T13:40:09+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/11/HPE-GettyImages-185240496.jpg https://hospitalpharmacyeurope.com/news/ukcpa-announces-winner-of-2019-lifetime-achievement-award/ 2024-08-16T13:40:31+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/11/HPE-GettyImages-1059170602.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/vitamin-d-reduces-the-aggression-in-melanoma-cells/ 2024-08-16T13:42:51+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/11/HPE_GettyImages-1048156970.jpg https://hospitalpharmacyeurope.com/news/uk-trust-first-to-provide-breakthrough-treatment-for-rare-eye-condition/ 2024-08-16T13:43:51+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/11/HPE-GettyImages-690010234.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/therapy-has-the-potential-to-be-the-first-chemotherapy-free-targeted-regimen-for-advanced-colorectal-cancer/ 2024-08-16T13:44:23+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/11/HPE-GettyImages-1168179699.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/dupilumab-approved-in-the-eu-for-severe-chronic-rhinosinusitis-with-nasal-polyposis/ 2024-08-16T13:46:18+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/10/HHE-GettyImages-468447670.jpg https://hospitalpharmacyeurope.com/clinical-zones/rheumatology/potential-new-target-for-treatment-of-gout/ 2024-08-16T13:46:49+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/10/Gout-GettyImages-487244380.jpg https://hospitalpharmacyeurope.com/clinical-zones/paediatrics/potential-treatment-for-peanut-allergy-protects-but-does-not-cure/ 2024-08-16T13:47:18+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/10/POIT-GettyImages-470321660.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/algorithm-helps-predict-which-cancer-patients-benefit-from-immunotherapy/ 2024-08-16T13:47:53+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/10/Immunotherapy-algorithm.jpg https://hospitalpharmacyeurope.com/in-depth/views/opinion-comment/drug-stability-in-the-clinical-environment/ 2024-08-16T13:48:44+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/10/Stability.jpg https://hospitalpharmacyeurope.com/reviews-research/managing-bone-and-joint-infections-in-rheumatological-disease/ 2024-08-16T13:49:36+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/10/rheumatological_disease_GettyImages_969556658_965x500px.jpg https://hospitalpharmacyeurope.com/reviews-research/long-term-macrolides-in-respiratory-care/ 2024-08-16T13:50:11+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/10/respiratory_care_GettyImages_681689612_965x500px.jpg https://hospitalpharmacyeurope.com/reviews-research/screening-and-early-detection-of-lung-cancer/ 2024-08-16T13:50:34+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/10/cancer_cells_GettyImages_1097423942_965x500px.jpg https://hospitalpharmacyeurope.com/news/optima-trial-data-presented-at-2019-chest-meeting/ 2024-08-16T13:51:21+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/10/Macitentan-OPTIMA.jpg https://hospitalpharmacyeurope.com/in-depth/views/opinion-comment/sun-safety/ 2024-08-16T13:52:56+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/10/Sun-safety.jpg https://hospitalpharmacyeurope.com/in-depth/views/opinion-comment/heralding-a-new-era-in-specialty-pharmacy-practice/ 2024-08-16T13:53:39+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/10/CAR-T-cell.jpg https://hospitalpharmacyeurope.com/clinical-zones/subcutaneous-formulation-of-infliximab-has-the-potential-to-change-the-way-patients-manage-their-ibd/ 2024-08-16T13:54:50+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/10/Infliximab.jpg https://hospitalpharmacyeurope.com/news/insomnia-drug-trialled-in-alcohol-use-disorder/ 2024-08-16T13:55:10+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/10/Suvorexant.jpg https://hospitalpharmacyeurope.com/reviews-research/optimising-and-strengthening-capacity-in-ibd-pharmacy/ 2024-08-16T13:56:08+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/10/Rope_knot_GettyImages_641133436_965x500px.jpg https://hospitalpharmacyeurope.com/reviews-research/the-heavy-human-cost-of-medication-errors/ 2024-08-16T13:56:31+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/10/hospital_pharmacy_GettyImages_185105134_965x500px.jpg https://hospitalpharmacyeurope.com/clinical-zones/gastroenterology/late-breaking-stelara-data-presented-at-uegw-congress/ 2024-08-16T13:57:15+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/10/Stelara-late-breaking.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/chmp-grants-positive-opinion-for-expanded-use-of-darzalex/ 2024-08-16T13:58:14+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/10/Darzalex.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/pioneering-oral-treatment-for-myeloma-receives-green-light-from-nice/ 2024-08-16T13:59:07+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/01/Pioneering-oral-treatment-for-myeloma-receives-green-light-from-NICE.jpg https://hospitalpharmacyeurope.com/clinical-zones/research-identifies-cause-of-ibs-pain-as-gut-itch/ 2024-08-16T14:09:25+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/10/IBS-gut-itch.jpg https://hospitalpharmacyeurope.com/clinical-zones/medicines-safety/sponsored-qimono-cstd-system-protects-healthcare-professionals-from-chemical-contamination/ 2024-08-16T14:09:55+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/10/vygon_image_GettyImages_1177326450_965x500px.jpg https://hospitalpharmacyeurope.com/clinical-zones/bimekizumab-phase-iii-study-meets-all-endpoints/ 2024-08-16T14:10:01+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/10/BeVIVID.jpg https://hospitalpharmacyeurope.com/clinical-zones/need-to-improve-easy-access-to-hiv-pre-exposure-prophylaxis/ 2024-08-16T14:10:51+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/10/PrEP.jpg https://hospitalpharmacyeurope.com/clinical-zones/haematology/european-results-from-global-etna-af-registry-presented/ 2024-08-16T14:11:39+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/10/ETNA.jpg https://hospitalpharmacyeurope.com/clinical-zones/common-denominator-that-triggers-allergic-sensitisation-and-asthma-identified/ 2024-08-16T14:11:56+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/10/GettyImages-1060623978.jpg https://hospitalpharmacyeurope.com/news/uk-government-acts-to-combat-antidepressant-shortages/ 2024-08-16T14:13:30+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/10/Prozac-1.jpg